CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: nucleoside analogue
Accession: CHEBI:60783
browse the term
Definition: An analogue of a nucleoside, being an N-glycosyl compound in which the nitrogen-containing moiety is a modified nucleotide base. They are commonly used as antiviral products to prevent viral replication in infected cells.
Synonyms: related_synonym: nucleoside analogues
G
Acta2
actin alpha 2, smooth muscle
multiple interactions
ISO
Azacitidine inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]
CTD
PMID:22841775
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif, 1
decreases expression
ISO
Azacitidine results in decreased expression of ADAMTS1 mRNA
CTD
PMID:20823114
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
G
Adrb1
adrenoceptor beta 1
affects expression
ISO
Azacitidine affects the expression of ADRB1 mRNA
CTD
PMID:19002953
NCBI chr 1:255,771,962...255,774,973
Ensembl chr 1:255,771,597...255,807,259
G
Adrb2
adrenoceptor beta 2
affects expression multiple interactions
ISO
Azacitidine affects the expression of ADRB2 mRNA Azacitidine inhibits the reaction [Particulate Matter results in decreased expression of ADRB2 mRNA]
CTD
PMID:19002953 PMID:30986742
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
G
Afp
alpha-fetoprotein
increases expression
ISO
Azacitidine results in increased expression of AFP mRNA
CTD
PMID:27590069
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
G
Aggf1
angiogenic factor with G patch and FHA domains 1
increases expression
ISO
Azacitidine results in increased expression of AGGF1 mRNA
CTD
PMID:19194470
NCBI chr 2:26,619,336...26,646,050
Ensembl chr 2:26,619,339...26,645,952
G
Ahr
aryl hydrocarbon receptor
increases expression multiple interactions
ISO
Azacitidine results in increased expression of AHR mRNA [Azacitidine co-treated with Butyrates] inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene promotes the reaction [AHR protein binds to CYP1A1 promoter]]]; Azacitidine inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene promotes the reaction [AHR protein binds to CYP1A1 promoter]]]
CTD
PMID:12927368 PMID:17682057
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Ak5
adenylate kinase 5
increases expression
ISO
Azacitidine results in increased expression of AK5 mRNA
CTD
PMID:20823114
NCBI chr 2:241,397,297...241,581,483
Ensembl chr 2:241,397,297...241,581,458
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
ISO
Azacitidine inhibits the reaction [TGFB1 protein results in increased phosphorylation of AKT1 protein]
CTD
PMID:22841775
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Alad
aminolevulinate dehydratase
decreases expression
ISO
Azacitidine results in decreased expression of ALAD mRNA
CTD
PMID:19194470
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
G
Alb
albumin
decreases expression increases expression
ISO
Azacitidine results in decreased expression of ALB protein Azacitidine results in increased expression of ALB mRNA
CTD
PMID:27590069
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Aldh3a1
aldehyde dehydrogenase 3 family, member A1
multiple interactions
ISO
[Azacitidine co-treated with Butyrates] inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of ALDH3A1 mRNA]]; Azacitidine inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of ALDH3A1 mRNA]]
CTD
PMID:17682057
NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
G
Andpro
androgen regulated protein
increases expression
ISO
Azacitidine results in increased expression of CST4 mRNA
CTD
PMID:20823114
NCBI chr 3:136,718,601...136,725,131
Ensembl chr 3:136,718,602...136,724,966
G
Anxa1
annexin A1
decreases expression
EXP
Azacitidine results in decreased expression of ANXA1 protein
CTD
PMID:17105402
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
App
amyloid beta precursor protein
decreases methylation multiple interactions
ISO
Azacitidine results in decreased methylation of APP promoter Azacitidine results in increased expression of and results in increased cleavage of APP protein; Betaine inhibits the reaction [Azacitidine results in decreased methylation of APP promoter]; Betaine inhibits the reaction [Azacitidine results in increased expression of and results in increased cleavage of APP protein]
CTD
PMID:19635394
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Aqp5
aquaporin 5
decreases methylation increases expression multiple interactions
ISO
Azacitidine results in decreased methylation of AQP5 promoter Azacitidine results in increased expression of AQP5 protein [Azacitidine results in decreased methylation of AQP5 promoter] which results in increased expression of AQP5 mRNA; Azacitidine promotes the reaction [SP1 protein binds to AQP5 promoter]
CTD
PMID:17198683
NCBI chr 7:130,722,675...130,726,207
Ensembl chr 7:130,721,748...130,726,209
G
Aqp9
aquaporin 9
multiple interactions increases expression
ISO
[Azacitidine results in increased expression of AQP9 mRNA] which results in increased uptake of arsenic trioxide; HNF1A mutant form inhibits the reaction [Azacitidine results in increased expression of AQP9 mRNA]
CTD
PMID:25953102
NCBI chr 8:71,797,231...71,837,485
Ensembl chr 8:71,797,234...71,837,395
G
Ar
androgen receptor
multiple interactions increases expression
ISO
[Azacitidine analog results in increased expression of AR protein] which results in increased susceptibility to bicalutamide; [Azacitidine analog results in increased expression of AR protein] which results in increased susceptibility to Dihydrotestosterone
CTD
PMID:18324645
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Arhgap35
Rho GTPase activating protein 35
increases expression
ISO
Azacitidine results in increased expression of ARHGAP35 mRNA
CTD
PMID:20823114
NCBI chr 1:77,202,436...77,319,298
Ensembl chr 1:77,202,436...77,319,298
G
Arhgef2
Rho/Rac guanine nucleotide exchange factor 2
decreases expression
ISO
Azacitidine results in decreased expression of ARHGEF2 mRNA
CTD
PMID:20823114
NCBI chr 2:174,061,126...174,118,355
Ensembl chr 2:174,062,976...174,118,355
G
Art1
ADP-ribosyltransferase 1
increases expression
ISO
Azacitidine results in increased expression of ART1 mRNA
CTD
PMID:20823114
NCBI chr 1:156,478,096...156,487,172
Ensembl chr 1:156,482,621...156,487,172
G
Asb2
ankyrin repeat and SOCS box-containing 2
increases expression
ISO
Azacitidine results in increased expression of ASB2 mRNA
CTD
PMID:20823114
NCBI chr 6:122,474,754...122,511,014
Ensembl chr 6:122,474,756...122,510,854
G
Atp2b1
ATPase plasma membrane Ca2+ transporting 1
decreases expression
ISO
Azacitidine results in decreased expression of ATP2B1 mRNA
CTD
PMID:20823114
NCBI chr 7:33,735,595...33,845,226
Ensembl chr 7:33,735,871...33,843,295
G
Atp6v0c
ATPase H+ transporting V0 subunit C
increases expression
ISO
Azacitidine results in increased expression of ATP6V0C mRNA
CTD
PMID:20823114
NCBI chr10:13,196,204...13,202,580
Ensembl chr10:13,196,204...13,201,500
G
Aurka
aurora kinase A
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of AURKA mRNA
CTD
PMID:18720364
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
G
Bad
BCL2-associated agonist of cell death
increases expression multiple interactions
EXP
Azacitidine results in increased expression of BAD mRNA [Azacitidine co-treated with entinostat] results in increased expression of BAD mRNA
CTD
PMID:21224363
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bak1
BCL2-antagonist/killer 1
multiple interactions increases expression
EXP
[Azacitidine co-treated with entinostat] results in increased expression of BAK1 mRNA Azacitidine results in increased expression of BAK1 mRNA
CTD
PMID:21224363
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions increases expression
ISO
Bleomycin inhibits the reaction [Azacitidine results in increased expression of BAX mRNA]
CTD
PMID:32278510
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcat1
branched chain amino acid transaminase 1
decreases expression
ISO
Azacitidine results in decreased expression of BCAT1 mRNA
CTD
PMID:20823114
NCBI chr 4:177,964,834...178,046,573
Ensembl chr 4:177,964,834...178,046,597
G
Bcl2
BCL2, apoptosis regulator
multiple interactions decreases expression
ISO
Bleomycin inhibits the reaction [Azacitidine results in decreased expression of BCL2 mRNA]; Bleomycin inhibits the reaction [Azacitidine results in decreased expression of BCL2 protein] Azacitidine results in decreased expression of BCL2 mRNA; Azacitidine results in decreased expression of BCL2 protein
CTD
PMID:32278510
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
multiple interactions affects expression
ISO
[metacept-1 co-treated with Azacitidine] results in decreased expression of BCL2L1 [Azacitidine affects the expression of IL6R protein] which affects the expression of BCL2L1 protein
CTD
PMID:18443271 PMID:19148494
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Bcl2l13
Bcl2-like 13
increases expression
ISO
Azacitidine results in increased expression of BCL2L13 mRNA
CTD
PMID:20823114
NCBI chr 4:154,056,116...154,112,890
Ensembl chr 4:154,056,127...154,108,985
G
Bdnf
brain-derived neurotrophic factor
increases expression decreases methylation multiple interactions
ISO
Azacitidine results in increased expression of BDNF mRNA Azacitidine results in decreased methylation of BDNF promoter Tetrodotoxin inhibits the reaction [Azacitidine results in decreased methylation of BDNF promoter]; Tetrodotoxin inhibits the reaction [Azacitidine results in increased expression of BDNF mRNA]
CTD
PMID:18184782
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Bglap
bone gamma-carboxyglutamate protein
decreases expression
EXP
Azacitidine results in decreased expression of BGLAP protein
CTD
PMID:18037191
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
G
Bicd1
BICD cargo adaptor 1
decreases expression
ISO
Azacitidine results in decreased expression of BICD1 mRNA
CTD
PMID:20823114
NCBI chr 4:182,479,071...182,631,504
Ensembl chr 4:182,479,071...182,627,434
G
Bik
BCL2-interacting killer
multiple interactions increases expression
EXP
[Azacitidine co-treated with entinostat] results in increased expression of BIK mRNA Azacitidine results in increased expression of BIK mRNA
CTD
PMID:21224363
NCBI chr 7:114,672,277...114,691,296
Ensembl chr 7:114,672,277...114,691,296
G
Bmp15
bone morphogenetic protein 15
increases expression
ISO
Azacitidine results in increased expression of BMP15 mRNA
CTD
PMID:23395740
NCBI chr X:16,169,123...16,174,187
Ensembl chr X:16,169,123...16,174,187
G
Bnip3
BCL2 interacting protein 3
increases expression
ISO
Azacitidine results in increased expression of BNIP3 mRNA
CTD
PMID:25446377
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
G
Bok
BCL2 family apoptosis regulator BOK
multiple interactions increases expression
EXP
[Azacitidine co-treated with entinostat] results in increased expression of BOK mRNA Azacitidine results in increased expression of BOK mRNA
CTD
PMID:21224363
NCBI chr 9:94,223,493...94,234,476
Ensembl chr 9:94,223,389...94,234,476
G
Bub1b
BUB1 mitotic checkpoint serine/threonine kinase B
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of BUB1B mRNA
CTD
PMID:18720364
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
G
C17h6orf62
similar to human chromosome 6 open reading frame 62
increases expression
ISO
Azacitidine results in increased expression of C6ORF62 mRNA
CTD
PMID:19194470
NCBI chr17:40,256,211...40,267,851
Ensembl chr17:40,256,211...40,276,020
G
C3ar1
complement C3a receptor 1
increases expression
ISO
Azacitidine results in increased expression of C3AR1 mRNA
CTD
PMID:19194470
NCBI chr 4:156,074,747...156,084,680
Ensembl chr 4:156,075,389...156,084,701
G
Calca
calcitonin-related polypeptide alpha
decreases methylation
ISO
Azacitidine results in decreased methylation of CALCA promoter
CTD
PMID:19299654
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
G
Cald1
caldesmon 1
increases expression
ISO
Azacitidine results in increased expression of CALD1 mRNA
CTD
PMID:20823114
NCBI chr 4:63,265,781...63,446,938
Ensembl chr 4:63,265,942...63,446,932
G
Calhm2
calcium homeostasis modulator family member 2
increases expression multiple interactions
ISO
Azacitidine results in increased expression of CALHM2 mRNA Cisplatin affects the reaction [Azacitidine results in increased expression of CALHM2 mRNA]
CTD
PMID:36336710
NCBI chr 1:246,022,324...246,028,050
Ensembl chr 1:246,022,324...246,028,218
G
Casp3
caspase 3
affects expression increases activity increases expression multiple interactions
ISO
Azacitidine affects the expression of CASP3 protein 5-azacytidine co-treated with doxorubicin increases activity of CASP3 protein in lung cancer cells Azacitidine results in increased expression of CASP3 mRNA [metacept-1 co-treated with Azacitidine] results in increased expression of CASP3
CTD RGD
PMID:18443271 PMID:19148494 PMID:23395740 PMID:24356455
RGD:153344603
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
increases expression
ISO
Azacitidine results in increased expression of CASP8 mRNA
CTD
PMID:18082045 PMID:23395740
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases expression
ISO
Azacitidine results in increased expression of CASP9 mRNA
CTD
PMID:23395740
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ccna1
cyclin A1
multiple interactions decreases expression
ISO
Azacitidine inhibits the reaction [MECP2 protein binds to CCNA1 promoter]; Azacitidine promotes the reaction [H3-4 protein modified form binds to CCNA1 promoter]; Azacitidine promotes the reaction [H4C16 protein modified form binds to CCNA1 promoter] Azacitidine results in decreased expression of CCNA1 mRNA
CTD
PMID:17698632
NCBI chr 2:139,231,738...139,278,066
Ensembl chr 2:139,201,074...139,243,157
G
Ccna2
cyclin A2
multiple interactions decreases expression
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of CCNA2 mRNA Azacitidine results in decreased expression of CCNA2 mRNA
CTD
PMID:18720364 PMID:20823114
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb1
cyclin B1
multiple interactions increases expression
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of CCNB1 mRNA Azacitidine results in increased expression of CCNB1 protein
CTD
PMID:18720364 PMID:20607034
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccnd1
cyclin D1
increases expression
ISO
Azacitidine results in increased expression of CCND1 mRNA
CTD
PMID:20823114
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccnd2
cyclin D2
affects methylation multiple interactions
ISO
Azacitidine affects the methylation of CCND2 promoter [Azacitidine affects the methylation of CCND2 promoter] which affects the expression of CCND2 mRNA
CTD
PMID:17016690
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
G
Ccng2
cyclin G2
decreases expression
ISO
Azacitidine results in decreased expression of CCNG2 mRNA
CTD
PMID:21245298
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
G
Cd274
CD274 molecule
multiple interactions
ISO
Azacitidine inhibits the reaction [Oleanolic Acid inhibits the reaction [IL1B protein results in increased expression of CD274 mRNA]]; Azacitidine inhibits the reaction [Oleanolic Acid inhibits the reaction [IL1B protein results in increased expression of CD274 protein]]
CTD
PMID:32894642
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
G
Cdc20
cell division cycle 20
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of CDC20 mRNA
CTD
PMID:18720364
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
G
Cdc42bpa
CDC42 binding protein kinase alpha
decreases expression
ISO
Azacitidine results in decreased expression of CDC42BPA mRNA
CTD
PMID:20823114
NCBI chr13:91,683,775...91,903,732
Ensembl chr13:91,684,007...91,903,732
G
Cdh1
cadherin 1
decreases methylation increases expression
ISO
Azacitidine results in decreased methylation of CDH1 promoter Azacitidine results in increased expression of CDH1 mRNA
CTD
PMID:17520682
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cdh2
cadherin 2
increases expression
EXP
Azacitidine results in increased expression of CDH2 mRNA
CTD
PMID:18037191
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
G
Cdk1
cyclin-dependent kinase 1
multiple interactions increases expression
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of CDK1 mRNA Azacitidine analog results in increased expression of CDK1 protein
CTD
PMID:18324645 PMID:18720364
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
G
Cdk2
cyclin dependent kinase 2
decreases expression
ISO
Azacitidine analog results in decreased expression of CDK2 protein
CTD
PMID:18324645
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
G
Cdk4
cyclin-dependent kinase 4
decreases expression
ISO
Azacitidine analog results in decreased expression of CDK4 protein
CTD
PMID:18324645
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression multiple interactions
ISO EXP
Azacitidine analog results in increased expression of CDKN1A protein; Azacitidine results in increased expression of CDKN1A mRNA [Azacitidine co-treated with entinostat] results in increased expression of CDKN1A mRNA; Azacitidine inhibits the reaction [potassium bromate results in increased expression of CDKN1A protein] [metacept-1 co-treated with Azacitidine] results in increased expression of CDKN1A
CTD
PMID:18324645 PMID:19148494 PMID:20823114 PMID:21224363 PMID:25015661
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1c
cyclin-dependent kinase inhibitor 1C
increases expression
ISO
Azacitidine results in increased expression of CDKN1C mRNA
CTD
PMID:19194470
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
multiple interactions decreases methylation affects methylation increases expression
EXP ISO
[Azacitidine co-treated with entinostat] results in decreased methylation of CDKN2A gene; [Azacitidine co-treated with entinostat] results in increased expression of CDKN2A mRNA Azacitidine inhibits the reaction [Particulate Matter results in increased methylation of CDKN2A promoter] Hydroxyurea inhibits the reaction [Azacitidine results in decreased methylation of CDKN2A gene] Azacitidine affects the methylation of CDKN2A gene Azacitidine results in increased expression of CDKN2A mRNA
CTD
PMID:17686055 PMID:18443271 PMID:21224363 PMID:22355787
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
decreases methylation multiple interactions affects response to substance
ISO
Azacitidine results in decreased methylation of CDKN2B promoter [metacept-1 co-treated with Azacitidine] results in increased expression of CDKN2B CDKN2B promoter modified form affects the susceptibility to Azacitidine
CTD
PMID:17611569 PMID:19148494 PMID:19194470
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
G
Cebpa
CCAAT/enhancer binding protein alpha
decreases methylation increases expression
ISO
Azacitidine results in decreased methylation of CEBPA promoter Azacitidine results in increased expression of CEBPA mRNA
CTD
PMID:19194470 PMID:27590069
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Cenpa
centromere protein A
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of CENPA mRNA
CTD
PMID:18720364
NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675
G
Cenpf
centromere protein F
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of CENPF mRNA
CTD
PMID:18720364
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
G
Cenpo
centromere protein O
increases expression
ISO
Azacitidine results in increased expression of CENPO mRNA
CTD
PMID:19194470
NCBI chr 6:27,203,642...27,218,394
Ensembl chr 6:27,188,537...27,218,314
G
Chat
choline O-acetyltransferase
increases expression
ISO
Azacitidine results in increased expression of CHAT mRNA; Azacitidine results in increased expression of CHAT protein
CTD
PMID:19151599
NCBI chr16:7,657,362...7,717,093
Ensembl chr16:7,657,362...7,717,093
G
Chga
chromogranin A
decreases expression
ISO
Azacitidine results in decreased expression of CHGA protein
CTD
PMID:20607034
NCBI chr 6:121,696,051...121,707,399
Ensembl chr 6:121,696,051...121,707,398
G
Chit1
chitinase 1
increases expression
ISO
Azacitidine results in increased expression of CHIT1 mRNA
CTD
PMID:20823114
NCBI chr13:45,565,841...45,613,593
Ensembl chr13:45,593,845...45,613,592
G
Chrm1
cholinergic receptor, muscarinic 1
affects expression
ISO
Azacitidine affects the expression of CHRM1 mRNA
CTD
PMID:19002953
NCBI chr 1:205,567,226...205,583,001
Ensembl chr 1:205,567,220...205,582,356
G
Chrm2
cholinergic receptor, muscarinic 2
affects expression
ISO
Azacitidine affects the expression of CHRM2 mRNA
CTD
PMID:19002953
NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
G
Chst14
carbohydrate sulfotransferase 14
increases expression
EXP
Azacitidine results in increased expression of CHST14 mRNA
CTD
PMID:27415467
NCBI chr 3:105,916,481...105,918,538
Ensembl chr 3:105,916,466...105,918,548
G
Ciita
class II, major histocompatibility complex, transactivator
multiple interactions increases expression
ISO
[Azacitidine promotes the reaction [IFNG protein results in increased expression of CIITA mRNA]] which results in increased expression of HLA-DRA protein; [Azacitidine results in decreased methylation of CIITA promoter] promotes the reaction [IFNG protein results in increased expression of CIITA mRNA] Azacitidine results in increased expression of CIITA mRNA
CTD
PMID:18829986 PMID:20823114
NCBI chr10:5,139,947...5,187,493
Ensembl chr10:5,140,178...5,187,440
G
Cldn10
claudin 10
decreases expression
ISO
Azacitidine results in decreased expression of CLDN10 mRNA
CTD
PMID:19194470
NCBI chr15:95,862,785...95,954,526
Ensembl chr15:95,862,760...95,954,526
G
Cldn6
claudin 6
increases expression decreases methylation multiple interactions
ISO
Azacitidine results in increased expression of CLDN6 mRNA Azacitidine results in decreased methylation of CLDN6 promoter [trichostatin A co-treated with Azacitidine] results in decreased methylation of CLDN6 promoter
CTD
PMID:18661270
NCBI chr10:12,710,302...12,713,987
Ensembl chr10:12,709,960...12,715,973
G
Cldn7
claudin 7
multiple interactions decreases expression
ISO
Cisplatin affects the reaction [Azacitidine results in decreased expression of CLDN7 mRNA]
CTD
PMID:36336710
NCBI chr10:54,689,684...54,692,177
Ensembl chr10:54,689,987...54,692,171
G
Cldn8
claudin 8
increases expression
ISO
Azacitidine results in increased expression of CLDN8 mRNA
CTD
PMID:18661270
NCBI chr11:27,875,857...27,878,106
Ensembl chr11:27,875,692...27,878,513
G
Cldn9
claudin 9
decreases methylation multiple interactions increases expression
ISO
Azacitidine results in decreased methylation of CLDN9 promoter [trichostatin A co-treated with Azacitidine] results in decreased methylation of CLDN9 promoter Azacitidine results in increased expression of CLDN9 mRNA
CTD
PMID:18661270
NCBI chr10:12,714,137...12,715,568
G
Cnnm2
cyclin and CBS domain divalent metal cation transport mediator 2
decreases expression
ISO
Azacitidine results in decreased expression of CNNM2 mRNA
CTD
PMID:19194470
NCBI chr 1:245,643,682...245,769,542
Ensembl chr 1:245,643,768...245,763,286
G
Col14a1
collagen type XIV alpha 1 chain
increases expression
ISO
Azacitidine results in increased expression of COL14A1 mRNA
CTD
PMID:19194470
NCBI chr 7:86,722,093...86,937,215
Ensembl chr 7:86,722,094...86,937,214
G
Col1a1
collagen type I alpha 1 chain
multiple interactions
ISO
Azacitidine inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]; Azacitidine inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein]
CTD
PMID:22841775
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Col6a3
collagen type VI alpha 3 chain
decreases expression
ISO
Azacitidine results in decreased expression of COL6A3 mRNA
CTD
PMID:20823114
NCBI chr 9:91,361,578...91,439,434
Ensembl chr 9:91,361,583...91,439,471
G
Col9a3
collagen type IX alpha 3 chain
decreases expression
ISO
Azacitidine results in decreased expression of COL9A3 mRNA
CTD
PMID:18033690
NCBI chr 3:167,711,776...167,734,468
Ensembl chr 3:167,711,840...167,734,465
G
Cox6a2
cytochrome c oxidase subunit 6A2
increases expression
ISO
Azacitidine results in increased expression of COX6A2 mRNA
CTD
PMID:20823114
NCBI chr 1:182,788,528...182,790,746
Ensembl chr 1:182,788,528...182,789,274
G
Cpe
carboxypeptidase E
increases expression
ISO
Azacitidine results in increased expression of CPE mRNA
CTD
PMID:20823114
NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233
G
Cplx1
complexin 1
increases expression
ISO
Azacitidine results in increased expression of CPLX1 mRNA
CTD
PMID:20823114
NCBI chr14:1,184,677...1,216,392
G
Creb1
cAMP responsive element binding protein 1
multiple interactions
ISO
Azacitidine promotes the reaction [CREB1 protein modified form binds to PPP2CA promoter]
CTD
PMID:19155497
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Creb3l4
cAMP responsive element binding protein 3-like 4
increases expression
EXP
Azacitidine results in increased expression of CREB3L4 mRNA
CTD
PMID:27415467
NCBI chr 2:175,690,340...175,695,846
Ensembl chr 2:175,690,335...175,695,932
G
Crem
cAMP responsive element modulator
decreases expression
ISO
Azacitidine results in decreased expression of CREM mRNA
CTD
PMID:20823114
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
G
Cryaa
crystallin, alpha A
increases expression
EXP
Azacitidine results in increased expression of CRYAA protein
CTD
PMID:17105402
NCBI chr20:9,783,605...9,787,351
Ensembl chr20:9,783,605...9,787,349
G
Cryab
crystallin, alpha B
increases expression
EXP
Azacitidine results in increased expression of CRYAB protein
CTD
PMID:17105402
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
G
Csf1
colony stimulating factor 1
increases expression
EXP
Azacitidine results in increased expression of CSF1 mRNA
CTD
PMID:17156202
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
G
Csn1s1
casein alpha s1
increases expression
ISO
Azacitidine results in increased expression of CSN1S1 mRNA
CTD
PMID:20823114
NCBI chr14:20,343,620...20,359,614
Ensembl chr14:20,343,619...20,359,614
G
Cst3
cystatin C
increases expression
ISO
Azacitidine results in increased expression of CST3 mRNA
CTD
PMID:20823114
NCBI chr 3:136,336,923...136,340,796
Ensembl chr 3:136,336,920...136,340,822
G
Cxcl12
C-X-C motif chemokine ligand 12
decreases methylation increases expression
ISO
Azacitidine results in decreased methylation of CXCL12 promoter Azacitidine results in increased expression of CXCL12 mRNA; Azacitidine results in increased expression of CXCL12 protein
CTD
PMID:19748759
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions increases expression
ISO
Azacitidine promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; Azacitidine promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] [Azacitidine co-treated with Butyrates] inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene promotes the reaction [AHR protein binds to CYP1A1 promoter]]]; [Azacitidine co-treated with Butyrates] inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]]; Azacitidine inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene promotes the reaction [AHR protein binds to CYP1A1 promoter]]]; Azacitidine inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]] Azacitidine results in increased expression of CYP1A1 mRNA
CTD
PMID:11281733 PMID:12927368 PMID:17682057 PMID:27590069
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions increases expression
ISO
Azacitidine promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] Azacitidine results in increased expression of CYP1A2 mRNA
CTD
PMID:12927368
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
multiple interactions increases expression
ISO
Azacitidine promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] Azacitidine results in increased expression of CYP1B1 mRNA
CTD
PMID:12927368 PMID:27590069
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases expression
ISO
Azacitidine results in increased expression of CYP3A4 mRNA
CTD
PMID:27590069
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyth1
cytohesin 1
increases expression
ISO
Azacitidine results in increased expression of CYTH1 mRNA
CTD
PMID:19194470
NCBI chr10:103,402,727...103,485,826
Ensembl chr10:103,366,145...103,485,760
G
Dapk1
death associated protein kinase 1
affects methylation
ISO
Azacitidine affects the methylation of DAPK1 promoter
CTD
PMID:17557868
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
G
Dcn
decorin
multiple interactions decreases expression
ISO
Azacitidine promotes the reaction [[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of DCN protein] Azacitidine results in decreased expression of DCN mRNA
CTD
PMID:20823114
NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
G
Des
desmin
increases expression multiple interactions
EXP ISO
Azacitidine results in increased expression of DES mRNA; Azacitidine results in increased expression of DES protein [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate co-treated with Azacitidine] results in increased expression of DES mRNA
CTD
PMID:18037191 PMID:20823114
NCBI chr 9:76,850,979...76,858,695
Ensembl chr 9:76,850,982...76,858,699
G
Dhx9
DExH-box helicase 9
decreases expression
ISO
Azacitidine results in decreased expression of DHX9 mRNA
CTD
PMID:20823114
NCBI chr13:65,602,322...65,639,098
Ensembl chr13:65,602,323...65,639,069
G
Dio2
iodothyronine deiodinase 2
decreases expression
ISO
Azacitidine results in decreased expression of DIO2 mRNA
CTD
PMID:20823114
NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:109,665,523...109,679,809
G
Dlk1
delta like non-canonical Notch ligand 1
decreases methylation
ISO
Azacitidine results in decreased methylation of DLK1 promoter
CTD
PMID:19194470
NCBI chr 6:128,410,216...128,417,518
Ensembl chr 6:128,410,316...128,417,522
G
Dlx5
distal-less homeobox 5
increases expression
ISO
Azacitidine results in increased expression of DLX5 mRNA
CTD
PMID:17085970
NCBI chr 4:34,999,139...35,003,504
Ensembl chr 4:34,999,139...35,003,407
G
Dlx6
distal-less homeobox 6
increases expression
ISO
Azacitidine results in increased expression of DLX6 mRNA
CTD
PMID:20823114
NCBI chr 4:34,984,264...34,989,926
Ensembl chr 4:34,984,232...34,991,343
G
Dnmt1
DNA methyltransferase 1
multiple interactions decreases expression
ISO EXP
[SLC28A1 protein results in increased uptake of Azacitidine] which results in decreased expression of DNMT1 protein; Arsenic Trioxide promotes the reaction [Azacitidine results in decreased expression of DNMT1 protein]; Azacitidine inhibits the reaction [DNMT1 protein binds to MIR497 promoter] [Azacitidine co-treated with entinostat] results in decreased expression of DNMT1 protein; [Cisplatin co-treated with Azacitidine] results in decreased expression of DNMT1 protein
CTD
PMID:19139132 PMID:19723570 PMID:21224363 PMID:28901456 PMID:35066776
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
G
Dnmt3a
DNA methyltransferase 3 alpha
multiple interactions
ISO
Azacitidine inhibits the reaction [DNMT3A protein binds to MIR497 promoter]
CTD
PMID:35066776
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
G
Dnmt3b
DNA methyltransferase 3 beta
multiple interactions
ISO
Azacitidine inhibits the reaction [DNMT3B protein binds to MIR497 promoter]
CTD
PMID:35066776
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
G
Dpyd
dihydropyrimidine dehydrogenase
decreases methylation multiple interactions decreases response to substance
ISO
Azacitidine results in decreased methylation of DPYD promoter [Azacitidine results in decreased methylation of DPYD promoter] which results in increased expression of DPYD mRNA DPYD protein results in decreased susceptibility to Azacitidine
CTD
PMID:15501990
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
G
Dusp1
dual specificity phosphatase 1
increases expression
ISO
Azacitidine results in increased expression of DUSP1 mRNA
CTD
PMID:20823114
NCBI chr10:16,680,478...16,683,275
G
Dusp6
dual specificity phosphatase 6
increases expression
ISO
Azacitidine results in increased expression of DUSP6 mRNA
CTD
PMID:21245298
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
E2f1
E2F transcription factor 1
multiple interactions
ISO
E2F1 protein affects the reaction [Azacitidine results in decreased activity of TERT protein]; E2F1 protein affects the reaction [Azacitidine results in decreased expression of TERT mRNA]
CTD
PMID:19451745
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
G
Eef1a1
eukaryotic translation elongation factor 1 alpha 1
decreases expression
ISO
Azacitidine results in decreased expression of EEF1A1 mRNA
CTD
PMID:20823114
NCBI chr 8:79,341,554...79,344,784
Ensembl chr 8:79,341,557...79,344,839
G
Efna3
ephrin A3
increases expression
ISO
Azacitidine results in increased expression of EFNA3 mRNA
CTD
PMID:20823114
NCBI chr 2:174,729,192...174,738,111
Ensembl chr 2:174,729,764...174,738,736
G
Egr2
early growth response 2
increases expression
ISO
Azacitidine results in increased expression of EGR2 mRNA
CTD
PMID:20823114
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
G
Eno2
enolase 2
decreases expression
ISO
Azacitidine results in decreased expression of ENO2 protein
CTD
PMID:20607034
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
G
Entpd1
ectonucleoside triphosphate diphosphohydrolase 1
increases expression
ISO
Azacitidine results in increased expression of ENTPD1 mRNA
CTD
PMID:20823114
NCBI chr 1:239,425,515...239,552,323
Ensembl chr 1:239,425,430...239,552,317
G
Esr1
estrogen receptor 1
increases expression
ISO
Azacitidine results in increased expression of ESR1 protein
CTD
PMID:22558281
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Ets1
ETS proto-oncogene 1, transcription factor
multiple interactions
ISO
Azacitidine promotes the reaction [ETS1 protein binds to KIR2DL2 promoter]; Azacitidine promotes the reaction [ETS1 protein binds to KIR2DL4 promoter]
CTD
PMID:18945643
NCBI chr 8:31,045,909...31,168,010
Ensembl chr 8:31,045,945...31,168,010
G
Eya1
EYA transcriptional coactivator and phosphatase 1
decreases expression
ISO
Azacitidine results in decreased expression of EYA1 mRNA
CTD
PMID:20823114
NCBI chr 5:4,863,501...5,101,483
Ensembl chr 5:4,955,543...5,101,483
G
Fads2
fatty acid desaturase 2
decreases expression
ISO
Azacitidine results in decreased expression of FADS2 mRNA
CTD
PMID:20823114
NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
G
Fam8a1
family with sequence similarity 8, member A1
increases expression
ISO
Azacitidine results in increased expression of FAM8A1 mRNA
CTD
PMID:19194470
NCBI chr17:18,026,601...18,035,509
Ensembl chr17:18,026,601...18,035,470
G
Faslg
Fas ligand
increases response to substance
ISO
Azacitidine results in increased susceptibility to FASLG protein
CTD
PMID:18829727
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fbln1
fibulin 1
increases expression
ISO
Azacitidine results in increased expression of FBLN1 mRNA
CTD
PMID:21245298
NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
G
Fen1
flap structure-specific endonuclease 1
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of FEN1 mRNA
CTD
PMID:18720364
NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003
G
Fgf7
fibroblast growth factor 7
decreases expression
ISO
Azacitidine results in decreased expression of FGF7 mRNA
CTD
PMID:20823114
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
G
Filip1l
filamin A interacting protein 1-like
decreases expression
ISO
Azacitidine results in decreased expression of FILIP1L mRNA
CTD
PMID:20823114
NCBI chr11:42,937,353...43,177,085
Ensembl chr11:42,940,467...43,177,415
G
Foxo1
forkhead box O1
multiple interactions
ISO
[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate co-treated with Azacitidine] results in increased expression of FOXO1 mRNA
CTD
PMID:20823114
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
G
Foxp3
forkhead box P3
multiple interactions
ISO
[Azacitidine co-treated with TGFB1 protein] results in increased expression of FOXP3 protein; [Azacitidine results in decreased methylation of FOXP3 gene] which results in increased expression of FOXP3 protein
CTD
PMID:18493985
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
G
Ftl1
ferritin light chain 1
decreases expression
EXP
Azacitidine results in decreased expression of FTL1 protein
CTD
PMID:17105402
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725
G
Fyn
FYN proto-oncogene, Src family tyrosine kinase
increases expression
ISO
Azacitidine results in increased expression of FYN mRNA
CTD
PMID:21245298
NCBI chr20:42,767,733...42,960,903
Ensembl chr20:42,766,369...42,959,911
G
Gabrb1
gamma-aminobutyric acid type A receptor subunit beta1
increases expression
ISO
Azacitidine results in increased expression of GABRB1 mRNA
CTD
PMID:19194470
NCBI chr14:36,068,725...36,548,946
Ensembl chr14:36,080,393...36,548,948
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
decreases methylation multiple interactions increases expression
ISO
Azacitidine results in decreased methylation of GADD45A promoter [Azacitidine results in increased expression of GADD45A protein] which results in increased susceptibility to docetaxel Azacitidine results in increased expression of GADD45A mRNA; Azacitidine results in increased expression of GADD45A protein
CTD
PMID:19190346
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
multiple interactions
ISO
Azacitidine promotes the reaction [Depsipeptides results in increased expression of GADD45B]
CTD
PMID:18225533
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
G
Gata4
GATA binding protein 4
increases expression
EXP
Azacitidine results in increased expression of GATA4 mRNA; Azacitidine results in increased expression of GATA4 protein
CTD
PMID:18037191
NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636
G
Gbp2
guanylate binding protein 2
decreases expression
ISO
Azacitidine results in decreased expression of GBP2 mRNA
CTD
PMID:20823114
NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571
G
Gcnt2
glucosaminyl (N-acetyl) transferase 2
decreases expression
ISO
Azacitidine results in decreased expression of GCNT2 mRNA
CTD
PMID:20823114
NCBI chr17:23,796,859...23,901,625
Ensembl chr17:23,796,859...23,901,611
G
Gdf9
growth differentiation factor 9
increases expression
ISO
Azacitidine results in increased expression of GDF9 mRNA
CTD
PMID:23395740
NCBI chr10:37,589,200...37,599,970
Ensembl chr10:37,595,679...37,599,672
G
Gja1
gap junction protein, alpha 1
increases expression decreases expression
EXP ISO
Azacitidine results in increased expression of GJA1 protein Azacitidine results in decreased expression of GJA1 mRNA
CTD
PMID:18037191 PMID:20823114
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Gng7
G protein subunit gamma 7
affects methylation
ISO
Azacitidine affects the methylation of GNG7 promoter
CTD
PMID:18219292
NCBI chr 7:8,697,458...8,761,239
Ensembl chr 7:8,697,521...8,761,240
G
Gpkow
G patch domain and KOW motifs
increases expression
ISO
Azacitidine results in increased expression of GPKOW mRNA
CTD
PMID:20823114
NCBI chr X:14,791,601...14,806,384
Ensembl chr X:14,791,610...14,806,384
G
Gpnmb
glycoprotein nmb
decreases expression
ISO
Azacitidine results in decreased expression of GPNMB mRNA
CTD
PMID:20823114
NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367
G
Gpx3
glutathione peroxidase 3
increases expression
ISO
5-azacytidine increases expression of GPX3 mRNA in epithelial cells of stomach
RGD
PMID:16229808
RGD:151665354
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
decreases methylation
ISO
Azacitidine results in decreased methylation of GRIN2B gene
CTD
PMID:18618247
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
G
Guk1
guanylate kinase 1
increases expression
ISO
Azacitidine results in increased expression of GUK1 mRNA
CTD
PMID:20823114
NCBI chr10:43,971,514...43,988,658
Ensembl chr10:43,971,509...43,980,107
G
Gzmb
granzyme B
multiple interactions
ISO
Azacitidine inhibits the reaction [IL2 protein results in increased secretion of GZMB protein]
CTD
PMID:19394699
NCBI chr15:30,343,352...30,346,814
Ensembl chr15:30,173,603...30,346,814
G
H1f0
H1.0 linker histone
increases expression
ISO
Azacitidine results in increased expression of H1-0 protein
CTD
PMID:16006241
NCBI chr 7:110,592,834...110,594,694
Ensembl chr 7:110,592,208...110,594,694
G
H2ax
H2A.X variant histone
increases expression multiple interactions
ISO EXP
Azacitidine results in increased expression of H2AX protein Azacitidine inhibits the reaction [potassium bromate results in increased phosphorylation of H2AX protein]
CTD
PMID:17991895 PMID:25015661
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
H3f4
H3.4 histone, cluster member
multiple interactions
ISO
Azacitidine promotes the reaction [H3-4 protein modified form binds to CCNA1 promoter]
CTD
PMID:17698632
NCBI chr10:43,740,702...43,741,262
G
Hgd
homogentisate 1, 2-dioxygenase
increases expression
ISO
Azacitidine results in increased expression of HGD mRNA
CTD
PMID:20823114
NCBI chr11:63,086,750...63,138,325
Ensembl chr11:63,086,752...63,138,323
G
Hgf
hepatocyte growth factor
increases expression
ISO
Azacitidine results in increased expression of HGF mRNA
CTD
PMID:19194470
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
G
Hhex
hematopoietically expressed homeobox
increases expression
ISO
Azacitidine results in increased expression of HHEX mRNA
CTD
PMID:27590069
NCBI chr 1:235,190,455...235,196,042
Ensembl chr 1:235,190,455...235,196,042
G
Hmga1
high mobility group AT-hook 1
increases expression
ISO
Azacitidine results in increased expression of HMGA1 mRNA
CTD
PMID:20823114
NCBI chr20:5,611,088...5,618,755
Ensembl chr20:5,611,694...5,618,752
G
Hmga2
high mobility group AT-hook 2
increases expression multiple interactions
ISO
Azacitidine results in increased expression of HMGA2 mRNA TP73 protein promotes the reaction [Azacitidine results in increased expression of HMGA2 mRNA]
CTD
PMID:21245298
NCBI chr 7:55,877,145...55,998,813
Ensembl chr 7:55,880,112...55,994,784
G
Hmgb1
high mobility group box 1
decreases expression multiple interactions
ISO
Azacitidine results in decreased expression of HMGB1 mRNA Azacitidine results in decreased expression of and results in increased secretion of HMGB1 protein; Bleomycin inhibits the reaction [Azacitidine results in decreased expression of and results in increased secretion of HMGB1 protein]; Bleomycin inhibits the reaction [Azacitidine results in decreased expression of HMGB1 mRNA]
CTD
PMID:32278510
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hnf1a
HNF1 homeobox A
decreases methylation multiple interactions increases expression
ISO
Azacitidine results in decreased methylation of HNF1A promoter HNF1A mutant form inhibits the reaction [Azacitidine results in increased expression of AQP9 mRNA] Azacitidine results in increased expression of HNF1A mRNA; Azacitidine results in increased expression of HNF1A protein
CTD
PMID:25953102
NCBI chr12:41,638,536...41,672,806
Ensembl chr12:41,645,587...41,672,104
G
Hnf4a
hepatocyte nuclear factor 4, alpha
increases expression
ISO
Azacitidine results in increased expression of HNF4A mRNA
CTD
PMID:27590069
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
G
Hoxa1
homeobox A1
multiple interactions increases expression
ISO
Azacitidine inhibits the reaction [[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of HOXA1 mRNA] Azacitidine results in increased expression of HOXA1 mRNA
CTD
PMID:20823114
NCBI chr 4:81,255,814...81,258,587
Ensembl chr 4:81,255,883...81,258,504
G
Hpgd
15-hydroxyprostaglandin dehydrogenase
decreases methylation multiple interactions increases expression
ISO
Azacitidine results in decreased methylation of HPGD gene trichostatin A promotes the reaction [Azacitidine results in increased expression of HPGD mRNA]
CTD
PMID:19584167
NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228
G
Hsd3b1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
affects expression
ISO
Azacitidine affects the expression of HSD3B1 mRNA
CTD
PMID:18033690
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
G
Hsf1
heat shock transcription factor 1
decreases activity
ISO
Azacitidine results in decreased activity of HSF1 protein
CTD
PMID:34170685
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
G
Hspa6l-ps1
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
increases expression
ISO
Azacitidine results in increased expression of HSPA6 mRNA
CTD
PMID:19194470
NCBI chr13:83,273,176...83,274,317
G
Id1
inhibitor of DNA binding 1
increases expression
ISO
Azacitidine results in increased expression of ID1 mRNA
CTD
PMID:19194470
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
G
Id3
inhibitor of DNA binding 3
increases expression
ISO
Azacitidine results in increased expression of ID3 mRNA
CTD
PMID:19194470
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
G
Ifng
interferon gamma
multiple interactions
ISO
[Azacitidine promotes the reaction [IFNG protein results in increased expression of CIITA mRNA]] which results in increased expression of HLA-DRA protein; [Azacitidine results in decreased methylation of CIITA promoter] promotes the reaction [IFNG protein results in increased expression of CIITA mRNA]; [Azacitidine results in increased expression of KIR2DL4 protein] which results in increased secretion of IFNG protein
CTD
PMID:18829986 PMID:18945643
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Igfbp1
insulin-like growth factor binding protein 1
multiple interactions increases expression
ISO
Azacitidine inhibits the reaction [[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 mRNA]; Azacitidine promotes the reaction [[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 protein] Azacitidine results in increased expression of IGFBP1 mRNA
CTD
PMID:20823114
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
G
Igfbp4
insulin-like growth factor binding protein 4
increases expression
ISO
Azacitidine results in increased expression of IGFBP4 mRNA
CTD
PMID:20823114
NCBI chr10:83,995,253...84,007,272
Ensembl chr10:83,989,591...84,007,225
G
Il12b
interleukin 12B
increases expression
ISO
Azacitidine results in increased expression of IL12B mRNA
CTD
PMID:20823114
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
G
Il1b
interleukin 1 beta
increases expression multiple interactions
EXP ISO
Azacitidine results in increased expression of IL1B mRNA Azacitidine inhibits the reaction [Oleanolic Acid inhibits the reaction [IL1B protein results in increased expression of CD274 mRNA]]; Azacitidine inhibits the reaction [Oleanolic Acid inhibits the reaction [IL1B protein results in increased expression of CD274 protein]]
CTD
PMID:17156202 PMID:32894642
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il2
interleukin 2
multiple interactions
ISO
Azacitidine inhibits the reaction [IL2 protein results in increased secretion of GZMB protein]; Azacitidine inhibits the reaction [IL2 protein results in increased secretion of PRF1 protein]
CTD
PMID:19394699
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il4
interleukin 4
affects methylation
ISO
Azacitidine affects the methylation of IL4 promoter
CTD
PMID:18158872
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il6
interleukin 6
affects secretion affects methylation
ISO
Azacitidine affects the secretion of IL6 protein Azacitidine affects the methylation of IL6 promoter
CTD
PMID:18158872 PMID:18443271
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il6r
interleukin 6 receptor
affects expression multiple interactions
ISO
[Azacitidine affects the expression of IL6R protein] which affects the expression of BCL2L1 protein; Azacitidine affects the expression of IL6R mRNA [Azacitidine affects the expression of IL6R protein] which affects the phosphorylation of STAT3 protein
CTD
PMID:18443271
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
G
Isca1
iron-sulfur cluster assembly 1
increases expression
ISO
Azacitidine results in increased expression of ISCA1 mRNA
CTD
PMID:19194470
NCBI chr17:4,905,291...4,917,955
Ensembl chr17:4,905,287...4,917,955
G
Itgb1
integrin subunit beta 1
decreases expression
ISO
Azacitidine results in decreased expression of ITGB1 mRNA
CTD
PMID:20823114
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
G
Itgb2
integrin subunit beta 2
decreases expression
ISO
Azacitidine results in decreased expression of ITGB2 mRNA
CTD
PMID:19194470
NCBI chr20:11,061,394...11,097,656
Ensembl chr20:11,061,430...11,097,600
G
Itprid2
ITPR interacting domain containing 2
increases expression
ISO
Azacitidine results in increased expression of ITPRID2 mRNA
CTD
PMID:20823114
NCBI chr 3:64,536,707...64,573,978
Ensembl chr 3:64,536,707...64,573,978
G
Kdr
kinase insert domain receptor
increases expression
EXP
Azacitidine results in increased expression of KDR mRNA
CTD
PMID:18037191
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Kif2c
kinesin family member 2C
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of KIF2C mRNA
CTD
PMID:18720364
NCBI chr 5:130,637,347...130,662,680
Ensembl chr 5:130,637,347...130,662,637
G
Kir3dl1
killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1
increases expression decreases methylation
ISO
Azacitidine results in increased expression of KIR3DL1 mRNA; Azacitidine results in increased expression of KIR3DL1 protein Azacitidine results in decreased methylation of KIR3DL1 promoter
CTD
PMID:18945643 PMID:19394699
NCBI chr 1:69,715,529...69,754,050
Ensembl chr 1:69,715,535...69,754,050
G
Klf6
KLF transcription factor 6
increases expression multiple interactions
ISO
Azacitidine results in increased expression of KLF6 mRNA TP73 protein promotes the reaction [Azacitidine results in increased expression of KLF6 mRNA]
CTD
PMID:21245298
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
G
Klk1c10
kallikrein 1-related peptidase C10
increases expression
ISO
Azacitidine analog results in increased expression of KLK3 protein
CTD
PMID:18324645
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
G
Krt19
keratin 19
increases expression
ISO
Azacitidine results in increased expression of KRT19 mRNA
CTD
PMID:20823114
NCBI chr10:85,075,835...85,080,552
Ensembl chr10:85,066,802...85,171,799
G
Krt32
keratin 32
increases expression
ISO
Azacitidine results in increased expression of KRT32 mRNA
CTD
PMID:20823114
NCBI chr10:85,013,551...85,020,578
Ensembl chr10:85,013,554...85,020,534
G
Krt8
keratin 8
multiple interactions increases expression
ISO
Azacitidine inhibits the reaction [[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of KRT8 mRNA] Azacitidine results in increased expression of KRT8 mRNA
CTD
PMID:20823114
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
G
Lama1
laminin subunit alpha 1
affects localization
ISO
Azacitidine affects the localization of LAMA1 protein
CTD
PMID:18033690
NCBI chr 9:107,692,770...107,816,847
Ensembl chr 9:107,692,770...107,817,478
G
Lamb2
laminin subunit beta 2
increases expression
ISO
Azacitidine results in increased expression of LAMB2 mRNA
CTD
PMID:20823114
NCBI chr 8:109,178,367...109,190,552
Ensembl chr 8:109,178,409...109,190,549
G
Ldhb
lactate dehydrogenase B
increases expression
ISO
Azacitidine results in increased expression of LDHB mRNA
CTD
PMID:23437403
NCBI chr 4:175,428,382...175,446,403
Ensembl chr 4:175,428,385...175,446,403
G
Lims1
LIM zinc finger domain containing 1
increases expression
ISO
Azacitidine results in increased expression of LIMS1 mRNA
CTD
PMID:19194470
NCBI chr20:26,309,833...26,418,511
Ensembl chr20:26,309,895...26,418,500
G
Litaf
lipopolysaccharide-induced TNF factor
decreases expression
ISO
Azacitidine results in decreased expression of LITAF mRNA
CTD
PMID:19194470
NCBI chr10:4,656,308...4,692,981
Ensembl chr10:4,625,552...4,692,763
G
Ltb4r
leukotriene B4 receptor
decreases expression
ISO
Azacitidine results in decreased expression of LTB4R mRNA
CTD
PMID:20823114
NCBI chr15:29,263,199...29,265,716
G
Lyz2
lysozyme 2
increases expression
ISO
Azacitidine results in increased expression of LYZ mRNA
CTD
PMID:19194470
NCBI chr 7:52,906,810...52,912,154
Ensembl chr 7:52,906,811...52,912,106
G
Mad1l1
mitotic arrest deficient 1 like 1
decreases expression
ISO
Azacitidine results in decreased expression of MAD1L1 mRNA
CTD
PMID:19194470
NCBI chr12:14,320,892...14,630,750
Ensembl chr12:14,320,892...14,630,703
G
Mafb
MAF bZIP transcription factor B
increases expression multiple interactions
ISO
Azacitidine results in increased expression of MAFB mRNA Cisplatin affects the reaction [Azacitidine results in increased expression of MAFB mRNA]
CTD
PMID:36336710
NCBI chr 3:148,998,111...149,000,031
Ensembl chr 3:148,998,122...149,000,031
G
Map1a
microtubule-associated protein 1A
decreases expression
ISO
Azacitidine results in decreased expression of MAP1A mRNA
CTD
PMID:20823114
NCBI chr 3:108,263,217...108,283,936
Ensembl chr 3:108,263,151...108,282,899
G
Map2k5
mitogen activated protein kinase kinase 5
decreases expression
ISO
Azacitidine results in decreased expression of MAP2K5 mRNA
CTD
PMID:20823114
NCBI chr 8:63,625,220...63,852,090
Ensembl chr 8:63,625,221...63,851,983
G
Mapt
microtubule-associated protein tau
decreases expression
ISO
Azacitidine results in decreased expression of MAPT protein
CTD
PMID:16930453
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
decreases expression
ISO
5-azacytidine decreases expression of MCL1 protein in lung cancer cells
RGD
PMID:24356455
RGD:153344603
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
G
Mcm5
minichromosome maintenance complex component 5
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of MCM5 mRNA
CTD
PMID:18720364
NCBI chr19:13,483,030...13,504,389
Ensembl chr19:13,483,066...13,504,389
G
Mdc1
mediator of DNA damage checkpoint 1
increases expression
ISO
Azacitidine results in increased expression of MDC1 mRNA
CTD
PMID:20823114
NCBI chr20:2,893,693...2,912,394
Ensembl chr20:2,895,505...2,910,240
G
Mdm2
MDM2 proto-oncogene
increases expression
ISO
Azacitidine results in increased expression of MDM2 mRNA
CTD
PMID:20823114
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
G
Mecp2
methyl CpG binding protein 2
multiple interactions
ISO
Azacitidine inhibits the reaction [MECP2 protein binds to CCNA1 promoter]
CTD
PMID:17698632
NCBI chr X:151,781,177...151,844,687
Ensembl chr X:151,789,930...151,844,689
G
Mef2a
myocyte enhancer factor 2a
increases expression affects expression
ISO
Azacitidine results in increased expression of MEF2A Azacitidine affects the expression of MEF2A protein
CTD
PMID:12094073 PMID:19002953
NCBI chr 1:120,847,874...120,982,488
Ensembl chr 1:120,850,080...120,981,948
G
Mef2d
myocyte enhancer factor 2D
affects expression increases expression
ISO
Azacitidine affects the expression of MEF2D protein Azacitidine results in increased expression of MEF2D
CTD
PMID:12094073 PMID:19002953
NCBI chr 2:173,606,054...173,635,620
Ensembl chr 2:173,606,490...173,634,457
G
Megf6
multiple EGF-like-domains 6
decreases expression
ISO
Azacitidine results in decreased expression of MEGF6 mRNA
CTD
PMID:19194470
NCBI chr 5:164,738,272...164,839,142
Ensembl chr 5:164,738,352...164,839,139
G
Mesd
mesoderm development LRP chaperone
decreases expression
EXP
Azacitidine results in decreased expression of MESD protein
CTD
PMID:17105402
NCBI chr 1:137,866,707...137,879,999
Ensembl chr 1:137,874,242...137,879,999
G
Mfap2
microfibril associated protein 2
decreases expression
ISO
Azacitidine results in decreased expression of MFAP2 mRNA
CTD
PMID:20823114
NCBI chr 5:153,312,068...153,320,266
Ensembl chr 5:153,314,711...153,320,259
G
Mfge8
milk fat globule EGF and factor V/VIII domain containing
affects expression
ISO
Azacitidine affects the expression of MFGE8 mRNA
CTD
PMID:18033690
NCBI chr 1:133,064,665...133,080,069
Ensembl chr 1:133,064,665...133,080,073
G
Mgmt
O-6-methylguanine-DNA methyltransferase
increases expression decreases methylation
ISO
Azacitidine results in increased expression of MGMT mRNA Azacitidine results in decreased methylation of MGMT protein
CTD
PMID:7511991 PMID:12807730
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
G
Mir193a
microRNA 193a
increases expression
ISO
5-azacytidine increases expression of MIR193A in liver cells 5-azacytidine increases expression of MIR193a RNA in lung cancer cells
RGD
PMID:28036298 PMID:24356455
RGD:153344564 , RGD:153344603
NCBI chr10:64,672,343...64,672,454
Ensembl chr10:64,672,343...64,672,454
G
Mir23b
microRNA 23b
increases expression
ISO
5-azacytidine increases expression of MIR23B miRNA in liver cells
RGD
PMID:28036298
RGD:153344564
NCBI chr17:1,813,667...1,813,763
Ensembl chr17:1,813,667...1,813,763
G
Mir497
microRNA 497
increases expression multiple interactions decreases methylation
ISO
Azacitidine results in increased expression of MIR497 mRNA Azacitidine inhibits the reaction [DNMT1 protein binds to MIR497 promoter]; Azacitidine inhibits the reaction [DNMT3A protein binds to MIR497 promoter]; Azacitidine inhibits the reaction [DNMT3B protein binds to MIR497 promoter] Azacitidine results in decreased methylation of MIR497 promoter
CTD
PMID:35066776
NCBI chr10:54,951,514...54,951,582
Ensembl chr10:54,951,505...54,951,584
G
Mir9-3
microRNA 9-3
increases expression
ISO
5-azacytidine increases expression of MIR9-3 in lung cancer cells
RGD
PMID:24356455
RGD:153344603
NCBI chr 1:133,440,049...133,440,138
G
Mki67
marker of proliferation Ki-67
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of MKI67 mRNA
CTD
PMID:18720364
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Mmp1
matrix metallopeptidase 1
increases expression
ISO
Azacitidine results in increased expression of MMP1 mRNA
CTD
PMID:20823114
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Mmp9
matrix metallopeptidase 9
multiple interactions
ISO
metacept-1 inhibits the reaction [Azacitidine results in increased expression of MMP9]
CTD
PMID:19148494
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Morf4l2
mortality factor 4 like 2
decreases expression
ISO
Azacitidine results in decreased expression of MORF4L2 mRNA
CTD
PMID:20823114
NCBI chr X:100,082,562...100,093,658
Ensembl chr X:100,082,404...100,093,728
G
Mov10l1
Mov10 like RNA helicase 1
increases expression
ISO
Azacitidine results in increased expression of MOV10L1 mRNA
CTD
PMID:20823114
NCBI chr 7:120,070,171...120,135,406
Ensembl chr 7:120,070,135...120,134,765
G
Msrb2
methionine sulfoxide reductase B2
increases expression
ISO
Azacitidine results in increased expression of MSRB2 mRNA
CTD
PMID:19194470
NCBI chr17:81,974,378...82,000,044
Ensembl chr17:81,974,196...82,000,043
G
Mthfd2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
decreases expression
ISO
Azacitidine results in decreased expression of MTHFD2 mRNA
CTD
PMID:20823114
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
G
Mtrex
Mtr4 exosome RNA helicase
increases expression
ISO
Azacitidine results in increased expression of MTREX mRNA
CTD
PMID:20823114
NCBI chr 2:44,500,326...44,560,624
Ensembl chr 2:44,461,444...44,560,627
G
Myc
MYC proto-oncogene, bHLH transcription factor
decreases expression multiple interactions
ISO
Azacitidine analog results in decreased expression of MYC mRNA MYC protein affects the reaction [Azacitidine results in decreased activity of TERT protein]; MYC protein affects the reaction [Azacitidine results in decreased expression of TERT mRNA]
CTD
PMID:18045574 PMID:19451745
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Myf5
myogenic factor 5
increases expression
ISO
Azacitidine results in increased expression of MYF5 mRNA
CTD
PMID:18938140
NCBI chr 7:42,802,946...42,806,177
Ensembl chr 7:42,802,946...42,806,177
G
Myh7
myosin heavy chain 7
increases expression
EXP
Azacitidine results in increased expression of MYH7 mRNA; Azacitidine results in increased expression of MYH7 protein
CTD
PMID:17105402
NCBI chr15:28,446,550...28,469,888
Ensembl chr15:28,446,550...28,468,217
G
Myl2
myosin light chain 2
increases expression
EXP
Azacitidine results in increased expression of MYL2 mRNA
CTD
PMID:17105402
NCBI chr12:34,454,223...34,468,554
Ensembl chr12:34,454,218...34,468,983
G
Myod1
myogenic differentiation 1
increases expression
EXP ISO
Azacitidine results in increased expression of MYOD1 mRNA
CTD
PMID:18037191 PMID:18938140
NCBI chr 1:96,884,864...96,887,574
Ensembl chr 1:96,884,948...96,887,554
G
Myog
myogenin
increases expression
ISO
Azacitidine results in increased expression of MYOG mRNA
CTD
PMID:18938140
NCBI chr13:45,745,455...45,748,044
Ensembl chr13:45,745,436...45,748,039
G
Ncam1
neural cell adhesion molecule 1
increases expression
EXP
Azacitidine results in increased expression of NCAM1 mRNA
CTD
PMID:18037191
NCBI chr 8:49,865,629...50,165,687
Ensembl chr 8:49,865,633...50,166,014
G
Nefl
neurofilament light chain
increases expression
ISO
Azacitidine results in increased expression of NEFL mRNA
CTD
PMID:20823114
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
G
Nfatc1
nuclear factor of activated T-cells 1
increases expression
ISO
Azacitidine results in increased expression of NFATC1 mRNA
CTD
PMID:20823114
NCBI chr18:74,046,422...74,156,041
Ensembl chr18:74,046,904...74,156,028
G
Niban1
niban apoptosis regulator 1
increases expression multiple interactions
ISO
Azacitidine results in increased expression of NIBAN1 mRNA TP73 protein promotes the reaction [Azacitidine results in increased expression of NIBAN1 mRNA]
CTD
PMID:21245298
NCBI chr13:63,674,240...63,827,748
Ensembl chr13:63,674,171...63,827,729
G
Nkx2-5
NK2 homeobox 5
increases expression
ISO
Azacitidine results in increased expression of NKX2-5 mRNA
CTD
PMID:18557828
NCBI chr10:16,340,428...16,347,004
Ensembl chr10:16,344,159...16,346,934
G
Nlgn3
neuroligin 3
increases expression
ISO
Azacitidine results in increased expression of NLGN3 mRNA
CTD
PMID:20823114
NCBI chr X:66,427,926...66,457,378
Ensembl chr X:66,429,458...66,451,876
G
Nme2
NME/NM23 nucleoside diphosphate kinase 2
increases expression
EXP
Azacitidine results in increased expression of NME2 protein
CTD
PMID:17105402
NCBI chr10:78,898,097...78,903,514
Ensembl chr10:78,897,770...78,903,538
G
Nmi
N-myc (and STAT) interactor
increases expression
ISO
Azacitidine results in increased expression of NMI mRNA
CTD
PMID:21245298
NCBI chr 3:36,415,607...36,439,716
Ensembl chr 3:36,415,607...36,439,498
G
Nnt
nicotinamide nucleotide transhydrogenase
increases expression
ISO
Azacitidine results in increased expression of NNT mRNA; Azacitidine results in increased expression of NNT protein
CTD
PMID:36336710
NCBI chr 2:51,411,413...51,505,125
Ensembl chr 2:51,411,413...51,504,823
G
Nom1
nucleolar protein with MIF4G domain 1
decreases expression
ISO
Azacitidine results in decreased expression of NOM1 mRNA
CTD
PMID:20823114
NCBI chr 4:5,891,220...5,910,741
Ensembl chr 4:5,892,909...5,909,709
G
Nphp1
nephrocystin 1
increases expression
ISO
Azacitidine results in increased expression of NPHP1 mRNA
CTD
PMID:20823114
NCBI chr 3:114,960,650...115,016,234
Ensembl chr 3:114,960,650...115,016,234
G
Nppa
natriuretic peptide A
increases expression
ISO
Azacitidine results in increased expression of NPPA
CTD
PMID:15005238
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
G
Nppb
natriuretic peptide B
increases expression
ISO
Azacitidine results in increased expression of NPPB
CTD
PMID:15005238
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
ISO
[Azacitidine co-treated with Butyrates] inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of NQO1 mRNA]]; Azacitidine inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of NQO1 mRNA]]
CTD
PMID:17682057
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
multiple interactions
ISO
[metacept-1 co-treated with Azacitidine] results in increased expression of NR4A1
CTD
PMID:19148494
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
G
Nrip1
nuclear receptor interacting protein 1
decreases expression
ISO
Azacitidine results in decreased expression of NRIP1 mRNA
CTD
PMID:20823114
NCBI chr11:14,895,843...14,979,490
Ensembl chr11:14,895,553...14,981,761
G
Nrn1
neuritin 1
decreases expression
ISO
Azacitidine results in decreased expression of NRN1 mRNA
CTD
PMID:19194470
NCBI chr17:28,129,969...28,138,898
Ensembl chr17:28,129,977...28,138,896
G
Nt5e
5' nucleotidase, ecto
increases expression
ISO
Azacitidine results in increased expression of NT5E mRNA
CTD
PMID:20823114
NCBI chr 8:89,271,046...89,314,918
Ensembl chr 8:89,270,696...89,314,881
G
Nts
neurotensin
decreases expression
ISO
Azacitidine results in decreased expression of NTS mRNA
CTD
PMID:20823114
NCBI chr 7:37,564,944...37,574,350
Ensembl chr 7:37,564,533...37,574,423
G
Nusap1
nucleolar and spindle associated protein 1
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of NUSAP1 mRNA
CTD
PMID:18720364
NCBI chr 3:106,603,273...106,633,428
Ensembl chr 3:106,603,289...106,633,624
G
Nxt2
nuclear transport factor 2-like export factor 2
increases expression
ISO
Azacitidine results in increased expression of NXT2 mRNA
CTD
PMID:19194470
NCBI chr X:105,855,616...105,862,902
Ensembl chr X:105,855,608...105,862,899
G
Ocln
occludin
increases expression
ISO
Azacitidine results in increased expression of OCLN mRNA
CTD
PMID:18661270
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
G
Ogfrl1
opioid growth factor receptor-like 1
increases expression
ISO
Azacitidine results in increased expression of OGFRL1 mRNA
CTD
PMID:20823114
NCBI chr 9:25,828,865...25,842,424
Ensembl chr 9:25,828,869...25,842,352
G
Ogg1
8-oxoguanine DNA glycosylase
decreases expression decreases methylation
ISO
Azacitidine results in decreased expression of OGG1 protein Azacitidine results in decreased methylation of OGG1 promoter
CTD
PMID:22064374
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
G
Or8b8
olfactory receptor family 8 subfamily B member 8
increases expression
ISO
Azacitidine results in increased expression of OR8B8 mRNA
CTD
PMID:20823114
NCBI chr 8:37,693,578...37,694,510
Ensembl chr 8:37,693,499...37,694,547
G
Oxr1
oxidation resistance 1
increases expression
ISO
Azacitidine results in increased expression of OXR1 mRNA
CTD
PMID:20823114
NCBI chr 7:72,528,750...72,965,666
Ensembl chr 7:72,528,786...72,965,666
G
Oxtr
oxytocin receptor
decreases expression
ISO
Azacitidine results in decreased expression of OXTR mRNA
CTD
PMID:21245298
NCBI chr 4:145,598,549...145,614,674
Ensembl chr 4:145,599,561...145,614,674
G
P4hb
prolyl 4-hydroxylase subunit beta
increases expression
EXP ISO
Azacitidine results in increased expression of P4HB protein Azacitidine results in increased expression of P4HB mRNA
CTD
PMID:17105402 PMID:20823114
NCBI chr10:105,836,972...105,848,583
Ensembl chr10:105,836,982...105,848,500
G
Paep
progestagen associated endometrial protein
decreases expression
ISO
Azacitidine results in decreased expression of PAEP mRNA
CTD
PMID:20823114
NCBI chr 3:8,531,136...8,534,430
Ensembl chr 3:8,531,138...8,534,430
G
Pak1
p21 (RAC1) activated kinase 1
increases expression
ISO
Azacitidine results in increased expression of PAK1 mRNA
CTD
PMID:20823114
NCBI chr 1:152,111,172...152,226,390
Ensembl chr 1:152,111,188...152,226,383
G
Pank3
pantothenate kinase 3
decreases expression
ISO
Azacitidine results in decreased expression of PANK3 mRNA
CTD
PMID:19194470
NCBI chr10:20,229,129...20,252,955
Ensembl chr10:20,229,129...20,252,955
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage multiple interactions
ISO
Azacitidine results in increased cleavage of PARP1 protein Bleomycin inhibits the reaction [Azacitidine results in increased cleavage of PARP1 protein]
CTD
PMID:32278510
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pax4
paired box 4
increases expression
ISO
Azacitidine results in increased expression of PAX4 mRNA
CTD
PMID:18949370
NCBI chr 4:57,058,453...57,065,995
Ensembl chr 4:57,058,462...57,063,408
G
Pcdh18
protocadherin 18
decreases expression
ISO
Azacitidine results in decreased expression of PCDH18 mRNA
CTD
PMID:20823114
NCBI chr 2:133,831,996...133,845,992
Ensembl chr 2:133,832,001...133,845,883
G
Pcdha1
protocadherin alpha 1
affects methylation
ISO
Azacitidine affects the methylation of PCDHA1 promoter
CTD
PMID:18204046
Ensembl chr18:28,581,225...28,846,211
G
Pcdha10
protocadherin alpha 10
affects methylation
ISO
Azacitidine affects the methylation of PCDHA10 promoter
CTD
PMID:18204046
Ensembl chr18:28,581,225...28,846,211
G
Pcdha11
protocadherin alpha 11
affects methylation
ISO
Azacitidine affects the methylation of PCDHA11 promoter
CTD
PMID:18204046
Ensembl chr18:28,581,225...28,846,211
G
Pcdha2
protocadherin alpha 2
affects methylation
ISO
Azacitidine affects the methylation of PCDHA2 promoter
CTD
PMID:18204046
Ensembl chr18:28,581,225...28,846,211
G
Pcdha3
protocadherin alpha 3
affects methylation
ISO
Azacitidine affects the methylation of PCDHA3 promoter
CTD
PMID:18204046
Ensembl chr18:28,581,225...28,846,211
G
Pcdha4
protocadherin alpha 4
affects methylation
ISO
Azacitidine affects the methylation of PCDHA4 promoter
CTD
PMID:18204046
NCBI chr18:28,581,040...28,846,214
Ensembl chr18:28,581,225...28,846,211
G
Pcdha5
protocadherin alpha 5
affects methylation
ISO
Azacitidine affects the methylation of PCDHA5 promoter
CTD
PMID:18204046
Ensembl chr18:28,581,225...28,846,211
G
Pcdha6
protocadherin alpha 6
affects methylation
ISO
Azacitidine affects the methylation of PCDHA6 promoter
CTD
PMID:18204046
Ensembl chr18:28,581,225...28,846,211
G
Pcdha7
protocadherin alpha 7
affects methylation
ISO
Azacitidine affects the methylation of PCDHA7 promoter
CTD
PMID:18204046
Ensembl chr18:28,581,225...28,846,211
G
Pcdha9
protocadherin alpha 9
affects methylation
ISO
Azacitidine affects the methylation of PCDHA8 promoter; Azacitidine affects the methylation of PCDHA9 promoter
CTD
PMID:18204046
Ensembl chr18:28,581,225...28,846,211
G
Pcdhb20
protocadherin beta 20
decreases expression
ISO
Azacitidine results in decreased expression of PCDHB14 mRNA
CTD
PMID:20823114
NCBI chr18:29,211,878...29,215,272
Ensembl chr18:29,211,883...29,215,258
G
Pcdhb5
protocadherin beta 5
decreases expression
ISO
Azacitidine results in decreased expression of PCDHB4 mRNA
CTD
PMID:20823114
NCBI chr18:29,024,315...29,032,183
Ensembl chr18:29,028,382...29,053,259
G
Pcna
proliferating cell nuclear antigen
decreases expression multiple interactions
EXP
Azacitidine results in decreased expression of PCNA protein [Cisplatin co-treated with Azacitidine] results in decreased expression of PCNA protein
CTD
PMID:19723570
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pdk1
pyruvate dehydrogenase kinase 1
increases expression
ISO
Azacitidine results in increased expression of PDK1 mRNA
CTD
PMID:20823114
NCBI chr 3:56,705,824...56,733,040
Ensembl chr 3:56,705,871...56,733,038
G
Pdk4
pyruvate dehydrogenase kinase 4
increases expression decreases methylation
ISO
Azacitidine results in increased expression of PDK4 protein Azacitidine results in decreased methylation of PDK4 promoter
CTD
PMID:28003426
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
G
Pecam1
platelet and endothelial cell adhesion molecule 1
increases expression
EXP
Azacitidine results in increased expression of PECAM1 mRNA
CTD
PMID:18037191
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
G
Pfn1
profilin 1
increases expression
ISO
Azacitidine results in increased expression of PFN1 mRNA
CTD
PMID:20823114
NCBI chr10:55,365,263...55,367,968
Ensembl chr10:55,365,262...55,527,631
G
Phactr2
phosphatase and actin regulator 2
increases expression
ISO
Azacitidine results in increased expression of PHACTR2 mRNA
CTD
PMID:20823114
NCBI chr 1:7,591,254...7,860,431
Ensembl chr 1:7,597,927...7,860,289
G
Pip5k1a
phosphatidylinositol-4-phosphate 5-kinase, type 1, alpha
decreases expression
ISO
Azacitidine results in decreased expression of PIP5K1A mRNA
CTD
PMID:19194470
NCBI chr 2:182,628,299...182,671,584
Ensembl chr 2:182,628,300...182,671,598
G
Pitpnc1
phosphatidylinositol transfer protein, cytoplasmic 1
decreases expression
ISO
Azacitidine results in decreased expression of PITPNC1 mRNA
CTD
PMID:20823114
NCBI chr10:92,163,558...92,428,971
Ensembl chr10:92,167,196...92,429,297
G
Pitx3
paired-like homeodomain 3
increases expression
EXP
Azacitidine results in increased expression of PITX3 mRNA
CTD
PMID:27415467
NCBI chr 1:245,001,106...245,013,881
Ensembl chr 1:245,001,164...245,013,892
G
Pja1
praja ring finger ubiquitin ligase 1
increases expression
ISO
Azacitidine results in increased expression of PJA1 mRNA
CTD
PMID:19194470
NCBI chr X:64,580,938...64,585,846
Ensembl chr X:64,580,849...64,585,833
G
Pkd2l1
polycystin 2 like 1, transient receptor potential cation channel
increases expression
ISO
Azacitidine results in increased expression of PKD2L1 mRNA
CTD
PMID:20823114
NCBI chr 1:243,032,891...243,070,031
Ensembl chr 1:243,032,913...243,070,031
G
Pkm
pyruvate kinase M1/2
increases expression
ISO
Azacitidine results in increased expression of PKM mRNA
CTD
PMID:20823114
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
G
Plcb1
phospholipase C beta 1
decreases methylation decreases response to substance increases response to substance increases expression
ISO
Azacitidine results in decreased methylation of PLCB1 promoter PLCB1 promoter modified form results in decreased susceptibility to Azacitidine PLCB1 mRNA results in increased susceptibility to Azacitidine; PLCB1 protein results in increased susceptibility to Azacitidine Azacitidine results in increased expression of PLCB1 mRNA; Azacitidine results in increased expression of PLCB1 protein
CTD
PMID:19805378
NCBI chr 3:122,059,988...122,772,896
Ensembl chr 3:122,060,031...122,772,869
G
Plpp1
phospholipid phosphatase 1
increases expression
ISO
Azacitidine results in increased expression of PLPP1 mRNA
CTD
PMID:19194470
NCBI chr 2:44,439,002...44,500,430
Ensembl chr 2:44,438,994...44,501,268
G
Pls3
plastin 3
decreases expression
ISO
Azacitidine results in decreased expression of PLS3 mRNA
CTD
PMID:20823114
NCBI chr X:111,589,193...111,683,908
Ensembl chr X:111,589,254...111,683,891
G
Pml
PML nuclear body scaffold
increases expression
ISO
Azacitidine results in increased expression of PML mRNA
CTD
PMID:19194470
NCBI chr 8:58,627,347...58,661,927
Ensembl chr 8:58,628,837...58,658,971
G
Pparg
peroxisome proliferator-activated receptor gamma
decreases methylation increases expression
ISO
Azacitidine results in decreased methylation of PPARG promoter Azacitidine results in increased expression of PPARG mRNA
CTD
PMID:19589179
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppp2ca
protein phosphatase 2 catalytic subunit alpha
multiple interactions increases expression decreases methylation
ISO
Azacitidine promotes the reaction [CREB1 protein modified form binds to PPP2CA promoter] Azacitidine results in increased expression of PPP2CA mRNA Azacitidine results in decreased methylation of PPP2CA promoter
CTD
PMID:19155497
NCBI chr10:36,358,110...36,377,864
Ensembl chr10:36,358,101...36,377,862
G
Prdx4
peroxiredoxin 4
decreases expression
EXP
Azacitidine results in decreased expression of PRDX4 protein
CTD
PMID:17105402
NCBI chr X:40,026,762...40,044,066
Ensembl chr X:40,026,651...40,044,066
G
Prf1
perforin 1
multiple interactions
ISO
Azacitidine inhibits the reaction [IL2 protein results in increased secretion of PRF1 protein]
CTD
PMID:19394699
NCBI chr20:29,246,202...29,251,712
Ensembl chr20:29,246,202...29,251,701
G
Prl
prolactin
multiple interactions
ISO
[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate co-treated with Azacitidine] results in increased expression of PRL mRNA; [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate co-treated with Azacitidine] results in increased expression of PRL protein
CTD
PMID:20823114
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Prom1
prominin 1
increases expression
EXP
Azacitidine results in increased expression of PROM1 mRNA
CTD
PMID:18037191
NCBI chr14:66,989,545...67,094,534
Ensembl chr14:66,990,160...67,094,527
G
Prss12
serine protease 12
decreases expression
ISO
Azacitidine results in decreased expression of PRSS12 mRNA
CTD
PMID:20823114
NCBI chr 2:211,624,134...211,684,126
Ensembl chr 2:211,624,134...211,684,126
G
Psen1
presenilin 1
decreases methylation multiple interactions
ISO
Azacitidine results in decreased methylation of PSEN1 promoter Betaine inhibits the reaction [Azacitidine results in decreased methylation of PSEN1 promoter]
CTD
PMID:19635394
NCBI chr 6:103,323,052...103,375,088
Ensembl chr 6:103,323,120...103,371,650
G
Pten
phosphatase and tensin homolog
multiple interactions
ISO
Azacitidine inhibits the reaction [TGFB1 protein results in decreased expression of PTEN mRNA]; Azacitidine inhibits the reaction [TGFB1 protein results in decreased expression of PTEN protein]; Azacitidine inhibits the reaction [TGFB1 protein results in increased methylation of PTEN promoter]
CTD
PMID:22841775
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
G
Pthlh
parathyroid hormone-like hormone
decreases expression
ISO
Azacitidine results in decreased expression of PTHLH mRNA
CTD
PMID:20823114
NCBI chr 4:180,188,792...180,199,847
Ensembl chr 4:180,188,792...180,199,847
G
Ptpa
protein phosphatase 2 phosphatase activator
increases expression
ISO
Azacitidine results in increased expression of PTPA mRNA
CTD
PMID:20823114
NCBI chr 3:13,689,742...13,720,287
Ensembl chr 3:13,689,741...13,722,549
G
Ptprc
protein tyrosine phosphatase, receptor type, C
increases expression
ISO
Azacitidine results in increased expression of PTPRC mRNA
CTD
PMID:19194470
NCBI chr13:49,596,193...49,708,283
Ensembl chr13:49,596,193...49,708,692
G
Ptpro
protein tyrosine phosphatase, receptor type, O
increases expression
EXP
Azacitidine results in increased expression of PTPRO mRNA
CTD
PMID:14508512
NCBI chr 4:170,164,071...170,374,790
Ensembl chr 4:170,164,431...170,374,771
G
Rab13
RAB13, member RAS oncogene family
decreases methylation
ISO
Azacitidine results in decreased methylation of RAB13 promoter
CTD
PMID:19194470
NCBI chr 2:175,674,894...175,680,043
Ensembl chr 2:175,675,005...175,680,036
G
Rab1b
RAB1B, member RAS oncogene family
increases expression
ISO
Azacitidine results in increased expression of RAB1B mRNA
CTD
PMID:20823114
NCBI chr 1:202,405,759...202,413,850
Ensembl chr 1:202,405,759...202,413,868 Ensembl chr X:202,405,759...202,413,868
G
Racgap1
Rac GTPase-activating protein 1
increases expression
ISO
Azacitidine results in increased expression of RACGAP1 mRNA
CTD
PMID:20823114
NCBI chr 7:130,750,936...130,780,891
Ensembl chr 7:130,750,936...130,780,831
G
Ranbp2
RAN binding protein 2
increases expression
ISO
Azacitidine results in increased expression of RANBP2 mRNA
CTD
PMID:19194470
NCBI chr20:26,442,156...26,493,481
Ensembl chr20:26,442,217...26,493,481
G
Rasa3
RAS p21 protein activator 3
increases expression
ISO
Azacitidine results in increased expression of RASA3 mRNA
CTD
PMID:20823114
NCBI chr16:75,855,360...75,969,349
Ensembl chr16:75,855,265...75,970,804
G
Rcn1
reticulocalbin 1
decreases expression
ISO
Azacitidine results in decreased expression of RCN1 mRNA
CTD
PMID:20823114
NCBI chr 3:91,841,052...91,855,295
Ensembl chr 3:91,841,052...91,855,295
G
Rela
RELA proto-oncogene, NF-kB subunit
affects localization decreases expression
ISO
Azacitidine affects the localization of RELA protein 5-azacytidine decreases expression of RELA protein in lung cancer cells
CTD RGD
PMID:18443271 PMID:24356455
RGD:153344603
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Ret
ret proto-oncogene
decreases expression
ISO
Azacitidine results in decreased expression of RET mRNA
CTD
PMID:20823114
NCBI chr 4:151,325,969...151,368,176
Ensembl chr 4:151,326,431...151,368,176
G
Rfc3
replication factor C subunit 3
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of RFC3 mRNA
CTD
PMID:18720364
NCBI chr12:1,000,987...1,011,778
Ensembl chr12:1,000,994...1,011,778
G
Rhob
ras homolog family member B
multiple interactions
ISO
[trichostatin A co-treated with Azacitidine] results in increased expression of RHOB protein; Azacitidine promotes the reaction [trichostatin A results in increased expression of RHOB mRNA]
CTD
PMID:18047684
NCBI chr 6:31,363,752...31,365,926
Ensembl chr 6:31,363,548...31,366,108
G
Rin1
Ras and Rab interactor 1
increases expression
ISO
Azacitidine results in increased expression of RIN1 mRNA
CTD
PMID:20823114
NCBI chr 1:202,355,729...202,362,731
Ensembl chr 1:202,355,890...202,362,729
G
Rpp21
ribonuclease P/MRP subunit p21
increases expression
ISO
Azacitidine results in increased expression of RPP21 mRNA
CTD
PMID:20823114
NCBI chr20:2,018,170...2,020,100
Ensembl chr20:2,018,147...2,020,106
G
Rps6
ribosomal protein S6
decreases phosphorylation
ISO
Azacitidine results in decreased phosphorylation of RPS6 protein
CTD
PMID:21245298
NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
G
Rpsa
ribosomal protein SA
decreases expression
ISO
Azacitidine results in decreased expression of RPSA mRNA
CTD
PMID:20823114
NCBI chr 8:119,851,225...119,855,103
Ensembl chr 8:119,851,225...119,855,247
G
Rrm2
ribonucleotide reductase regulatory subunit M2
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of RRM2 mRNA
CTD
PMID:18720364
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
G
Rrm2b
ribonucleotide reductase regulatory TP53 inducible subunit M2B
increases expression
ISO
Azacitidine results in increased expression of RRM2B mRNA
CTD
PMID:19010910
NCBI chr 7:69,077,024...69,108,742
Ensembl chr 7:69,078,291...69,108,633
G
RT1-Da
RT1 class II, locus Da
multiple interactions
ISO
[Azacitidine promotes the reaction [IFNG protein results in increased expression of CIITA mRNA]] which results in increased expression of HLA-DRA protein
CTD
PMID:18829986
NCBI chr20:4,513,464...4,518,457
Ensembl chr20:4,512,911...4,518,455
G
Runx1
RUNX family transcription factor 1
multiple interactions
ISO
Azacitidine promotes the reaction [RUNX1 protein binds to KIR2DL2 promoter]; Azacitidine promotes the reaction [RUNX1 protein binds to KIR2DL4 promoter]
CTD
PMID:18945643
NCBI chr11:31,839,880...32,074,427
Ensembl chr11:31,843,764...32,074,542
G
Runx3
RUNX family transcription factor 3
affects methylation
ISO
Azacitidine affects the methylation of RUNX3 gene
CTD
PMID:18058463
NCBI chr 5:147,360,587...147,419,161
Ensembl chr 5:147,360,994...147,419,156
G
S100a14
S100 calcium binding protein A14
decreases expression
ISO
Azacitidine results in decreased expression of S100A14 mRNA
CTD
PMID:20823114
NCBI chr 2:176,008,395...176,010,423
Ensembl chr 2:176,008,395...176,010,423
G
S100a9
S100 calcium binding protein A9
increases expression
ISO
Azacitidine results in increased expression of S100A9 mRNA
CTD
PMID:19194470
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
Sall4
spalt-like transcription factor 4
affects methylation
ISO
Azacitidine affects the methylation of SALL4 promoter
CTD
PMID:17546590
NCBI chr 3:157,474,067...157,491,055
Ensembl chr 3:157,474,642...157,490,822
G
Scamp4
secretory carrier membrane protein 4
increases expression
ISO
Azacitidine results in increased expression of SCAMP4 mRNA
CTD
PMID:20823114
NCBI chr 7:9,101,504...9,113,929
Ensembl chr 7:9,101,489...9,113,967
G
Sdcbp
syndecan binding protein
decreases expression
ISO
Azacitidine results in decreased expression of SDCBP mRNA
CTD
PMID:20823114
NCBI chr 5:19,473,499...19,517,188
Ensembl chr 5:19,489,961...19,527,572
G
Sema3a
semaphorin 3A
increases expression
ISO
Azacitidine results in increased expression of SEMA3A mRNA
CTD
PMID:20823114
NCBI chr 4:21,282,398...21,754,834
Ensembl chr 4:21,287,982...21,494,432
G
Sema6c
semaphorin 6C
increases expression
ISO
Azacitidine results in increased expression of SEMA6C mRNA
CTD
PMID:20823114
NCBI chr 2:182,733,635...182,750,066
Ensembl chr 2:182,737,474...182,746,856
G
Senp3
SUMO specific peptidase 3
increases expression
ISO
Azacitidine results in increased expression of SENP3 mRNA
CTD
PMID:20823114
NCBI chr10:54,390,698...54,399,590
Ensembl chr10:54,390,694...54,399,593
G
Six2
SIX homeobox 2
decreases expression multiple interactions
ISO
Azacitidine results in decreased expression of SIX2 mRNA Cisplatin affects the reaction [Azacitidine results in decreased expression of SIX2 mRNA]
CTD
PMID:36336710
NCBI chr 6:8,974,859...8,981,345
Ensembl chr 6:8,967,157...8,981,193
G
Slbp
stem-loop histone mRNA binding protein
multiple interactions
ISO
Azacitidine inhibits the reaction [sodium arsenite results in decreased expression of SLBP mRNA]
CTD
PMID:25266719
NCBI chr14:77,071,441...77,081,911
Ensembl chr14:77,071,632...77,081,906
G
Slc28a1
solute carrier family 28 member 1
increases response to substance multiple interactions increases uptake
ISO
SLC28A1 protein results in increased susceptibility to Azacitidine [SLC28A1 protein results in increased uptake of Azacitidine] which results in decreased expression of DNMT1 protein; Sodium affects the reaction [SLC28A1 protein results in increased uptake of Azacitidine]
CTD
PMID:19139132
NCBI chr 1:135,079,375...135,122,791
Ensembl chr 1:135,081,385...135,122,464
G
Slc29a2
solute carrier family 29 member 2
decreases expression
ISO
Azacitidine results in decreased expression of SLC29A2 mRNA
CTD
PMID:19194470
NCBI chr 1:202,327,641...202,335,185
Ensembl chr 1:202,327,354...202,335,171
G
Slc5a5
solute carrier family 5 member 5
multiple interactions increases expression
ISO
[Azacitidine co-treated with Butyrates] affects the expression of SLC5A5 mRNA Azacitidine results in increased expression of SLC5A5 mRNA
CTD
PMID:16954431 PMID:17164311
NCBI chr16:18,546,709...18,556,698
Ensembl chr16:18,546,709...18,556,697
G
Snu13
small nuclear ribonucleoprotein 13
increases expression
ISO
Azacitidine results in increased expression of SNU13 mRNA
CTD
PMID:20823114
NCBI chr 7:113,565,293...113,570,887
Ensembl chr 7:113,565,295...113,570,872 Ensembl chr 1:113,565,295...113,570,872
G
Socs3
suppressor of cytokine signaling 3
affects expression
ISO
Azacitidine affects the expression of SOCS3 protein
CTD
PMID:18443271
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Sox13
SRY-box transcription factor 13
decreases expression
ISO
Azacitidine results in decreased expression of SOX13 mRNA
CTD
PMID:20823114
NCBI chr13:44,831,097...44,875,522
Ensembl chr13:44,831,085...44,875,762
G
Sox2
SRY-box transcription factor 2
increases expression
EXP
Azacitidine results in increased expression of SOX2 mRNA
CTD
PMID:27415467
NCBI chr 2:117,536,929...117,539,340
Ensembl chr 2:117,536,929...117,539,338
G
Sox8
SRY-box transcription factor 8
decreases expression
ISO
Azacitidine results in decreased expression of SOX8 mRNA
CTD
PMID:18033690
NCBI chr10:14,584,829...14,589,818
Ensembl chr10:14,584,829...14,589,818
G
Sox9
SRY-box transcription factor 9
affects expression
ISO
Azacitidine affects the expression of SOX9 mRNA
CTD
PMID:18033690
NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994
G
Sp1
Sp1 transcription factor
multiple interactions decreases expression
ISO
Azacitidine promotes the reaction [SP1 protein binds to KIR2DL2 promoter]; Azacitidine promotes the reaction [SP1 protein binds to KIR2DL4 promoter] Azacitidine results in decreased expression of SP1 mRNA Azacitidine promotes the reaction [SP1 protein binds to AQP5 promoter]
CTD
PMID:17198683 PMID:18945643 PMID:20823114
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
G
Sp7
Sp7 transcription factor
increases expression
ISO
Azacitidine results in increased expression of SP7 mRNA
CTD
PMID:17085970
NCBI chr 7:133,484,609...133,494,788
Ensembl chr 7:133,484,609...133,494,847
G
Spag5
sperm associated antigen 5
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of SPAG5 mRNA
CTD
PMID:18720364
NCBI chr10:63,198,717...63,216,746
Ensembl chr10:63,198,768...63,216,745
G
Srpx
sushi-repeat-containing protein, X-linked
decreases expression
ISO
Azacitidine results in decreased expression of SRPX mRNA
CTD
PMID:19194470
NCBI chr X:12,676,984...12,751,296
Ensembl chr X:12,566,645...12,747,882
G
Srsf7
serine and arginine rich splicing factor 7
decreases expression
ISO
Azacitidine results in decreased expression of SRSF7 mRNA
CTD
PMID:20823114
NCBI chr 6:14,811,775...14,818,968
Ensembl chr 6:14,811,808...14,818,965
G
Ssx2ip
SSX family member 2 interacting protein
increases expression
ISO
Azacitidine results in increased expression of SSX2IP mRNA
CTD
PMID:20823114
NCBI chr 2:235,298,012...235,330,750
Ensembl chr 2:235,298,088...235,330,745
G
St3gal6
ST3 beta-galactoside alpha-2,3-sialyltransferase 6
increases expression
ISO
Azacitidine results in increased expression of ST3GAL6 mRNA
CTD
PMID:19194470
NCBI chr11:42,061,282...42,121,801
Ensembl chr11:42,077,621...42,121,776
G
St8sia2
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2
decreases expression
ISO
Azacitidine results in decreased expression of ST8SIA2 mRNA
CTD
PMID:20823114
NCBI chr 1:127,762,573...127,838,017
Ensembl chr 1:127,762,573...127,838,091
G
Stat3
signal transducer and activator of transcription 3
multiple interactions
ISO
[Azacitidine affects the expression of IL6R protein] which affects the phosphorylation of STAT3 protein
CTD
PMID:18443271
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stc2
stanniocalcin 2
decreases expression
ISO
Azacitidine results in decreased expression of STC2 mRNA
CTD
PMID:19194470
NCBI chr10:16,251,046...16,260,815
Ensembl chr10:16,250,853...16,262,973
G
Stk38
serine/threonine kinase 38
decreases expression
ISO
Azacitidine results in decreased expression of STK38 mRNA
CTD
PMID:20823114
NCBI chr20:7,034,245...7,067,803
Ensembl chr20:7,034,242...7,068,198
G
Sulf1
sulfatase 1
decreases expression
ISO
Azacitidine results in decreased expression of SULF1 mRNA
CTD
PMID:20823114
NCBI chr 5:6,362,894...6,526,174
Ensembl chr 5:6,362,911...6,525,584
G
Sult1c2a
sulfotransferase family 1C member 2A
increases expression
ISO
Azacitidine results in increased expression of SULT1C2 mRNA
CTD
PMID:19194470
NCBI chr 9:6,873,697...6,904,736
Ensembl chr 9:6,874,249...6,904,734
G
Tat
tyrosine aminotransferase
increases expression
ISO
Azacitidine results in increased expression of TAT mRNA
CTD
PMID:27590069
NCBI chr19:37,947,153...37,957,717
Ensembl chr19:37,947,112...37,958,031
G
Tbc1d4
TBC1 domain family, member 4
decreases expression
ISO
Azacitidine results in decreased expression of TBC1D4 mRNA
CTD
PMID:19194470
NCBI chr15:78,256,030...78,434,168
Ensembl chr15:78,257,121...78,434,265
G
Tcea1
transcription elongation factor A1
decreases expression
ISO
Azacitidine results in decreased expression of TCEA1 mRNA
CTD
PMID:20823114
NCBI chr 5:14,631,454...14,668,769
Ensembl chr 5:14,631,454...14,668,745 Ensembl chr15:14,631,454...14,668,745
G
Tecpr2
tectonin beta-propeller repeat containing 2
increases expression
ISO
Azacitidine results in increased expression of TECPR2 mRNA
CTD
PMID:19194470
NCBI chr 6:129,899,541...130,001,975
Ensembl chr 6:129,899,636...130,001,974
G
Tek
TEK receptor tyrosine kinase
increases expression
EXP
Azacitidine results in increased expression of TEK mRNA
CTD
PMID:18037191
NCBI chr 5:109,607,077...109,733,805
Ensembl chr 5:109,607,077...109,733,804
G
Tert
telomerase reverse transcriptase
decreases expression multiple interactions decreases methylation decreases activity
ISO
Azacitidine analog results in decreased expression of TERT mRNA; Azacitidine results in decreased expression of TERT mRNA E2F1 protein affects the reaction [Azacitidine results in decreased activity of TERT protein]; E2F1 protein affects the reaction [Azacitidine results in decreased expression of TERT mRNA]; MYC protein affects the reaction [Azacitidine results in decreased activity of TERT protein]; MYC protein affects the reaction [Azacitidine results in decreased expression of TERT mRNA] Azacitidine results in decreased methylation of TERT promoter
CTD
PMID:18045574 PMID:19451745
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
G
Tfe3
transcription factor binding to IGHM enhancer 3
increases expression
ISO
Azacitidine results in increased expression of TFE3 mRNA
CTD
PMID:19194470
NCBI chr X:14,729,547...14,742,830
Ensembl chr X:14,729,550...14,742,571
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO
[Azacitidine co-treated with TGFB1 protein] results in increased expression of FOXP3 protein Azacitidine inhibits the reaction [TGFB1 protein results in decreased expression of PTEN mRNA]; Azacitidine inhibits the reaction [TGFB1 protein results in decreased expression of PTEN protein]; Azacitidine inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]; Azacitidine inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]; Azacitidine inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein]; Azacitidine inhibits the reaction [TGFB1 protein results in increased methylation of PTEN promoter]; Azacitidine inhibits the reaction [TGFB1 protein results in increased phosphorylation of AKT1 protein]
CTD
PMID:18493985 PMID:22841775
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Thumpd1
THUMP domain containing 1
increases expression
ISO
Azacitidine results in increased expression of THUMPD1 mRNA
CTD
PMID:19194470
NCBI chr 1:174,078,875...174,084,915
Ensembl chr 1:174,078,878...174,084,937
G
Timp1
TIMP metallopeptidase inhibitor 1
increases expression
ISO
Azacitidine results in increased expression of TIMP1 mRNA
CTD
PMID:20823114
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Tjp1
tight junction protein 1
increases expression
ISO
Azacitidine results in increased expression of TJP1 mRNA
CTD
PMID:18661270
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
G
Tmed3
transmembrane p24 trafficking protein 3
increases expression
ISO
Azacitidine results in increased expression of TMED3 mRNA
CTD
PMID:20823114
NCBI chr 8:90,241,516...90,249,429
Ensembl chr 8:90,241,516...90,249,346
G
Tmpo
thymopoietin
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of TMPO mRNA
CTD
PMID:18720364
NCBI chr 7:25,642,752...25,667,756
Ensembl chr 7:25,586,725...25,667,727
G
Tnc
tenascin C
decreases expression
ISO
Azacitidine results in decreased expression of TNC mRNA
CTD
PMID:20823114
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
G
Tnf
tumor necrosis factor
increases expression increases response to substance
EXP ISO
Azacitidine results in increased expression of TNF mRNA Azacitidine results in increased susceptibility to TNF protein
CTD
PMID:17156202 PMID:18829727
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfsf10
TNF superfamily member 10
increases response to substance
ISO
Azacitidine results in increased susceptibility to TNFSF10 protein
CTD
PMID:18829727
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tnni3
troponin I3, cardiac type
increases expression
EXP
Azacitidine results in increased expression of TNNI3 protein
CTD
PMID:17105402
NCBI chr 1:69,299,900...69,303,582
Ensembl chr 1:69,299,900...69,303,580
G
Tnnt2
troponin T2, cardiac type
increases expression
EXP
Azacitidine results in increased expression of TNNT2 protein
CTD
PMID:22496879
NCBI chr13:47,267,325...47,285,390
Ensembl chr13:47,267,204...47,285,388
G
Top2a
DNA topoisomerase II alpha
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of TOP2A mRNA; [Curcumin co-treated with Azacitidine] results in decreased expression of TOP2A mRNA
CTD
PMID:18348204 PMID:18720364
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
G
Tp53
tumor protein p53
affects activity
ISO
Azacitidine affects the activity of TP53 protein
CTD
PMID:35435491
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp73
tumor protein p73
multiple interactions
ISO
TP73 protein promotes the reaction [Azacitidine results in increased expression of HMGA2 mRNA]; TP73 protein promotes the reaction [Azacitidine results in increased expression of KLF6 mRNA]; TP73 protein promotes the reaction [Azacitidine results in increased expression of NIBAN1 mRNA]
CTD
PMID:21245298
NCBI chr 5:164,621,377...164,703,958
Ensembl chr 5:164,621,377...164,681,128
G
Tpd52
tumor protein D52
increases expression
EXP
Azacitidine results in increased expression of TPD52 mRNA
CTD
PMID:27415467
NCBI chr 2:92,735,365...92,816,079
Ensembl chr 2:92,735,620...92,816,622
G
Tpm2
tropomyosin 2
increases expression
ISO
Azacitidine results in increased expression of TPM2 mRNA
CTD
PMID:20823114
NCBI chr 5:57,770,919...57,780,278
Ensembl chr 5:57,770,864...57,779,992
G
Tpo
thyroid peroxidase
increases expression
ISO
Azacitidine results in increased expression of TPO mRNA
CTD
PMID:17679169
NCBI chr 6:46,698,402...46,768,199
Ensembl chr 6:46,698,414...46,768,199
G
Tpsg1
tryptase gamma 1
decreases expression
ISO
Azacitidine results in decreased expression of TPSG1 mRNA
CTD
PMID:20823114
NCBI chr10:14,386,352...14,390,258
Ensembl chr10:14,386,352...14,390,258
G
Trh
thyrotropin releasing hormone
decreases expression
ISO
Azacitidine results in decreased expression of TRH mRNA
CTD
PMID:19194470
NCBI chr 4:124,742,111...124,777,094
Ensembl chr 4:124,742,111...124,744,637
G
Trib1
tribbles pseudokinase 1
decreases expression
ISO
Azacitidine results in decreased expression of TRIB1 mRNA
CTD
PMID:19194470
NCBI chr 7:91,206,579...91,213,126
Ensembl chr 7:91,206,579...91,214,731
G
Trim8
tripartite motif-containing 8
increases expression
ISO
Azacitidine results in increased expression of TRIM8 mRNA
CTD
PMID:19194470
NCBI chr 1:245,369,632...245,384,513
Ensembl chr 1:245,369,632...245,384,513
G
Tsc1
TSC complex subunit 1
multiple interactions
ISO
[Azacitidine affects the methylation of TSC1 promoter] which affects the expression of TSC1 mRNA
CTD
PMID:18538015
NCBI chr 3:11,969,547...12,018,591
Ensembl chr 3:11,979,729...12,015,674
G
Tsc2
TSC complex subunit 2
decreases methylation multiple interactions increases expression
ISO
Azacitidine results in decreased methylation of TSC2 promoter [Azacitidine affects the methylation of TSC2 promoter] which affects the expression of TSC2 mRNA Azacitidine results in increased expression of TSC2 mRNA
CTD
PMID:18538015 PMID:19250671
NCBI chr10:13,621,135...13,655,773
Ensembl chr10:13,621,136...13,655,951
G
Tshr
thyroid stimulating hormone receptor
increases expression
ISO
Azacitidine results in increased expression of TSHR mRNA
CTD
PMID:17679169
NCBI chr 6:110,341,585...110,475,297
Ensembl chr 6:110,341,581...110,474,538
G
Tspan32
tetraspanin 32
decreases expression
ISO
Azacitidine results in decreased expression of TSPAN32 mRNA
CTD
PMID:19194470
NCBI chr 1:198,190,128...198,204,447
Ensembl chr 1:198,190,164...198,204,445
G
Ttk
Ttk protein kinase
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of TTK mRNA
CTD
PMID:18720364
NCBI chr 8:84,754,329...84,792,653
Ensembl chr 8:84,754,315...84,792,651
G
Ube2c
ubiquitin-conjugating enzyme E2C
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of UBE2C mRNA
CTD
PMID:18720364
NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
G
Uhmk1
U2AF homology motif kinase 1
increases expression
ISO
Azacitidine results in increased expression of UHMK1 mRNA
CTD
PMID:20823114
NCBI chr13:82,396,646...82,416,292
Ensembl chr13:82,401,187...82,416,292
G
Ush2a
usherin
increases expression
ISO
Azacitidine results in increased expression of USH2A mRNA
CTD
PMID:20823114
NCBI chr13:99,837,445...100,503,935
Ensembl chr13:99,837,445...100,503,922
G
Ushbp1
USH1 protein network component harmonin binding protein 1
decreases expression
ISO
Azacitidine results in decreased expression of USHBP1 mRNA
CTD
PMID:20823114
NCBI chr16:18,057,321...18,067,933
Ensembl chr16:18,057,326...18,067,877
G
Vim
vimentin
decreases expression increases expression multiple interactions
EXP ISO
Azacitidine results in decreased expression of VIM protein Azacitidine results in increased expression of VIM mRNA; Azacitidine results in increased expression of VIM protein [Azacitidine co-treated with Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of VIM protein
CTD
PMID:17105402 PMID:20823114
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Wdr47
WD repeat domain 47
decreases expression
ISO
Azacitidine results in decreased expression of WDR47 mRNA
CTD
PMID:19194470
NCBI chr 2:196,226,757...196,287,739
Ensembl chr 2:196,205,238...196,287,739
G
Wnt10b
Wnt family member 10B
increases expression
EXP
Azacitidine results in increased expression of WNT10B mRNA
CTD
PMID:27415467
NCBI chr 7:129,922,088...129,927,892
Ensembl chr 7:129,922,088...129,927,892
G
Wnt5a
Wnt family member 5A
increases expression
ISO
Azacitidine results in increased expression of WNT5A mRNA
CTD
PMID:20823114
NCBI chr16:3,697,032...3,718,230
Ensembl chr16:3,697,032...3,718,234
G
Wwtr1
WW domain containing transcription regulator 1
increases expression
ISO
Azacitidine results in increased expression of WWTR1 mRNA
CTD
PMID:20823114
NCBI chr 2:141,651,159...141,766,919
Ensembl chr 2:141,648,108...141,766,968
G
Xaf1
XIAP associated factor 1
decreases expression decreases methylation increases expression
ISO
Azacitidine results in decreased expression of XAF1 mRNA alternative form Azacitidine results in decreased methylation of XAF1 promoter Azacitidine results in increased expression of XAF1 mRNA; Azacitidine results in increased expression of XAF1 protein
CTD
PMID:19077051 PMID:19549372
NCBI chr10:56,917,378...56,929,791
Ensembl chr10:56,917,121...56,929,770
G
Zfp189
zinc finger protein 189
decreases expression
ISO
Azacitidine results in decreased expression of ZNF189 mRNA
CTD
PMID:20823114
NCBI chr 5:63,872,596...63,884,348
Ensembl chr 5:63,872,738...63,884,121
G
Zfp64
zinc finger protein 64
affects methylation
ISO
Azacitidine affects the methylation of ZFP64 promoter
CTD
PMID:17546590
NCBI chr 3:157,666,819...157,695,774
Ensembl chr 3:157,633,211...157,695,809
G
Zp3
zona pellucida glycoprotein 3
increases expression
ISO
Azacitidine results in increased expression of ZP3 mRNA
CTD
PMID:20823114
NCBI chr12:20,690,547...20,697,513
Ensembl chr12:20,690,547...20,697,513
G
Gcg
glucagon
multiple interactions
ISO
9-(tetrahydro-2-furyl)-adenine inhibits the reaction [geraniol results in increased secretion of GCG protein]
CTD
PMID:29070885
NCBI chr 3:47,113,914...47,122,958
Ensembl chr 3:47,113,914...47,122,929
G
Pnpla6
patatin-like phospholipase domain containing 6
decreases expression
ISO
9-(tetrahydro-2-furyl)-adenine results in decreased expression of PNPLA6 mRNA; 9-(tetrahydro-2-furyl)-adenine results in decreased expression of PNPLA6 protein
CTD
PMID:20380879
NCBI chr12:1,574,387...1,603,735
Ensembl chr12:1,560,363...1,603,734
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
9-(tetrahydro-2-furyl)-adenine inhibits the reaction [methylmercuric chloride results in increased expression of PTGS2 protein]
CTD
PMID:28958600
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Abcb11
ATP binding cassette subfamily B member 11
decreases expression multiple interactions
EXP ISO
acadesine decreases expression of Abcb11 mRNA in primary hepatocytes acadesine inhibits the reaction [picroside II inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 mRNA]]; acadesine inhibits the reaction [picroside II inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 protein]]
CTD RGD
PMID:32976922 PMID:27090119
RGD:15090804
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcc2
ATP binding cassette subfamily C member 2
decreases expression
EXP
acadesine decreases expression of Abcc2 mRNA in primary hepatocytes
RGD
PMID:27090119
RGD:15090804
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Acaca
acetyl-CoA carboxylase alpha
increases phosphorylation
EXP
acadesine results in increased phosphorylation of ACACA protein
CTD
PMID:22496244
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
G
Acads
acyl-CoA dehydrogenase short chain
multiple interactions
EXP
acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of ACADS mRNA]; acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of and results in decreased activity of ACADS protein]
CTD
PMID:26989860
NCBI chr12:41,493,650...41,502,897
Ensembl chr12:41,493,626...41,502,898
G
Agrp
agouti related neuropeptide
increases expression
ISO
acadesine results in increased expression of AGRP mRNA
CTD
PMID:32575098
NCBI chr19:33,447,992...33,481,602
Ensembl chr19:33,447,992...33,449,584
G
Agt
angiotensinogen
multiple interactions
EXP
acadesine inhibits the reaction [AGT protein results in decreased expression of GJA1 protein]; acadesine inhibits the reaction [AGT protein results in decreased expression of GJA5 protein]; dorsomorphin inhibits the reaction [acadesine inhibits the reaction [AGT protein results in decreased expression of GJA1 protein]]
CTD
PMID:33676887
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Akt1
AKT serine/threonine kinase 1
increases phosphorylation decreases phosphorylation
ISO
acadesine results in increased phosphorylation of AKT1 protein acadesine results in decreased phosphorylation of AKT1 protein
CTD
PMID:22137261 PMID:25603053
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Apln
apelin
multiple interactions
ISO
acadesine inhibits the reaction [Thioctic Acid results in increased expression of APLN mRNA]; acadesine inhibits the reaction [Thioctic Acid results in increased secretion of APLN protein]
CTD
PMID:21461750
NCBI chr X:127,180,801...127,213,567
Ensembl chr X:127,203,823...127,213,391
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
EXP
acadesine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]
CTD
PMID:26989860
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
EXP ISO
acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein] acadesine promotes the reaction [Artesunate results in decreased expression of BCL2 protein]
CTD
PMID:26989860 PMID:33002460
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Becn1
beclin 1
multiple interactions
ISO
acadesine promotes the reaction [Zearalenone results in increased expression of BECN1 protein]
CTD
PMID:31982503
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Casp3
caspase 3
multiple interactions increases cleavage
ISO EXP
acadesine promotes the reaction [Isoniazid results in increased cleavage of CASP3 protein] acadesine inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein] acadesine results in increased cleavage of CASP3 protein
CTD
PMID:22137261 PMID:25603053 PMID:26989860 PMID:28556920
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
increases cleavage
ISO
acadesine results in increased cleavage of CASP9 protein
CTD
PMID:22137261
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cdh1
cadherin 1
multiple interactions
ISO
acadesine promotes the reaction [Capsaicin results in increased expression of CDH1 protein]
CTD
PMID:36044967
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cdh2
cadherin 2
multiple interactions
ISO
acadesine promotes the reaction [Capsaicin results in decreased expression of CDH2 protein]
CTD
PMID:36044967
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
G
Cldn2
claudin 2
multiple interactions decreases expression
ISO
acadesine promotes the reaction [solasodine results in decreased expression of CLDN2 protein] acadesine results in decreased expression of CLDN2 protein
CTD
PMID:37121296
NCBI chr X:103,459,870...103,473,794
Ensembl chr X:103,459,780...103,474,838
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions
EXP
acadesine inhibits the reaction [Acrylamide results in increased expression of CYP2E1 protein]; acadesine inhibits the reaction [glycidamide results in increased expression of CYP2E1 protein]
CTD
PMID:33545342
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
multiple interactions
ISO
acadesine promotes the reaction [picroside II promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP8B1 mRNA]]; acadesine promotes the reaction [picroside II promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP8B1 protein]]
CTD
PMID:32976922
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
G
Ednra
endothelin receptor type A
multiple interactions
EXP
acadesine inhibits the reaction [Smoke results in increased expression of EDNRA protein]
CTD
PMID:36183783
NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
G
Ednrb
endothelin receptor type B
multiple interactions
EXP
acadesine inhibits the reaction [Smoke results in increased expression of EDNRB protein]
CTD
PMID:36183783
NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115
G
Fasn
fatty acid synthase
multiple interactions
ISO
acadesine inhibits the reaction [Dibutyl Phthalate results in increased expression of FASN protein]
CTD
PMID:33508418
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Fndc5
fibronectin type III domain containing 5
multiple interactions
ISO
acadesine inhibits the reaction [Palmitates results in decreased expression of FNDC5 mRNA]; acadesine inhibits the reaction [Palmitates results in decreased expression of FNDC5 protein]
CTD
PMID:36375515
NCBI chr 5:141,481,593...141,491,257
Ensembl chr 5:141,481,590...141,490,731
G
Gja1
gap junction protein, alpha 1
multiple interactions
EXP
acadesine inhibits the reaction [AGT protein results in decreased expression of GJA1 protein]; dorsomorphin inhibits the reaction [acadesine inhibits the reaction [AGT protein results in decreased expression of GJA1 protein]]
CTD
PMID:33676887
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Gja5
gap junction protein, alpha 5
multiple interactions
EXP
acadesine inhibits the reaction [AGT protein results in decreased expression of GJA5 protein]
CTD
PMID:33676887
NCBI chr 2:184,602,407...184,621,952
Ensembl chr 2:184,564,475...184,621,952
G
Gpam
glycerol-3-phosphate acyltransferase, mitochondrial
multiple interactions
ISO
acadesine inhibits the reaction [[Oleic Acid co-treated with Dibutyl Phthalate] results in increased expression of GPAM protein]; acadesine inhibits the reaction [Dibutyl Phthalate results in increased expression of GPAM protein]
CTD
PMID:33508418
NCBI chr 1:254,106,323...254,170,755
Ensembl chr 1:254,106,331...254,142,639
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
multiple interactions
ISO
acadesine promotes the reaction [Capsaicin affects the localization of MAP1LC3A protein]
CTD
PMID:36044967
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
multiple interactions
ISO
acadesine promotes the reaction [Artesunate results in increased lipidation of MAP1LC3B protein]
CTD
PMID:33002460
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
EXP
acadesine inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK1 protein]; acadesine inhibits the reaction [glycidamide results in increased phosphorylation of MAPK1 protein]
CTD
PMID:33545342
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
EXP
acadesine inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK3 protein]; acadesine inhibits the reaction [glycidamide results in increased phosphorylation of MAPK3 protein]
CTD
PMID:33545342
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mef2c
myocyte enhancer factor 2C
decreases expression
ISO
acadesine results in decreased expression of MEF2C mRNA
CTD
PMID:15864539
NCBI chr 2:13,973,299...14,136,065
Ensembl chr 2:13,993,438...14,132,880
G
Mtor
mechanistic target of rapamycin kinase
multiple interactions
ISO
acadesine promotes the reaction [Zearalenone results in decreased phosphorylation of MTOR protein] acadesine promotes the reaction [Artesunate results in decreased phosphorylation of MTOR protein]; acadesine promotes the reaction [Capsaicin results in decreased phosphorylation of MTOR protein]
CTD
PMID:31982503 PMID:33002460 PMID:36044967
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
decreases expression multiple interactions
EXP ISO
acadesine decreases expression of Nr1h4 mRNA and protein in primary hepatocytes acadesine inhibits the reaction [picroside II inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 mRNA]]; acadesine inhibits the reaction [picroside II inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 protein]]
CTD RGD
PMID:32976922 PMID:27090119
RGD:15090804
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Nrf1
nuclear respiratory factor 1
multiple interactions increases expression
ISO
acadesine inhibits the reaction [Isoniazid results in decreased expression of NRF1 protein] acadesine results in increased expression of NRF1 protein
CTD
PMID:28556920
NCBI chr 4:58,664,932...58,772,328
Ensembl chr 4:58,664,957...58,825,328
G
Ocln
occludin
multiple interactions
ISO
acadesine promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of OCLN protein]
CTD
PMID:33400020
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
acadesine promotes the reaction [Artesunate results in increased cleavage of PARP1 protein]
CTD
PMID:33002460
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions
EXP
acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARA mRNA]; acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARA protein]
CTD
PMID:26989860
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Ppargc1a
PPARG coactivator 1 alpha
multiple interactions increases expression
ISO EXP
acadesine inhibits the reaction [Isoniazid results in decreased expression of PPARGC1A protein] acadesine results in increased expression of PPARGC1A mRNA Dietary Fats promotes the reaction [acadesine results in increased expression of PPARGC1A mRNA] acadesine results in increased expression of PPARGC1A protein
CTD
PMID:22496244 PMID:28556920
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Prkaa1
protein kinase AMP-activated catalytic subunit alpha 1
increases phosphorylation multiple interactions
EXP ISO
acadesine increases phosphorylation of Prkaa1 in primary hepatocytes acadesine results in increased phosphorylation of PRKAA1 protein acadesine inhibits the reaction [Smoke results in decreased phosphorylation of PRKAA1 protein] acadesine promotes the reaction [Capsaicin results in increased expression of PRKAA1 protein]
CTD RGD
PMID:22815988 PMID:33676887 PMID:36044967 PMID:36183783 PMID:37121296 PMID:27090119 More...
RGD:15090804
NCBI chr 2:54,240,298...54,275,978
Ensembl chr 2:54,240,137...54,275,978
G
Prkaa2
protein kinase AMP-activated catalytic subunit alpha 2
multiple interactions
ISO
acadesine promotes the reaction [Capsaicin results in increased expression of PRKAA2 protein]
CTD
PMID:36044967
NCBI chr 5:119,807,992...119,879,987
Ensembl chr 5:119,813,226...119,879,543
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
acadesine inhibits the reaction [[Fluorouracil results in increased expression of PTGS2 protein] which results in increased abundance of and results in increased secretion of Dinoprostone]; acadesine inhibits the reaction [Fluorouracil results in increased expression of PTGS2 protein]
CTD
PMID:15896711
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Rhoa
ras homolog family member A
decreases expression
ISO
acadesine results in decreased expression of RHOA protein
CTD
PMID:37121296
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
G
Rps6kb1
ribosomal protein S6 kinase B1
multiple interactions
ISO
acadesine promotes the reaction [Zearalenone results in decreased phosphorylation of RPS6KB1 protein]
CTD
PMID:31982503
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
G
Sirt1
sirtuin 1
multiple interactions increases expression
ISO
acadesine inhibits the reaction [Isoniazid results in decreased expression of SIRT1 protein] acadesine results in increased expression of SIRT1 protein
CTD
PMID:28556920
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Slc10a1
solute carrier family 10 member 1
decreases expression
EXP
acadesine decreases expression of Slc10a1 mRNA in primary hepatocytes
RGD
PMID:27090119
RGD:15090804
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
G
Slc2a1
solute carrier family 2 member 1
increases expression
ISO
acadesine results in increased expression of SLC2A1 mRNA
CTD
PMID:15864539
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
G
Slco1a4
solute carrier organic anion transporter family, member 1a4
decreases expression
EXP
acadesine decreases expression of Slco1a4 mRNA in primary hepatocytes
RGD
PMID:27090119
RGD:15090804
NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions
ISO
acadesine inhibits the reaction [Dibutyl Phthalate results in increased expression of SREBF1 protein]
CTD
PMID:33508418
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Tjp1
tight junction protein 1
multiple interactions
ISO
acadesine inhibits the reaction [SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of TJP1 protein]]; acadesine promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of TJP1 protein]
CTD
PMID:33400020
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
G
Ulk1
unc-51 like autophagy activating kinase 1
multiple interactions
ISO
acadesine promotes the reaction [Artesunate results in increased phosphorylation of ULK1 protein]
CTD
PMID:33002460
NCBI chr12:45,851,710...45,877,966
Ensembl chr12:45,851,710...45,877,966
G
Zfp57
zinc finger protein 57
multiple interactions
ISO
acadesine inhibits the reaction [Palmitates results in increased expression of ZFP57 mRNA]; acadesine inhibits the reaction [Palmitates results in increased expression of ZFP57 protein]
CTD
PMID:36375515
NCBI chr20:1,521,323...1,534,884
Ensembl chr20:1,521,323...1,529,846
G
Abcb11
ATP binding cassette subfamily B member 11
decreases expression
EXP
AICA ribonucleotide results in decreased expression of ABCB11 mRNA
CTD
PMID:27090119
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcc2
ATP binding cassette subfamily C member 2
decreases expression
EXP
AICA ribonucleotide results in decreased expression of ABCC2 mRNA
CTD
PMID:27090119
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abl1
ABL proto-oncogene 1, non-receptor tyrosine kinase
multiple interactions
ISO
AICA ribonucleotide promotes the reaction [ABL1 protein mutant form binds to BECN1 protein]; AICA ribonucleotide promotes the reaction [ABL1 protein mutant form binds to XPO1 protein]; AICA ribonucleotide promotes the reaction [ABL1 protein mutant form binds to YWHAQ protein]; AICA ribonucleotide results in decreased expression of and affects the localization of ABL1 protein mutant form
CTD
PMID:33070465
NCBI chr 3:14,979,853...15,083,065
Ensembl chr 3:14,979,853...15,083,065
G
Acaca
acetyl-CoA carboxylase alpha
increases phosphorylation multiple interactions increases expression
ISO EXP
AICA ribonucleotide results in increased phosphorylation of ACACA protein AICA ribonucleotide inhibits the reaction [fipronil results in increased expression of and results in decreased phosphorylation of ACACA protein]; AICA ribonucleotide results in decreased expression of and results in increased phosphorylation of ACACA protein AICA ribonucleotide results in increased expression of ACACA protein modified form
CTD
PMID:15297373 PMID:16020477 PMID:16873680 PMID:20080969 PMID:25743752 PMID:27103584 More...
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
G
Acacb
acetyl-CoA carboxylase beta
increases phosphorylation
ISO
AICA ribonucleotide results in increased phosphorylation of ACACB protein
CTD
PMID:16873680
NCBI chr12:42,365,800...42,477,651
Ensembl chr12:42,366,548...42,457,655
G
Acadm
acyl-CoA dehydrogenase medium chain
multiple interactions increases expression
EXP ISO
AICA ribonucleotide inhibits the reaction [Phenylephrine results in decreased expression of ACADM mRNA] AICA ribonucleotide results in increased expression of ACADM mRNA; AICA ribonucleotide results in increased expression of ACADM protein
CTD
PMID:19699196 PMID:25743752
NCBI chr 2:242,858,865...242,883,036
Ensembl chr 2:242,858,865...242,883,147
G
Acta2
actin alpha 2, smooth muscle
multiple interactions
ISO
AICA ribonucleotide inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]
CTD
PMID:27688165
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
G
Adipoq
adiponectin, C1Q and collagen domain containing
increases expression multiple interactions
ISO EXP
AICA ribonucleotide results in increased expression of ADIPOQ protein AICA ribonucleotide inhibits the reaction [Palmitic Acid results in decreased expression of ADIPOQ mRNA]
CTD
PMID:20980258 PMID:25108154
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
ISO
AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form results in decreased oxidation of Fatty Acids]; AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form results in increased phosphorylation of EIF4EBP1 protein]; AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form results in increased susceptibility to Glucose deficiency]; PRKAA2 protein affects the reaction [AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form affects the susceptibility to Glucose deficiency]]
CTD
PMID:15806154
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
App
amyloid beta precursor protein
decreases expression
ISO
AICA ribonucleotide results in decreased expression of APP protein modified form
CTD
PMID:20080969
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Arg1
arginase 1
multiple interactions
EXP
AICA ribonucleotide inhibits the reaction [Palmitic Acid results in decreased expression of ARG1 mRNA]
CTD
PMID:25108154
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
G
Atg5
autophagy related 5
multiple interactions
ISO
AICA ribonucleotide inhibits the reaction [Ethanol results in decreased expression of ATG5 protein]
CTD
PMID:24582693
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
G
Becn1
beclin 1
increases expression multiple interactions
EXP ISO
AICA ribonucleotide results in increased expression of BECN1 protein AICA ribonucleotide promotes the reaction [ABL1 protein mutant form binds to BECN1 protein]; AICA ribonucleotide promotes the reaction [XPO1 protein binds to BECN1 protein]; AICA ribonucleotide results in increased expression of and affects the localization of BECN1 protein AICA ribonucleotide promotes the reaction [4-nonylphenol results in increased expression of BECN1 protein]
CTD
PMID:28041982 PMID:33070465
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Casp3
caspase 3
increases activity multiple interactions
EXP ISO
AICA ribonucleotide results in increased activity of CASP3 protein AICA ribonucleotide inhibits the reaction [sunitinib results in increased cleavage of CASP3 protein]
CTD
PMID:16469385 PMID:21906609
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
multiple interactions
ISO
AICA ribonucleotide inhibits the reaction [sunitinib results in increased cleavage of CASP7 protein]
CTD
PMID:21906609
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Casp9
caspase 9
increases activity
EXP
AICA ribonucleotide results in increased activity of CASP9 protein
CTD
PMID:16469385
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
multiple interactions increases expression
ISO
AICA ribonucleotide promotes the reaction [FOXO1 protein results in increased expression of CAT mRNA] AICA ribonucleotide results in increased expression of CAT mRNA; AICA ribonucleotide results in increased expression of CAT protein
CTD
PMID:25065674
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions decreases expression
EXP ISO
AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased expression of CCL2 mRNA] AICA ribonucleotide results in decreased expression of CCL2 mRNA AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; dorsomorphin inhibits the reaction [AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]]; dorsomorphin inhibits the reaction [AICA ribonucleotide results in decreased expression of CCL2 mRNA]
CTD
PMID:24465016 PMID:25108154
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl3
C-C motif chemokine ligand 3
multiple interactions
ISO
AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased expression of CCL3 mRNA]
CTD
PMID:21745629
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccna2
cyclin A2
multiple interactions decreases expression
ISO
AICA ribonucleotide inhibits the reaction [ELAVL1 protein binds to CCNA2 3' UTR] AICA ribonucleotide results in decreased expression of CCNA2 mRNA; AICA ribonucleotide results in decreased expression of CCNA2 protein
CTD
PMID:12730239
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb1
cyclin B1
multiple interactions decreases expression
ISO
AICA ribonucleotide inhibits the reaction [ELAVL1 protein binds to CCNB1 3' UTR] AICA ribonucleotide results in decreased expression of CCNB1 mRNA; AICA ribonucleotide results in decreased expression of CCNB1 protein
CTD
PMID:12730239
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Cd36
CD36 molecule
multiple interactions
ISO
AICA ribonucleotide results in increased expression of and affects the localization of CD36 protein
CTD
PMID:28038998
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cebpa
CCAAT/enhancer binding protein alpha
decreases expression multiple interactions
ISO
AICA ribonucleotide results in decreased expression of CEBPA protein AICA ribonucleotide inhibits the reaction [fipronil results in increased expression of CEBPA protein]
CTD
PMID:27103584
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Cebpb
CCAAT/enhancer binding protein beta
increases phosphorylation
ISO
AICA ribonucleotide results in increased phosphorylation of CEBPB protein
CTD
PMID:28038998
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
G
Cftr
CF transmembrane conductance regulator
multiple interactions
EXP
AICA ribonucleotide inhibits the reaction [Colforsin results in increased activity of CFTR protein]
CTD
PMID:12519745
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
G
Col1a1
collagen type I alpha 1 chain
multiple interactions
ISO
AICA ribonucleotide inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein]
CTD
PMID:27688165
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Cpt1a
carnitine palmitoyltransferase 1A
increases expression multiple interactions
ISO
AICA ribonucleotide results in increased expression of CPT1A mRNA; AICA ribonucleotide results in increased expression of CPT1A protein AICA ribonucleotide inhibits the reaction [TP53 gene mutant form results in increased expression of CPT1A protein] dorsomorphin inhibits the reaction [AICA ribonucleotide results in increased expression of CPT1A mRNA]
CTD
PMID:24465016 PMID:25743752 PMID:33070465
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
G
Cpt1b
carnitine palmitoyltransferase 1B
multiple interactions
EXP
AICA ribonucleotide inhibits the reaction [Phenylephrine results in decreased expression of CPT1B mRNA]; AICA ribonucleotide inhibits the reaction [Phenylephrine results in decreased expression of CPT1B protein]
CTD
PMID:19699196
NCBI chr 7:120,491,354...120,500,833
Ensembl chr 7:120,491,354...120,500,404
G
Ctnnb1
catenin beta 1
multiple interactions increases expression
ISO
[AICA ribonucleotide results in increased phosphorylation of HDAC5 protein] which results in increased expression of CTNNB1 mRNA; [AICA ribonucleotide results in increased phosphorylation of HDAC5 protein] which results in increased expression of CTNNB1 protein; AICA ribonucleotide inhibits the reaction [[HDAC5 protein binds to MEF2 protein] which binds to CTNNB1 promoter]; PRKAA2 protein affects the reaction [AICA ribonucleotide results in increased expression of CTNNB1 mRNA]; PRKAA2 protein affects the reaction [AICA ribonucleotide results in increased expression of CTNNB1 protein] AICA ribonucleotide results in increased expression of CTNNB1 mRNA; AICA ribonucleotide results in increased expression of CTNNB1 protein
CTD
PMID:21454484
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Cyba
cytochrome b-245 alpha chain
multiple interactions
EXP
AICA ribonucleotide inhibits the reaction [Cadmium Chloride results in increased expression of CYBA protein]
CTD
PMID:21195169
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
G
Cybb
cytochrome b-245 beta chain
multiple interactions
EXP
AICA ribonucleotide inhibits the reaction [Cadmium Chloride results in increased expression of CYBB protein]
CTD
PMID:21195169
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
multiple interactions
EXP
AICA ribonucleotide promotes the reaction [NR1I3 protein results in increased expression of CYP2B10 mRNA]; PRKAA2 protein promotes the reaction [AICA ribonucleotide promotes the reaction [NR1I3 protein results in increased expression of CYP2B10 mRNA]]
CTD
PMID:22815988
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Egfr
epidermal growth factor receptor
multiple interactions
ISO
AICA ribonucleotide inhibits the reaction [EGFR protein results in increased import of Deoxyglucose]
CTD
PMID:19625624
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
decreases phosphorylation
ISO
AICA ribonucleotide results in decreased phosphorylation of EIF2S1 protein
CTD
PMID:22898769
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
multiple interactions decreases phosphorylation
ISO EXP
AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form results in increased phosphorylation of EIF4EBP1 protein] AICA ribonucleotide results in decreased phosphorylation of EIF4EBP1 protein AICA ribonucleotide inhibits the reaction [Cadmium Chloride results in increased phosphorylation of EIF4EBP1 protein]
CTD
PMID:15806154 PMID:21195169 PMID:28041982
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
G
Elavl1
ELAV like RNA binding protein 1
multiple interactions decreases localization
ISO
AICA ribonucleotide inhibits the reaction [ELAVL1 protein binds to CCNA2 3' UTR]; AICA ribonucleotide inhibits the reaction [ELAVL1 protein binds to CCNB1 3' UTR] AICA ribonucleotide results in decreased localization of ELAVL1 protein
CTD
PMID:12730239
NCBI chr12:2,640,936...2,684,787
Ensembl chr12:2,645,061...2,684,784
G
Foxo1
forkhead box O1
multiple interactions increases expression increases phosphorylation increases activity
ISO
AICA ribonucleotide promotes the reaction [FOXO1 protein results in increased expression of CAT mRNA]; AICA ribonucleotide promotes the reaction [FOXO1 protein results in increased expression of SOD2 mRNA] AICA ribonucleotide results in increased expression of FOXO1 protein AICA ribonucleotide results in increased phosphorylation of FOXO1 protein AICA ribonucleotide results in increased activity of FOXO1 protein
CTD
PMID:25065674
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
G
Fshb
follicle stimulating hormone subunit beta
multiple interactions
EXP
AICA ribonucleotide inhibits the reaction [[IGF1 protein co-treated with FSHB protein] results in increased phosphorylation of MAPK1 protein]; AICA ribonucleotide inhibits the reaction [[IGF1 protein co-treated with FSHB protein] results in increased phosphorylation of MAPK3 protein]; AICA ribonucleotide inhibits the reaction [FSHB protein results in increased phosphorylation of MAPK3 protein]
CTD
PMID:16020477
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
decreases expression
EXP
AICA ribonucleotide results in decreased expression of G6PC1 mRNA
CTD
PMID:19664596
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
G
Gpr68
G protein-coupled receptor 68
multiple interactions
ISO
AICA ribonucleotide inhibits the reaction [TNF protein promotes the reaction [Oxygen deficiency results in increased expression of GPR68 mRNA]]; AICA ribonucleotide inhibits the reaction [TNF protein results in increased expression of GPR68 mRNA]
CTD
PMID:28174749
NCBI chr 6:120,135,620...120,166,089
Ensembl chr 6:120,135,436...120,166,089
G
Grb2
growth factor receptor bound protein 2
multiple interactions
EXP
GRB2 protein affects the reaction [AICA ribonucleotide results in increased activity of PRKCZ protein]
CTD
PMID:11978788
NCBI chr10:100,881,404...100,949,193
Ensembl chr10:100,869,718...100,949,309
G
Gstk1
glutathione S-transferase kappa 1
increases expression
ISO
AICA ribonucleotide results in increased expression of GSTK1 protein
CTD
PMID:20980258
NCBI chr 4:71,118,979...71,123,298
Ensembl chr 4:71,118,896...71,123,292
G
Hdac5
histone deacetylase 5
multiple interactions increases phosphorylation
ISO
[AICA ribonucleotide results in increased phosphorylation of HDAC5 protein] which results in increased expression of CTNNB1 mRNA; [AICA ribonucleotide results in increased phosphorylation of HDAC5 protein] which results in increased expression of CTNNB1 protein; AICA ribonucleotide inhibits the reaction [[HDAC5 protein binds to MEF2 protein] which binds to CTNNB1 promoter]
CTD
PMID:21454484
NCBI chr10:87,152,978...87,187,921
Ensembl chr10:87,152,978...87,188,235
G
Hnf4a
hepatocyte nuclear factor 4, alpha
decreases expression
ISO
AICA ribonucleotide results in decreased expression of HNF4A mRNA
CTD
PMID:24428821
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
G
Hsd3b1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
decreases expression
EXP
AICA ribonucleotide results in decreased expression of HSD3B1 mRNA; AICA ribonucleotide results in decreased expression of HSD3B1 protein
CTD
PMID:16020477
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
G
Igf1
insulin-like growth factor 1
multiple interactions
EXP
AICA ribonucleotide inhibits the reaction [[IGF1 protein co-treated with FSHB protein] results in increased phosphorylation of MAPK1 protein]; AICA ribonucleotide inhibits the reaction [[IGF1 protein co-treated with FSHB protein] results in increased phosphorylation of MAPK3 protein]; AICA ribonucleotide inhibits the reaction [IGF1 protein results in increased phosphorylation of MAPK1 protein]
CTD
PMID:16020477
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Il1b
interleukin 1 beta
multiple interactions decreases expression
ISO
AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; dorsomorphin inhibits the reaction [AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; dorsomorphin inhibits the reaction [AICA ribonucleotide results in decreased expression of IL1B mRNA]
CTD
PMID:24465016
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions decreases expression
EXP ISO
AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased expression of IL6 mRNA] AICA ribonucleotide results in decreased expression of IL6 mRNA AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; dorsomorphin inhibits the reaction [AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; dorsomorphin inhibits the reaction [AICA ribonucleotide results in decreased expression of IL6 mRNA]
CTD
PMID:24465016 PMID:25108154
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Ins1
insulin 1
multiple interactions
ISO
AICA ribonucleotide inhibits the reaction [INS1 protein results in increased phosphorylation of TBC1D1 protein]; AICA ribonucleotide inhibits the reaction [INS1 protein results in increased phosphorylation of TBC1D4 protein]
CTD
PMID:24343960 PMID:26627467
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
G
Insr
insulin receptor
multiple interactions decreases activity decreases expression
ISO
5'-amino-5'-deoxyadenosine inhibits the reaction [AICA ribonucleotide results in decreased activity of INSR promoter]; 5'-amino-5'-deoxyadenosine inhibits the reaction [AICA ribonucleotide results in decreased expression of INSR mRNA]; 5'-amino-5'-deoxyadenosine inhibits the reaction [AICA ribonucleotide results in decreased expression of INSR protein]; Dipyridamole inhibits the reaction [AICA ribonucleotide results in decreased activity of INSR promoter]; Dipyridamole inhibits the reaction [AICA ribonucleotide results in decreased expression of INSR mRNA]; Dipyridamole inhibits the reaction [AICA ribonucleotide results in decreased expression of INSR protein] AICA ribonucleotide results in decreased expression of INSR mRNA; AICA ribonucleotide results in decreased expression of INSR protein
CTD
PMID:15694368
NCBI chr12:1,193,193...1,330,976
Ensembl chr12:1,197,100...1,330,883
G
Kcnj11
potassium inwardly-rectifying channel, subfamily J, member 11
affects response to substance
ISO
KCNJ11 protein affects the susceptibility to AICA ribonucleotide
CTD
PMID:24498880
NCBI chr 1:96,591,048...96,594,574
Ensembl chr 1:96,591,049...96,594,082
G
Klf15
KLF transcription factor 15
decreases expression
ISO
AICA ribonucleotide results in decreased expression of KLF15 mRNA
CTD
PMID:24428821
NCBI chr 4:122,965,718...122,978,403
Ensembl chr 4:122,965,807...122,978,374
G
Map3k7
mitogen activated protein kinase kinase kinase 7
increases activity
EXP
AICAR increases activity of Map3k7 protein in cardiac muscle cells
RGD
PMID:17085580
RGD:155791450
NCBI chr 5:46,356,973...46,415,597
Ensembl chr 5:46,357,931...46,415,597
G
Mapk1
mitogen activated protein kinase 1
multiple interactions increases phosphorylation decreases phosphorylation
EXP ISO
AICA ribonucleotide inhibits the reaction [[IGF1 protein co-treated with FSHB protein] results in increased phosphorylation of MAPK1 protein]; AICA ribonucleotide inhibits the reaction [IGF1 protein results in increased phosphorylation of MAPK1 protein] AICA ribonucleotide results in increased phosphorylation of MAPK1 protein AICA ribonucleotide results in decreased phosphorylation of MAPK1 protein
CTD
PMID:16020477 PMID:28038998
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions increases phosphorylation decreases phosphorylation
EXP ISO
AICA ribonucleotide inhibits the reaction [[IGF1 protein co-treated with FSHB protein] results in increased phosphorylation of MAPK3 protein]; AICA ribonucleotide inhibits the reaction [FSHB protein results in increased phosphorylation of MAPK3 protein]; MAPK3 protein affects the reaction [AICA ribonucleotide results in increased uptake of Deoxyglucose]; PTK2B protein affects the reaction [AICA ribonucleotide results in increased activity of MAPK3 protein] AICA ribonucleotide results in increased phosphorylation of MAPK3 protein AICA ribonucleotide results in decreased phosphorylation of MAPK3 protein
CTD
PMID:11978788 PMID:16020477 PMID:28038998
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mfn1
mitofusin 1
multiple interactions
EXP
AICA ribonucleotide inhibits the reaction [Acetaminophen results in decreased expression of MFN1 protein]; AICA ribonucleotide inhibits the reaction [Diclofenac results in decreased expression of MFN1 protein]
CTD
PMID:27792760
NCBI chr 2:115,313,380...115,359,651
Ensembl chr 2:115,313,401...115,359,640
G
Mfn2
mitofusin 2
multiple interactions
EXP
AICA ribonucleotide inhibits the reaction [Acetaminophen results in decreased expression of MFN2 protein]; AICA ribonucleotide inhibits the reaction [Diclofenac results in decreased expression of MFN2 protein]
CTD
PMID:27792760
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
G
Mmp13
matrix metallopeptidase 13
multiple interactions
ISO
AICA ribonucleotide inhibits the reaction [TGFB1 protein results in decreased expression of MMP13 protein]
CTD
PMID:27688165
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
G
Mmp2
matrix metallopeptidase 2
decreases activity
ISO
AICA ribonucleotide results in decreased activity of MMP2 protein
CTD
PMID:20590612
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
decreases activity
ISO
AICA ribonucleotide results in decreased activity of MMP9 protein
CTD
PMID:20590612
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mpst
mercaptopyruvate sulfurtransferase
decreases expression
EXP
AICA ribonucleotide results in decreased expression of MPST mRNA
CTD
PMID:35577173
NCBI chr 7:109,955,581...109,963,155
Ensembl chr 7:109,955,675...109,963,141
G
Mtor
mechanistic target of rapamycin kinase
decreases activity decreases phosphorylation multiple interactions
ISO EXP
AICA ribonucleotide results in decreased activity of MTOR protein AICA ribonucleotide results in decreased phosphorylation of MTOR protein AICA ribonucleotide promotes the reaction [4-nonylphenol results in decreased phosphorylation of MTOR protein] AICA ribonucleotide promotes the reaction [Cadmium results in decreased phosphorylation of MTOR protein]
CTD
PMID:19625624 PMID:21767558 PMID:27363783 PMID:28041982
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Ncf1
neutrophil cytosolic factor 1
multiple interactions
EXP
AICA ribonucleotide inhibits the reaction [Cadmium Chloride results in increased expression of NCF1 protein]
CTD
PMID:21195169
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
G
Ncf2
neutrophil cytosolic factor 2
multiple interactions
EXP
AICA ribonucleotide inhibits the reaction [Cadmium Chloride results in increased expression of NCF2 protein]
CTD
PMID:21195169
NCBI chr13:64,955,622...64,986,144
Ensembl chr13:64,955,503...64,986,277
G
Ncf4
neutrophil cytosolic factor 4
multiple interactions
EXP
AICA ribonucleotide inhibits the reaction [Cadmium Chloride results in increased expression of NCF4 protein]
CTD
PMID:21195169
NCBI chr 7:109,825,420...109,843,389
Ensembl chr 7:109,826,020...109,843,389
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
ISO
AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased localization of NFKB1 protein]
CTD
PMID:22025971
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nos2
nitric oxide synthase 2
multiple interactions
EXP ISO
AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA] AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; dorsomorphin inhibits the reaction [AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]]
CTD
PMID:24465016 PMID:25108154
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
multiple interactions
EXP
AICA ribonucleotide inhibits the reaction [Palmitic Acid inhibits the reaction [Acetylcholine results in increased phosphorylation of NOS3 protein]]
CTD
PMID:25108154
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
decreases expression
ISO
AICA ribonucleotide results in decreased expression of NR0B2 mRNA
CTD
PMID:24428821
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
decreases expression
EXP
AICA ribonucleotide results in decreased expression of NR1H4 mRNA; AICA ribonucleotide results in decreased expression of NR1H4 protein
CTD
PMID:27090119
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
multiple interactions
EXP
AICA ribonucleotide inhibits the reaction [Phenobarbital results in increased localization of and results in increased activity of NR1I3 protein]; AICA ribonucleotide promotes the reaction [NR1I3 protein results in increased expression of CYP2B10 mRNA]; PRKAA2 protein promotes the reaction [AICA ribonucleotide promotes the reaction [NR1I3 protein results in increased expression of CYP2B10 mRNA]]
CTD
PMID:20686344 PMID:22815988
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Nrf1
nuclear respiratory factor 1
multiple interactions increases expression
EXP
dorsomorphin inhibits the reaction [AICA ribonucleotide results in increased expression of NRF1 mRNA]
CTD
PMID:20438809
NCBI chr 4:58,664,932...58,772,328
Ensembl chr 4:58,664,957...58,825,328
G
Opa1
OPA1, mitochondrial dynamin like GTPase
multiple interactions
EXP
AICA ribonucleotide inhibits the reaction [Acetaminophen results in decreased expression of OPA1 protein]; AICA ribonucleotide inhibits the reaction [Diclofenac results in decreased expression of OPA1 protein]
CTD
PMID:27792760
NCBI chr11:71,108,100...71,185,170
Ensembl chr11:71,109,873...71,185,109
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions
EXP
AICA ribonucleotide inhibits the reaction [Phenylephrine results in decreased expression of PPARA mRNA]; AICA ribonucleotide inhibits the reaction [Phenylephrine results in decreased expression of PPARA protein]
CTD
PMID:19699196
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions
EXP ISO
AICA ribonucleotide inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA] AICA ribonucleotide inhibits the reaction [TGFB1 protein results in decreased expression of PPARG protein]
CTD
PMID:25108154 PMID:27688165
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppargc1a
PPARG coactivator 1 alpha
multiple interactions increases expression decreases expression
EXP ISO
dorsomorphin inhibits the reaction [AICA ribonucleotide results in increased expression of PPARGC1A mRNA] AICA ribonucleotide results in decreased expression of PPARGC1A mRNA AICA ribonucleotide inhibits the reaction [Glucose results in decreased expression of PPARGC1A protein]; dorsomorphin promotes the reaction [AICA ribonucleotide results in decreased expression of PPARGC1A mRNA] AICA ribonucleotide inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARGC1A protein]
CTD
PMID:20438809 PMID:23090186 PMID:24428821 PMID:25522270
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Prkaa1
protein kinase AMP-activated catalytic subunit alpha 1
increases phosphorylation multiple interactions increases expression increases activity
EXP ISO
AICA ribonucleotide results in increased phosphorylation of PRKAA1 protein AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in decreased phosphorylation of PRKAA1 protein]; dorsomorphin inhibits the reaction [AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in decreased phosphorylation of PRKAA1 protein]]; dorsomorphin inhibits the reaction [AICA ribonucleotide results in increased phosphorylation of PRKAA1 protein] AICA ribonucleotide promotes the reaction [Quercetin results in increased phosphorylation of and results in increased activity of PRKAA1 protein]; AICA ribonucleotide results in increased phosphorylation of and results in increased activity of PRKAA1 protein; PRKAA1 protein affects the reaction [AICA ribonucleotide results in increased expression of CYP4F2 mRNA]; Quercetin promotes the reaction [AICA ribonucleotide results in increased phosphorylation of and results in increased activity of PRKAA1 protein] AICA ribonucleotide results in increased expression of PRKAA1 protein modified form [AICA ribonucleotide results in increased phosphorylation of PRKAA1 protein] which results in decreased secretion of Progesterone; AICA ribonucleotide inhibits the reaction [Cadmium Chloride results in decreased phosphorylation of PRKAA1 protein]; AICA ribonucleotide inhibits the reaction [Sodium Chloride, Dietary results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein]; AICA ribonucleotide inhibits the reaction [Sodium Chloride, Dietary results in increased expression of PRKAA1 mRNA] AICA ribonucleotide results in increased activity of PRKAA1 protein
CTD
PMID:12519745 PMID:16020477 PMID:16873680 PMID:19293639 PMID:20349193 PMID:21195169 PMID:21205922 PMID:23266269 PMID:24465016 PMID:25743752 PMID:28298333 More...
NCBI chr 2:54,240,298...54,275,978
Ensembl chr 2:54,240,137...54,275,978
G
Prkaa2
protein kinase AMP-activated catalytic subunit alpha 2
multiple interactions increases phosphorylation
ISO EXP
AICA ribonucleotide results in increased phosphorylation of and results in increased activity of PRKAA2 protein; PRKAA2 protein affects the reaction [AICA ribonucleotide results in increased expression of CYP4F2 mRNA] PRKAA2 protein promotes the reaction [AICA ribonucleotide promotes the reaction [NR1I3 protein results in increased expression of CYP2B10 mRNA]] AICA ribonucleotide results in increased phosphorylation of PRKAA2 protein PRKAA2 protein affects the reaction [AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form affects the susceptibility to Glucose deficiency]]; PRKAA2 protein affects the reaction [AICA ribonucleotide results in increased expression of CTNNB1 mRNA]; PRKAA2 protein affects the reaction [AICA ribonucleotide results in increased expression of CTNNB1 protein]
CTD
PMID:15806154 PMID:16873680 PMID:18482975 PMID:21205922 PMID:21454484 PMID:22815988 More...
NCBI chr 5:119,807,992...119,879,987
Ensembl chr 5:119,813,226...119,879,543
G
Prkcz
protein kinase C, zeta
multiple interactions increases activity
EXP
1-Butanol inhibits the reaction [AICA ribonucleotide results in increased activity of PRKCZ protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [AICA ribonucleotide results in increased activity of PRKCZ protein]; Genistein inhibits the reaction [AICA ribonucleotide results in increased activity of PRKCZ protein]; GRB2 protein affects the reaction [AICA ribonucleotide results in increased activity of PRKCZ protein]; PTK2B protein affects the reaction [AICA ribonucleotide results in increased activity of PRKCZ protein]
CTD
PMID:11978788
NCBI chr 5:165,817,786...165,930,386
Ensembl chr 5:165,819,466...165,930,367
G
Pten
phosphatase and tensin homolog
increases response to substance
ISO
PTEN protein results in increased susceptibility to AICA ribonucleotide
CTD
PMID:19625624
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]
CTD
PMID:22025971
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptk2b
protein tyrosine kinase 2 beta
multiple interactions
EXP
AICA ribonucleotide results in increased phosphorylation of and results in increased activity of PTK2B protein; PTK2B protein affects the reaction [AICA ribonucleotide results in increased activity of MAPK3 protein]; PTK2B protein affects the reaction [AICA ribonucleotide results in increased activity of PRKCZ protein]
CTD
PMID:11978788
NCBI chr15:40,360,722...40,481,235
Ensembl chr15:40,360,723...40,481,282
G
Rac1
Rac family small GTPase 1
multiple interactions
EXP
AICA ribonucleotide inhibits the reaction [Cadmium Chloride results in increased expression of RAC1 protein]
CTD
PMID:21195169
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
G
Raf1
Raf-1 proto-oncogene, serine/threonine kinase
multiple interactions
EXP
RAF1 protein affects the reaction [AICA ribonucleotide results in increased uptake of Deoxyglucose]
CTD
PMID:11978788
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO EXP
AICA ribonucleotide inhibits the reaction [Streptozocin results in increased phosphorylation of and results in increased activity of RELA protein] AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased phosphorylation of RELA protein]; dorsomorphin inhibits the reaction [AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased phosphorylation of RELA protein]]; Niacinamide inhibits the reaction [AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased phosphorylation of RELA protein]]
CTD
PMID:22058332 PMID:25108154
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Rps6
ribosomal protein S6
decreases phosphorylation
ISO
AICA ribonucleotide results in decreased phosphorylation of RPS6 protein
CTD
PMID:19625624
NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
G
Rps6kb1
ribosomal protein S6 kinase B1
multiple interactions decreases phosphorylation increases phosphorylation
EXP
AICA ribonucleotide inhibits the reaction [Cadmium Chloride results in increased phosphorylation of RPS6KB1 protein]; naringin inhibits the reaction [AICA ribonucleotide results in increased phosphorylation of RPS6KB1 protein] AICA ribonucleotide results in decreased phosphorylation of RPS6KB1 protein
CTD
PMID:15342961 PMID:21195169 PMID:28041982
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
G
Sirt1
sirtuin 1
multiple interactions increases expression
ISO EXP
AICA ribonucleotide inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in decreased expression of SIRT1 protein]; AICA ribonucleotide inhibits the reaction [Streptozocin results in decreased activity of SIRT1 protein]; dorsomorphin inhibits the reaction [AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in decreased expression of SIRT1 protein]]; dorsomorphin inhibits the reaction [AICA ribonucleotide results in increased expression of SIRT1 protein] AICA ribonucleotide inhibits the reaction [TGFB1 protein results in decreased expression of SIRT1 protein] [Niacinamide results in decreased activity of SIRT1 protein] which results in decreased susceptibility to AICA ribonucleotide
CTD
PMID:22058332 PMID:23090186 PMID:24465016 PMID:25108154 PMID:27688165
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Slc10a1
solute carrier family 10 member 1
decreases expression
EXP
AICA ribonucleotide results in decreased expression of SLC10A1 mRNA
CTD
PMID:27090119
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
G
Slc15a1
solute carrier family 15 member 1
decreases activity
ISO
AICA ribonucleotide results in decreased activity of SLC15A1 protein
CTD
PMID:22108913
NCBI chr15:98,537,641...98,582,544
Ensembl chr15:98,537,641...98,582,545
G
Slc2a4
solute carrier family 2 member 4
multiple interactions increases localization
EXP ISO
1-Butanol inhibits the reaction [AICA ribonucleotide results in increased localization of SLC2A4 protein]; Genistein inhibits the reaction [AICA ribonucleotide results in increased localization of SLC2A4 protein]; U 0126 inhibits the reaction [AICA ribonucleotide results in increased localization of SLC2A4 protein]; wortmannin inhibits the reaction [AICA ribonucleotide results in increased localization of SLC2A4 protein] AICA ribonucleotide inhibits the reaction [Palmitates results in decreased expression of SLC2A4 mRNA]
CTD
PMID:11978788 PMID:21802492
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
G
Slco1a4
solute carrier organic anion transporter family, member 1a4
decreases expression
EXP
AICA ribonucleotide results in decreased expression of SLCO1A2 mRNA
CTD
PMID:27090119
NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573
G
Sod2
superoxide dismutase 2
multiple interactions increases expression
ISO
AICA ribonucleotide promotes the reaction [FOXO1 protein results in increased expression of SOD2 mRNA] AICA ribonucleotide results in increased expression of SOD2 mRNA; AICA ribonucleotide results in increased expression of SOD2 protein
CTD
PMID:25065674
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sqstm1
sequestosome 1
multiple interactions increases expression
ISO
[AICA ribonucleotide co-treated with Sirolimus] results in increased expression of SQSTM1 protein; TP53 gene mutant form promotes the reaction [AICA ribonucleotide results in increased expression of SQSTM1 protein]
CTD
PMID:33070465
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Stk11
serine/threonine kinase 11
multiple interactions
ISO
AICA ribonucleotide inhibits the reaction [TGFB1 protein results in decreased phosphorylation of STK11 protein]
CTD
PMID:27688165
NCBI chr 7:9,574,553...9,591,315
Ensembl chr 7:9,575,269...9,591,315
G
Tbc1d1
TBC1 domain family member 1
multiple interactions
ISO
AICA ribonucleotide inhibits the reaction [INS1 protein results in increased phosphorylation of TBC1D1 protein]
CTD
PMID:26627467
NCBI chr14:43,936,820...44,135,133
Ensembl chr14:43,935,636...44,136,499
G
Tbc1d4
TBC1 domain family, member 4
multiple interactions
ISO
AICA ribonucleotide inhibits the reaction [INS1 protein results in increased phosphorylation of TBC1D4 protein]
CTD
PMID:24343960 PMID:26627467
NCBI chr15:78,256,030...78,434,168
Ensembl chr15:78,257,121...78,434,265
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO
AICA ribonucleotide inhibits the reaction [TGFB1 protein results in decreased expression of MMP13 protein]; AICA ribonucleotide inhibits the reaction [TGFB1 protein results in decreased expression of PPARG protein]; AICA ribonucleotide inhibits the reaction [TGFB1 protein results in decreased expression of SIRT1 protein]; AICA ribonucleotide inhibits the reaction [TGFB1 protein results in decreased phosphorylation of STK11 protein]; AICA ribonucleotide inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; AICA ribonucleotide inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein]; AICA ribonucleotide inhibits the reaction [TGFB1 protein results in increased expression of TIMP1 protein]
CTD
PMID:27688165
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Timp1
TIMP metallopeptidase inhibitor 1
multiple interactions
ISO
AICA ribonucleotide inhibits the reaction [TGFB1 protein results in increased expression of TIMP1 protein]
CTD
PMID:27688165
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Tnf
tumor necrosis factor
multiple interactions
ISO EXP
AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] AICA ribonucleotide inhibits the reaction [TNF protein promotes the reaction [Oxygen deficiency results in increased expression of GPR68 mRNA]]; AICA ribonucleotide inhibits the reaction [TNF protein results in increased expression of GPR68 mRNA] AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased expression of TNF mRNA]
CTD
PMID:22025971 PMID:25108154 PMID:28174749
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
multiple interactions
ISO
AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of TNFRSF1A protein]
CTD
PMID:22025971
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tp53
tumor protein p53
multiple interactions increases phosphorylation
ISO
[Resveratrol co-treated with AICA ribonucleotide] inhibits the reaction [Glucose results in increased expression of TP53 protein]; AICA ribonucleotide inhibits the reaction [TP53 gene mutant form results in increased expression of CPT1A protein]; AICA ribonucleotide promotes the reaction [TP53 gene mutant form results in increased phosphorylation of ULK1 protein]; TP53 gene mutant form promotes the reaction [AICA ribonucleotide results in increased expression of SQSTM1 protein]; TP53 gene mutant form promotes the reaction [AICA ribonucleotide results in increased phosphorylation of ULK1 protein] AICA ribonucleotide results in increased phosphorylation of TP53 protein
CTD
PMID:26188290 PMID:33070465
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Txnip
thioredoxin interacting protein
multiple interactions
ISO
AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased expression of TXNIP protein]
CTD
PMID:29031535
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
G
Ucp2
uncoupling protein 2
multiple interactions
EXP
AICA ribonucleotide inhibits the reaction [Indican results in decreased expression of UCP2 mRNA]
CTD
PMID:25703824
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
G
Ulk1
unc-51 like autophagy activating kinase 1
multiple interactions
ISO
AICA ribonucleotide promotes the reaction [TP53 gene mutant form results in increased phosphorylation of ULK1 protein]; AICA ribonucleotide results in increased expression of and results in increased phosphorylation of ULK1 protein; TP53 gene mutant form promotes the reaction [AICA ribonucleotide results in increased phosphorylation of ULK1 protein]
CTD
PMID:33070465
NCBI chr12:45,851,710...45,877,966
Ensembl chr12:45,851,710...45,877,966
G
Vegfa
vascular endothelial growth factor A
multiple interactions
ISO
AICA ribonucleotide inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased secretion of VEGFA protein]
CTD
PMID:30724446
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Xpo1
exportin 1
multiple interactions
ISO
AICA ribonucleotide promotes the reaction [ABL1 protein mutant form binds to XPO1 protein]; AICA ribonucleotide promotes the reaction [XPO1 protein binds to BECN1 protein]; AICA ribonucleotide promotes the reaction [XPO1 protein binds to YWHAQ protein]
CTD
PMID:33070465
NCBI chr14:97,233,282...97,275,536
Ensembl chr14:97,233,270...97,275,498
G
Ywhaq
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
multiple interactions
ISO
AICA ribonucleotide promotes the reaction [ABL1 protein mutant form binds to YWHAQ protein]; AICA ribonucleotide promotes the reaction [XPO1 protein binds to YWHAQ protein]
CTD
PMID:33070465
NCBI chr 6:40,935,714...40,966,240
Ensembl chr 6:40,935,949...40,966,273
G
Alb
albumin
affects binding
ISO
Emtricitabine binds to ALB protein
CTD
PMID:15814459 PMID:16336266
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions
ISO
[Emtricitabine co-treated with Tenofovir] results in increased expression of CDKN1A protein
CTD
PMID:31545371
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Dck
deoxycytidine kinase
multiple interactions affects binding
ISO
DCK protein results in increased phosphorylation of and results in increased activity of Emtricitabine Emtricitabine binds to DCK protein
CTD
PMID:17530837
NCBI chr14:19,305,218...19,326,247
Ensembl chr14:19,305,218...19,326,247
G
Prkn
parkin RBR E3 ubiquitin protein ligase
decreases expression multiple interactions
ISO
Emtricitabine results in decreased expression of PRKN protein [Emtricitabine co-treated with Tenofovir] results in decreased expression of PRKN protein
CTD
PMID:31545371
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
G
Tp53
tumor protein p53
multiple interactions
ISO
[Emtricitabine co-treated with Tenofovir] results in increased expression of TP53 protein
CTD
PMID:31545371
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Apex1
apurinic/apyrimidinic endodeoxyribonuclease 1
increases response to substance decreases response to substance
ISO
APEX1 protein mutant form results in increased susceptibility to Floxuridine APEX1 protein results in decreased susceptibility to Floxuridine
CTD
PMID:19470598 PMID:22194930
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
G
Atr
ATR serine/threonine kinase
decreases response to substance
ISO
ATR protein results in decreased susceptibility to Floxuridine
CTD
PMID:21613406 PMID:22194930
NCBI chr 8:96,426,704...96,524,152
Ensembl chr 8:96,426,724...96,524,136
G
C1qbp
complement C1q binding protein
decreases response to substance
ISO
C1QBP protein results in decreased susceptibility to Floxuridine
CTD
PMID:25354864
NCBI chr10:55,699,954...55,704,605
Ensembl chr10:55,699,954...55,704,649
G
Chek1
checkpoint kinase 1
multiple interactions
ISO
Floxuridine results in increased phosphorylation of and results in increased activity of CHEK1 protein
CTD
PMID:21613406 PMID:22194930
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
G
Chek2
checkpoint kinase 2
multiple interactions increases activity
ISO
Floxuridine results in increased phosphorylation of and results in increased activity of CHEK2 protein Floxuridine results in increased activity of CHEK2 protein
CTD
PMID:21613406 PMID:22194930
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
G
Mlh1
mutL homolog 1
multiple interactions decreases response to substance
ISO
olaparib inhibits the reaction [MLH1 protein results in decreased susceptibility to Floxuridine]
CTD
PMID:22194930
NCBI chr 8:111,196,468...111,233,721
Ensembl chr 8:111,196,468...111,233,617
G
Msh2
mutS homolog 2
multiple interactions decreases response to substance
ISO
olaparib inhibits the reaction [MSH2 protein results in decreased susceptibility to Floxuridine]
CTD
PMID:22194930
NCBI chr 6:6,813,793...6,872,960
Ensembl chr 6:6,813,795...6,872,938
G
Mthfr
methylenetetrahydrofolate reductase
affects response to substance
ISO
MTHFR protein affects the susceptibility to Floxuridine
CTD
PMID:18202788
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
G
Parp1
poly (ADP-ribose) polymerase 1
decreases response to substance
ISO
PARP1 protein results in decreased susceptibility to Floxuridine
CTD
PMID:21613406
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Timp3
TIMP metallopeptidase inhibitor 3
affects response to substance decreases response to substance
ISO
TIMP3 protein affects the susceptibility to Floxuridine TIMP3 gene modified form results in decreased susceptibility to Floxuridine
CTD
PMID:18202788
NCBI chr 7:17,520,827...17,571,850
Ensembl chr 7:17,521,919...17,571,839
G
Tk1
thymidine kinase 1
increases expression
ISO
Floxuridine results in increased expression of TK1 protein
CTD
PMID:16951200
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
G
Tp53
tumor protein p53
increases expression affects activity
ISO
Floxuridine results in increased expression of TP53 protein Floxuridine affects the activity of TP53 protein
CTD
PMID:19015155 PMID:35435491
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tyms
thymidylate synthetase
affects response to substance increases response to substance decreases response to substance
ISO
TYMS protein affects the susceptibility to Floxuridine TYMS results in increased susceptibility to Floxuridine TYMS protein results in decreased susceptibility to Floxuridine
CTD
PMID:2537495 PMID:10482907 PMID:15040806 PMID:17018589
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
G
Ung
uracil-DNA glycosylase
affects expression increases response to substance affects stability
ISO
Floxuridine affects the expression of UNG mRNA; Floxuridine affects the expression of UNG protein UNG protein results in increased susceptibility to Floxuridine Floxuridine affects the stability of UNG protein alternative form
CTD
PMID:16951200
NCBI chr12:42,485,276...42,494,217
Ensembl chr12:42,485,276...42,494,206
G
Xrcc1
X-ray repair cross complementing 1
decreases response to substance
ISO
XRCC1 protein results in decreased susceptibility to Floxuridine
CTD
PMID:21613406 PMID:22194930
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
G
Xrcc4
X-ray repair cross complementing 4
decreases response to substance
ISO
XRCC4 results in decreased susceptibility to Floxuridine
CTD
PMID:21785230
NCBI chr 2:20,948,464...21,197,705
Ensembl chr 2:20,951,200...21,197,808
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
Flucytosine results in decreased expression of BCL2 protein
CTD
PMID:15592511
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Mdm2
MDM2 proto-oncogene
increases expression
ISO
Flucytosine results in increased expression of MDM2 protein
CTD
PMID:15592511
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
G
Tp53
tumor protein p53
increases expression
ISO
Flucytosine results in increased expression of TP53 protein
CTD
PMID:15592511
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Acadsb
acyl-CoA dehydrogenase, short/branched chain
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of ACADSB mRNA
CTD
PMID:18313992
NCBI chr 1:186,188,939...186,227,796
Ensembl chr 1:186,188,987...186,230,379
G
Acsl6
acyl-CoA synthetase long-chain family member 6
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of ACSL6 mRNA
CTD
PMID:18313992
NCBI chr10:38,439,914...38,501,182
Ensembl chr10:38,440,080...38,498,757
G
Acta2
actin alpha 2, smooth muscle
decreases expression
ISO
Lamivudine results in decreased expression of ACTA2 protein
CTD
PMID:11738102
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
G
Adipoq
adiponectin, C1Q and collagen domain containing
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of ADIPOQ mRNA
CTD
PMID:16931933
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Aebp1
AE binding protein 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of AEBP1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of AEBP1 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of AEBP1 mRNA
CTD
PMID:16931933
NCBI chr14:80,738,800...80,748,878
Ensembl chr14:80,738,892...80,748,877
G
Afap1
actin filament associated protein 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of AFAP1 mRNA
CTD
PMID:15784690
NCBI chr14:74,743,322...74,856,300
Ensembl chr14:74,743,320...74,856,263
G
Alb
albumin
affects binding
ISO
Lamivudine binds to ALB protein
CTD
PMID:15814459 PMID:16336266
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ALOX5AP mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ALOX5AP mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of ALOX5AP mRNA
CTD
PMID:16931933
NCBI chr12:5,748,941...5,772,986
Ensembl chr12:5,748,944...5,772,986
G
Aqp9
aquaporin 9
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of AQP9 mRNA
CTD
PMID:18313992
NCBI chr 8:71,797,231...71,837,485
Ensembl chr 8:71,797,234...71,837,395
G
Arpp21
cAMP regulated phosphoprotein 21
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ARPP21 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ARPP21 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of ARPP21 mRNA
CTD
PMID:16931933
NCBI chr 8:112,034,636...112,199,273
Ensembl chr 8:112,034,642...112,194,297
G
Asic2
acid sensing ion channel subunit 2
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ASIC2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ASIC2 mRNA
CTD
PMID:16931933
NCBI chr10:65,870,592...66,940,577
Ensembl chr10:65,870,594...66,940,424
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of ASNS mRNA
CTD
PMID:15784690
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
G
Ass1
argininosuccinate synthase 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of ASS1 mRNA
CTD
PMID:15784690
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
G
Atf3
activating transcription factor 3
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of ATF3 mRNA
CTD
PMID:15784690
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Atp2a2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of ATP2A2 mRNA
CTD
PMID:11706060
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
G
Atp5f1c
ATP synthase F1 subunit gamma
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of ATP5F1C mRNA
CTD
PMID:18313992
NCBI chr17:68,423,927...68,446,169
Ensembl chr17:68,423,909...68,608,367
G
Atp5mc3
ATP synthase membrane subunit c locus 3
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of ATP5MC3 mRNA
CTD
PMID:18313992
NCBI chr 3:58,810,535...58,813,185
Ensembl chr 3:58,810,535...58,814,279
G
Atp5mf
ATP synthase membrane subunit f
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of ATP5MF mRNA
CTD
PMID:18313992
NCBI chr12:9,421,665...9,428,236
Ensembl chr12:9,421,579...9,428,236
G
Atp5pd
ATP synthase peripheral stalk subunit d
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of ATP5PD mRNA
CTD
PMID:18313992
NCBI chr10:100,657,700...100,662,960
Ensembl chr10:100,657,708...100,663,479
G
Atp5pf
ATP synthase peripheral stalk subunit F6
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of ATP5PF mRNA
CTD
PMID:18313992
NCBI chr11:23,881,594...23,889,581
Ensembl chr11:23,881,592...23,889,119
G
Atp5po
ATP synthase peripheral stalk subunit OSCP
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of ATP5PO mRNA
CTD
PMID:18313992
NCBI chr11:31,165,218...31,171,530
Ensembl chr11:31,165,217...31,171,592
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of BCL2 mRNA
CTD
PMID:18313992
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bnip3l
BCL2 interacting protein 3 like
increases expression
ISO
Lamivudine results in increased expression of BNIP3L protein
CTD
PMID:23640862
NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803
G
C1r
complement C1r
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of C1R mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of C1R mRNA
CTD
PMID:16931933
NCBI chr 4:157,412,718...157,423,483
Ensembl chr 4:157,412,692...157,423,484
G
C3ar1
complement C3a receptor 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of C3AR1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of C3AR1 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of C3AR1 mRNA
CTD
PMID:16931933
NCBI chr 4:156,074,747...156,084,680
Ensembl chr 4:156,075,389...156,084,701
G
Cars1
cysteinyl-tRNA synthetase 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of CARS1 mRNA
CTD
PMID:15784690
NCBI chr 1:198,753,689...198,796,016
Ensembl chr 1:198,753,691...198,795,941
G
Casp3
caspase 3
multiple interactions
EXP
[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased activity of CASP3 protein; Zinc inhibits the reaction [[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased activity of CASP3 protein]
CTD
PMID:36309141
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cat
catalase
multiple interactions
EXP
[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in decreased activity of CAT protein
CTD
PMID:34118364
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccna2
cyclin A2
multiple interactions decreases expression
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of CCNA2 mRNA Lamivudine results in decreased expression of CCNA2 mRNA
CTD
PMID:15784690
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnc
cyclin C
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of CCNC mRNA
CTD
PMID:15784690
NCBI chr 5:35,266,828...35,284,943
Ensembl chr 5:35,266,823...35,296,584
G
Ccnd1
cyclin D1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of CCND1 mRNA
CTD
PMID:15784690
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccnd2
cyclin D2
decreases expression multiple interactions
ISO
Lamivudine results in decreased expression of CCND2 mRNA [Zidovudine co-treated with Lamivudine] results in decreased expression of CCND2 mRNA
CTD
PMID:15784690
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
G
Ccne2
cyclin E2
multiple interactions decreases expression
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of CCNE2 mRNA Lamivudine results in decreased expression of CCNE2 mRNA
CTD
PMID:15784690
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
G
Cd36
CD36 molecule
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of CD36 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of CD36 mRNA
CTD
PMID:16931933
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cd44
CD44 molecule
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of CD44 mRNA
CTD
PMID:15784690
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cd83
CD83 molecule
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of CD83 mRNA
CTD
PMID:15784690
NCBI chr17:20,887,309...20,907,009
Ensembl chr17:20,887,309...20,907,083
G
Cdk7
cyclin-dependent kinase 7
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of CDK7 mRNA
CTD
PMID:15784690
NCBI chr 2:31,840,558...31,865,422
Ensembl chr 2:31,840,558...31,865,383
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
decreases expression multiple interactions
ISO
Lamivudine results in decreased expression of CDKN1A mRNA [Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN1A mRNA
CTD
PMID:15784690
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN1B mRNA
CTD
PMID:15784690
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cdkn1c
cyclin-dependent kinase inhibitor 1C
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN1C mRNA
CTD
PMID:15784690
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
G
Cdkn2c
cyclin-dependent kinase inhibitor 2C
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN2C mRNA
CTD
PMID:15784690
NCBI chr 5:124,411,123...124,416,278
Ensembl chr 5:124,411,124...124,416,278
G
Cfd
complement factor D
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of CFD mRNA
CTD
PMID:16931933
NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053
G
Cidec
cell death-inducing DFFA-like effector c
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of CIDEC mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of CIDEC mRNA
CTD
PMID:16931933
NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173
G
Clcn3
chloride voltage-gated channel 3
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of CLCN3 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of CLCN3 mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of CLCN3 mRNA
CTD
PMID:16931933
NCBI chr16:29,127,152...29,200,133
Ensembl chr16:29,127,419...29,200,119
G
Col3a1
collagen type III alpha 1 chain
decreases expression
ISO
Lamivudine results in decreased expression of COL3A1 protein
CTD
PMID:11738102
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
G
Comt
catechol-O-methyltransferase
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of COMT mRNA
CTD
PMID:15784690
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
G
Cox5a
cytochrome c oxidase subunit 5A
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of COX5A mRNA
CTD
PMID:18313992
NCBI chr 8:57,922,374...57,933,781
Ensembl chr 8:57,922,290...57,933,781
G
Cox5b
cytochrome c oxidase subunit 5B
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of COX5B mRNA
CTD
PMID:18313992
NCBI chr 9:38,921,980...38,923,806
Ensembl chr 9:38,921,967...38,925,052
G
Cox6a1
cytochrome c oxidase subunit 6A1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of COX6A1 mRNA
CTD
PMID:18313992
NCBI chr12:41,261,983...41,265,037
Ensembl chr12:41,261,967...41,265,041
G
Cox6c
cytochrome c oxidase subunit 6C
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of COX6C mRNA
CTD
PMID:18313992
NCBI chr 7:67,129,265...67,142,001
Ensembl chr 7:67,111,024...67,141,963
G
Cox7c
cytochrome c oxidase subunit 7C
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of COX7C mRNA
CTD
PMID:18313992
NCBI chr 2:16,841,771...16,843,796
Ensembl chr 2:16,840,837...16,843,760
G
Cpt1a
carnitine palmitoyltransferase 1A
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of CPT1A mRNA
CTD
PMID:18313992
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
G
Crat
carnitine O-acetyltransferase
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of CRAT mRNA
CTD
PMID:18313992
NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255
G
Cul7
cullin 7
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of CUL7 mRNA
CTD
PMID:18313992
NCBI chr 9:14,319,102...14,333,035
Ensembl chr 9:14,319,108...14,332,741
G
Cyb5a
cytochrome b5 type A
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of CYB5A mRNA
CTD
PMID:18313992
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of CYP11A1 mRNA
CTD
PMID:18313992
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
G
Dck
deoxycytidine kinase
multiple interactions
ISO
DCK protein results in increased phosphorylation of and results in increased activity of Lamivudine
CTD
PMID:17530837
NCBI chr14:19,305,218...19,326,247
Ensembl chr14:19,305,218...19,326,247
G
Dcn
decorin
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of DCN mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of DCN mRNA
CTD
PMID:16931933
NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
G
Ddit3
DNA-damage inducible transcript 3
increases expression multiple interactions
ISO
Lamivudine results in increased expression of DDIT3 mRNA [Zidovudine co-treated with Lamivudine] results in increased expression of DDIT3 mRNA
CTD
PMID:15784690
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Dhfr
dihydrofolate reductase
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of DHFR mRNA
CTD
PMID:15784690
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
G
Diablo
diablo, IAP-binding mitochondrial protein
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of DIABLO mRNA
CTD
PMID:18313992
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
G
Dlst
dihydrolipoamide S-succinyltransferase
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of DLST mRNA
CTD
PMID:18313992
NCBI chr 6:104,758,511...104,783,296
Ensembl chr 6:104,758,631...104,783,296
G
Dnaja3
DnaJ heat shock protein family (Hsp40) member A3
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of DNAJA3 mRNA
CTD
PMID:18313992
NCBI chr10:10,854,732...10,880,171
Ensembl chr10:10,854,732...10,880,161
G
Dusp3
dual specificity phosphatase 3
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of DUSP3 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of DUSP3 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of DUSP3 mRNA
CTD
PMID:16931933
NCBI chr10:86,920,014...86,933,739
Ensembl chr10:86,920,014...86,933,962
G
Echs1
enoyl-CoA hydratase, short chain 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of ECHS1 mRNA
CTD
PMID:18313992
NCBI chr 1:194,895,036...194,903,863
Ensembl chr 1:194,895,036...194,903,884
G
Eci1
enoyl-CoA delta isomerase 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of ECI1 mRNA
CTD
PMID:18313992
NCBI chr10:13,456,715...13,470,061
Ensembl chr10:13,456,563...13,470,061
G
Edn1
endothelin 1
multiple interactions increases secretion
ISO
coenzyme Q10 inhibits the reaction [Lamivudine results in increased secretion of EDN1 protein]
CTD
PMID:23640862
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of EIF4EBP1 mRNA
CTD
PMID:15784690
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
G
Elovl3
ELOVL fatty acid elongase 3
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of ELOVL3 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of ELOVL3 mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of ELOVL3 mRNA
CTD
PMID:16931933
NCBI chr 1:244,997,287...245,001,115
Ensembl chr 1:244,997,287...245,001,115
G
Esr2
estrogen receptor 2
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of ESR2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of ESR2 mRNA
CTD
PMID:16931933
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Etv6
ETS variant transcription factor 6
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ETV6 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ETV6 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of ETV6 mRNA
CTD
PMID:16931933
NCBI chr 4:166,849,031...167,085,211
Ensembl chr 4:166,847,686...167,084,992
G
Fads2
fatty acid desaturase 2
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of FADS2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of FADS2 mRNA
CTD
PMID:16931933
NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
G
Faim
Fas apoptotic inhibitory molecule
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of FAIM mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of FAIM mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of FAIM mRNA
CTD
PMID:16931933
NCBI chr 8:99,543,877...99,569,499
Ensembl chr 8:99,542,405...99,560,562
G
Fasn
fatty acid synthase
multiple interactions
ISO
[Stavudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of FASN mRNA; [Stavudine co-treated with Lamivudine] results in increased expression of FASN mRNA; [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of FASN mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of FASN mRNA
CTD
PMID:11741158
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Fdxr
ferredoxin reductase
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of FDXR mRNA
CTD
PMID:18313992
NCBI chr10:100,507,863...100,516,649
Ensembl chr10:100,507,865...100,516,658
G
Fh
fumarate hydratase
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of FH1 mRNA
CTD
PMID:18313992
NCBI chr13:87,524,331...87,550,215
Ensembl chr13:87,524,337...87,550,266
G
G0s2
G0/G1switch 2
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of G0S2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of G0S2 mRNA
CTD
PMID:16931933
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of G6PC1 mRNA
CTD
PMID:16931933
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
G
Ganc
glucosidase, alpha; neutral C
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of GANC mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of GANC mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of GANC mRNA
CTD
PMID:16931933
NCBI chr 3:107,353,369...107,406,104
Ensembl chr 3:107,353,369...107,405,241
G
Gars1
glycyl-tRNA synthetase 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of GARS1 mRNA
CTD
PMID:15784690
NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609
G
Gas1
growth arrest-specific 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of GAS1 mRNA
CTD
PMID:15784690
NCBI chr17:4,482,168...4,485,153
G
Grhl2
grainyhead-like transcription factor 2
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of GRHL2 mRNA
CTD
PMID:16931933
NCBI chr 7:68,400,287...68,530,269
Ensembl chr 7:68,400,477...68,530,258
G
Gucy1b1
guanylate cyclase 1 soluble subunit beta 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of GUCY1B1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of GUCY1B1 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of GUCY1B1 mRNA
CTD
PMID:16931933
NCBI chr 2:167,348,824...167,398,983
Ensembl chr 2:167,348,825...167,398,916
G
Gypa
glycophorin A
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased mutagenesis of GYPA gene
CTD
PMID:17358027
NCBI chr19:27,450,304...27,465,940
Ensembl chr19:27,450,308...27,465,822
G
Hadh
hydroxyacyl-CoA dehydrogenase
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of HADH mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of HADH mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of HADH mRNA
CTD
PMID:16931933
NCBI chr 2:219,787,935...219,830,335
Ensembl chr 2:219,787,927...219,830,353
G
Hadha
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of HADHA mRNA
CTD
PMID:18313992
NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
G
Hax1
HCLS1 associated protein X-1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of HAX1 mRNA
CTD
PMID:15784690
NCBI chr 2:175,434,242...175,437,926
Ensembl chr 2:175,434,238...175,437,714
G
Hcn1
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of HCN1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of HCN1 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of HCN1 mRNA
CTD
PMID:16931933
NCBI chr 2:49,495,771...49,899,983
Ensembl chr 2:49,495,771...49,899,774
G
Hist1h4b
histone cluster 1 H4 family member B
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of H4C9 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of H4C9 mRNA
CTD
PMID:16931933
NCBI chr17:42,480,467...42,484,912
Ensembl chr17:42,480,313...42,485,370
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of HMGCS2 mRNA
CTD
PMID:18313992
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
G
Hrk
harakiri, BCL2 interacting protein
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of HRK mRNA
CTD
PMID:16931933
NCBI chr12:38,387,484...38,409,652
G
Hsd3b1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of HSD3B2 mRNA
CTD
PMID:18313992
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
G
Hsd3b3
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 3
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of HSD3B3 mRNA
CTD
PMID:18313992
NCBI chr 2:186,138,044...186,144,024
Ensembl chr 2:186,138,044...186,144,033
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of IDH2 mRNA
CTD
PMID:18313992
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
G
Idh3a
isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of IDH3A mRNA
CTD
PMID:18313992
NCBI chr 8:54,971,694...54,991,085
Ensembl chr 8:54,971,740...54,991,084
G
Idh3g
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of IDH3G mRNA
CTD
PMID:18313992
NCBI chr X:151,515,244...151,524,175
Ensembl chr X:151,515,247...151,524,171
G
Ifng
interferon gamma
increases expression
ISO
Lamivudine results in increased expression of IFNG protein
CTD
PMID:16250037
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Ikzf4
IKAROS family zinc finger 4
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of IKZF4 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of IKZF4 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of IKZF4 mRNA
CTD
PMID:16931933
NCBI chr 7:1,063,283...1,102,940
Ensembl chr 7:1,056,890...1,084,341
G
Il1b
interleukin 1 beta
multiple interactions
EXP
[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased expression of IL1B protein; Zinc inhibits the reaction [[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased expression of IL1B protein]
CTD
PMID:36309141
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il27ra
interleukin 27 receptor subunit alpha
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of IL27RA mRNA
CTD
PMID:15784690
NCBI chr19:24,109,963...24,121,977
Ensembl chr19:24,109,972...24,121,938
G
Inpp5e
inositol polyphosphate-5-phosphatase E
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of INPP5E mRNA
CTD
PMID:18313992
NCBI chr 3:9,216,776...9,229,539
Ensembl chr 3:9,216,776...9,229,450
G
Kcng1
potassium voltage-gated channel modifier subfamily G member 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of KCNG1 mRNA
CTD
PMID:15784690
NCBI chr 3:156,960,717...156,992,877
Ensembl chr 3:156,973,156...156,992,635
G
Kifc2
kinesin family member C2
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of KIFC2 mRNA
CTD
PMID:16931933
NCBI chr 7:108,380,634...108,388,364
Ensembl chr 7:108,376,011...108,388,484
G
Klf4
KLF transcription factor 4
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of KLF4 mRNA
CTD
PMID:15784690
NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
G
Klhl28
kelch-like family member 28
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of KLHL28 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of KLHL28 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of KLHL28 mRNA
CTD
PMID:16931933
NCBI chr 6:82,987,360...83,018,971
Ensembl chr 6:82,990,945...83,016,164
G
Krt7
keratin 7
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of KRT7 mRNA
CTD
PMID:15784690
NCBI chr 7:132,528,881...132,545,052
Ensembl chr 7:132,528,895...132,545,052
G
Kynu
kynureninase
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of KYNU mRNA
CTD
PMID:15784690
NCBI chr 3:27,778,646...27,929,470
Ensembl chr 3:27,778,772...27,929,488
G
Lamb3
laminin subunit beta 3
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of LAMB3 mRNA
CTD
PMID:15784690
NCBI chr13:104,833,810...104,875,405
Ensembl chr13:104,833,873...104,875,405
G
Lamc2
laminin subunit gamma 2
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of LAMC2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of LAMC2 mRNA
CTD
PMID:16931933
NCBI chr13:65,284,664...65,344,164
Ensembl chr13:65,284,664...65,344,200
G
Lef1
lymphoid enhancer binding factor 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of LEF1 mRNA
CTD
PMID:16931933
NCBI chr 2:219,666,549...219,779,815
Ensembl chr 2:219,666,592...219,779,794
G
Lep
leptin
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of LEP mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of LEP mRNA
CTD
PMID:16931933
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lpl
lipoprotein lipase
decreases expression multiple interactions
ISO
Lamivudine results in decreased expression of LPL mRNA [Stavudine co-treated with Lamivudine co-treated with Indinavir] affects the expression of LPL mRNA; [Stavudine co-treated with Lamivudine co-treated with Nelfinavir] results in decreased expression of LPL mRNA; [Stavudine co-treated with Lamivudine] affects the expression of LPL mRNA; [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of LPL mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of LPL mRNA
CTD
PMID:11741158
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Mars1
methionyl-tRNA synthetase 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of MARS1 mRNA
CTD
PMID:15784690
NCBI chr 7:63,121,142...63,138,550
Ensembl chr 7:63,121,142...63,138,495
G
Me1
malic enzyme 1
multiple interactions increases expression
ISO
[Stavudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ME1 mRNA; [Stavudine co-treated with Lamivudine co-treated with Nelfinavir] results in decreased expression of ME1 mRNA; [Stavudine co-treated with Lamivudine] results in increased expression of ME1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ME1 mRNA; [Zidovudine co-treated with Lamivudine] affects the expression of ME1 mRNA Lamivudine results in increased expression of ME1 mRNA
CTD
PMID:11741158
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
G
Mfn1
mitofusin 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of MFN1 mRNA
CTD
PMID:18313992
NCBI chr 2:115,313,380...115,359,651
Ensembl chr 2:115,313,401...115,359,640
G
Mfn2
mitofusin 2
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of MFN2 mRNA
CTD
PMID:18313992
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
G
Mgat4c
MGAT4 family, member C
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of MGAT4C mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of MGAT4C mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of MGAT4C mRNA
CTD
PMID:16931933
NCBI chr 7:36,709,564...37,485,810
Ensembl chr 7:37,260,321...37,474,571
G
Mmp1
matrix metallopeptidase 1
increases expression
ISO
Lamivudine results in increased expression of MMP1 protein
CTD
PMID:15309715
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Mpo
myeloperoxidase
multiple interactions
EXP
[efavirenz co-treated with Lamivudine co-treated with Tenofovir] promotes the reaction [[isoniazid, pyrazinamide, rifampin drug combination co-treated with Ethambutol] results in increased activity of MPO protein]; [efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased activity of MPO protein
CTD
PMID:34118364
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Mrap
melanocortin 2 receptor accessory protein
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of MRAP mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of MRAP mRNA
CTD
PMID:16931933
NCBI chr11:29,991,974...30,003,024
Ensembl chr11:29,992,034...30,003,024
G
Mt-co1
mitochondrially encoded cytochrome c oxidase I
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of COX1 mRNA
CTD
PMID:17526437 PMID:18313992
NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
G
Mt-co2
mitochondrially encoded cytochrome c oxidase II
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of COX2 mRNA
CTD
PMID:18313992
NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689
Ensembl chr MT:7,006...7,689
G
Mt-co3
mitochondrially encoded cytochrome c oxidase III
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of COX3 mRNA
CTD
PMID:17526437 PMID:18313992
NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382
Ensembl chr MT:8,599...9,382
G
Mt-nd2
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of ND2 mRNA
CTD
PMID:18313992
NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942
Ensembl chr MT:3,904...4,942
G
Mt-nd5
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of ND5 mRNA
CTD
PMID:17526437 PMID:18313992
NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565
Ensembl chr MT:11,736...13,565
G
Mthfd2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of MTHFD2 mRNA
CTD
PMID:15784690
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
G
Myod1
myogenic differentiation 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of MYOD1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of MYOD1 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of MYOD1 mRNA
CTD
PMID:16931933
NCBI chr 1:96,884,864...96,887,574
Ensembl chr 1:96,884,948...96,887,554
G
Nap1l5
nucleosome assembly protein 1-like 5
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of NAP1L5 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of NAP1L5 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of NAP1L5 mRNA
CTD
PMID:16931933
NCBI chr 4:88,022,670...88,024,988
Ensembl chr 4:88,022,569...88,024,654
G
Ndufa4
Ndufa4, mitochondrial complex associated
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of NDUFA4 mRNA
CTD
PMID:18313992
NCBI chr 4:40,002,216...40,009,384
Ensembl chr 4:40,002,216...40,023,920
G
Ndufab1
NADH:ubiquinone oxidoreductase subunit AB1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of NDUFAB1 mRNA
CTD
PMID:18313992
NCBI chr 1:176,644,696...176,658,131
Ensembl chr 1:176,644,703...176,658,099
G
Ndufaf1
NADH:ubiquinone oxidoreductase complex assembly factor 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of NDUFAF1 mRNA
CTD
PMID:18313992
NCBI chr 3:106,639,025...106,650,549
Ensembl chr 3:106,639,851...106,650,212
G
Ndufb3
NADH:ubiquinone oxidoreductase subunit B3
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of NDUFB3 mRNA
CTD
PMID:18313992
NCBI chr 9:60,129,240...60,139,452
Ensembl chr 9:60,129,154...60,139,446
G
Ndufb5
NADH:ubiquinone oxidoreductase subunit B5
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of NDUFB5 mRNA
CTD
PMID:18313992
NCBI chr 2:115,519,248...115,533,589
Ensembl chr 2:115,519,154...115,533,589
G
Ndufb9
NADH:ubiquinone oxidoreductase subunit B9
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of NDUFB9 mRNA
CTD
PMID:18313992
NCBI chr 7:90,480,948...90,487,367
Ensembl chr 7:90,436,621...90,488,009
G
Ndufc1
NADH:ubiquinone oxidoreductase subunit C1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of NDUFC1 mRNA
CTD
PMID:18313992
NCBI chr 2:135,447,067...135,450,950
Ensembl chr 2:135,447,119...135,450,874
G
Ndufs1
NADH:ubiquinone oxidoreductase core subunit S1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of NDUFS1 mRNA
CTD
PMID:18313992
NCBI chr 9:64,546,430...64,579,751
Ensembl chr 9:64,546,225...64,579,893
G
Niban1
niban apoptosis regulator 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of NIBAN1 mRNA
CTD
PMID:15784690
NCBI chr13:63,674,240...63,827,748
Ensembl chr13:63,674,171...63,827,729
G
Noct
nocturnin
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of NOCT mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of NOCT mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of NOCT mRNA
CTD
PMID:16931933
NCBI chr 2:135,271,189...135,291,407
Ensembl chr 2:135,271,189...135,291,400
G
Nos3
nitric oxide synthase 3
multiple interactions decreases phosphorylation
ISO
coenzyme Q10 inhibits the reaction [Lamivudine results in decreased phosphorylation of NOS3 protein]
CTD
PMID:23640862
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Nppa
natriuretic peptide A
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of NPPA mRNA
CTD
PMID:11706060
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
G
Nup210
nucleoporin 210
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of NUP210 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of NUP210 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of NUP210 mRNA
CTD
PMID:16931933
NCBI chr 4:123,511,558...123,609,874
Ensembl chr 4:123,511,559...123,609,874
G
Nxnl2
nucleoredoxin-like 2
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of NXNL2 mRNA
CTD
PMID:16931933
NCBI chr17:14,031,151...14,035,897
Ensembl chr17:14,031,153...14,036,189
G
Oaz3
ornithine decarboxylase antizyme 3
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of OAZ3 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of OAZ3 mRNA
CTD
PMID:16931933
NCBI chr 2:182,073,212...182,076,147
Ensembl chr 2:182,073,215...182,082,399
G
Ogt
O-linked N-acetylglucosamine (GlcNAc) transferase
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of OGT mRNA
CTD
PMID:15784690
NCBI chr X:66,771,278...66,816,148
Ensembl chr X:66,771,349...66,816,146
G
Opa1
OPA1, mitochondrial dynamin like GTPase
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of OPA1 mRNA
CTD
PMID:18313992
NCBI chr11:71,108,100...71,185,170
Ensembl chr11:71,109,873...71,185,109
G
Oprl1
opioid related nociceptin receptor 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of OPRL1 mRNA
CTD
PMID:16931933
NCBI chr 3:168,831,934...168,839,920
Ensembl chr 3:168,834,003...168,839,920
G
Pcdh15
protocadherin related 15
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PCDH15 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PCDH15 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of PCDH15 mRNA
CTD
PMID:16931933
NCBI chr20:13,997,094...15,496,446
Ensembl chr20:13,963,565...15,494,719
G
Pck2
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of PCK2 mRNA
CTD
PMID:15784690
NCBI chr15:29,027,891...29,036,729
Ensembl chr15:29,027,894...29,037,283
G
Pfkfb3
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of PFKFB3 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of PFKFB3 mRNA
CTD
PMID:16931933
NCBI chr17:66,983,629...67,064,702
Ensembl chr17:66,983,686...67,063,125
G
Pgap6
post-GPI attachment to proteins 6
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of PGAP6 mRNA
CTD
PMID:16931933
NCBI chr10:15,138,918...15,148,431
Ensembl chr10:15,138,959...15,148,431
G
Phf6
PHD finger protein 6
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of PHF6 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of PHF6 mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of PHF6 mRNA
CTD
PMID:16931933
NCBI chr X:132,656,658...132,699,720
Ensembl chr X:132,656,672...132,699,127
G
Pidd1
p53-induced death domain protein 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PIDD1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PIDD1 mRNA
CTD
PMID:16931933
NCBI chr 1:196,536,815...196,542,808
Ensembl chr 1:196,536,834...196,542,699
G
Piwil2
piwi-like RNA-mediated gene silencing 2
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PIWIL2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PIWIL2 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of PIWIL2 mRNA
CTD
PMID:16931933
NCBI chr15:45,431,402...45,498,034
Ensembl chr15:45,431,703...45,497,702
G
Porcn
porcupine O-acyltransferase
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PPN mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PPN mRNA
CTD
PMID:16931933
NCBI chr X:14,285,864...14,298,481
Ensembl chr X:14,285,871...14,298,481
G
Pou5f1
POU class 5 homeobox 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of POU5F1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of POU5F1 mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of POU5F1 mRNA
CTD
PMID:16931933
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
G
Prdm1
PR/SET domain 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PRDM1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PRDM1 mRNA
CTD
PMID:16931933
NCBI chr20:47,959,858...47,981,488
Ensembl chr20:47,959,858...47,981,488
G
Psat1
phosphoserine aminotransferase 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of PSAT1 mRNA
CTD
PMID:15784690
NCBI chr 1:213,196,709...213,218,564
Ensembl chr 1:213,196,709...213,218,682
G
Rabepk
Rab9 effector protein with kelch motifs
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of RABEPK mRNA
CTD
PMID:15784690
NCBI chr 3:18,061,299...18,083,191
Ensembl chr 3:18,061,574...18,083,191
G
Rbl1
RB transcriptional corepressor like 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of RBL1 mRNA
CTD
PMID:15784690
NCBI chr 3:145,806,160...145,869,434
Ensembl chr 3:145,807,095...145,869,330
G
Rbl2
RB transcriptional corepressor like 2
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of RBL2 mRNA
CTD
PMID:15784690
NCBI chr19:15,876,852...15,923,632
Ensembl chr19:15,876,853...15,923,572
G
Reep6
receptor accessory protein 6
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of REEP6 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of REEP6 mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of REEP6 mRNA
CTD
PMID:16931933
NCBI chr 7:9,373,927...9,380,845
Ensembl chr 7:9,373,927...9,380,597
G
Ripk2
receptor-interacting serine-threonine kinase 2
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of RIPK2 mRNA
CTD
PMID:15784690
NCBI chr 5:29,630,806...29,662,804
Ensembl chr 5:29,631,570...29,662,657
G
Rnf151
ring finger protein 151
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of RNF151 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of RNF151 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of RNF151 mRNA
CTD
PMID:16931933
NCBI chr10:13,742,682...13,747,192
Ensembl chr10:13,742,682...13,745,000
G
Rpain
RPA interacting protein
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of RPAIN mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of RPAIN mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of RPAIN mRNA
CTD
PMID:16931933
NCBI chr10:55,692,410...55,699,910
Ensembl chr10:55,692,417...55,699,933
G
S100a8
S100 calcium binding protein A8
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of S100A8 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of S100A8 mRNA
CTD
PMID:16931933
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
G
Sdhb
succinate dehydrogenase complex iron sulfur subunit B
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of SDHB mRNA
CTD
PMID:18313992
NCBI chr 5:153,264,906...153,285,570
Ensembl chr 5:153,264,899...153,314,293
G
Serinc1
serine incorporator 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of SERINC1 mRNA
CTD
PMID:16931933
NCBI chr20:36,850,062...36,868,999
Ensembl chr20:36,850,076...36,896,691
G
Sfxn1
sideroflexin 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of SFXN1 mRNA
CTD
PMID:18313992
NCBI chr17:10,486,250...10,522,640
Ensembl chr17:10,486,271...10,522,529
G
Sfxn2
sideroflexin 2
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of SFXN2 mRNA
CTD
PMID:18313992
NCBI chr 1:245,447,014...245,459,312
Ensembl chr 1:245,447,015...245,468,411 Ensembl chr 1:245,447,015...245,468,411
G
Sfxn4
sideroflexin 4
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of SFXN4 mRNA
CTD
PMID:18313992
NCBI chr 1:259,976,480...259,998,778
Ensembl chr 1:259,976,481...259,998,754
G
Sgpp1
sphingosine-1-phosphate phosphatase 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of SGPP1 mRNA
CTD
PMID:18313992
NCBI chr 6:94,425,339...94,446,534
Ensembl chr 6:94,425,339...94,446,534
G
Slc1a4
solute carrier family 1 member 4
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of SLC1A4 mRNA
CTD
PMID:15784690
NCBI chr14:94,530,801...94,560,190
Ensembl chr14:94,529,084...94,560,418
G
Slc1a5
solute carrier family 1 member 5
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of SLC1A5 mRNA
CTD
PMID:15784690
NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:77,456,694...77,470,952
G
Slc22a1
solute carrier family 22 member 1
increases uptake
ISO
SLC22A1 protein results in increased uptake of Lamivudine
CTD
PMID:19141712
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
G
Slc22a2
solute carrier family 22 member 2
increases uptake
ISO
SLC22A2 protein results in increased uptake of Lamivudine
CTD
PMID:19141712
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Slc22a3
solute carrier family 22 member 3
increases uptake
ISO
SLC22A3 protein results in increased uptake of Lamivudine
CTD
PMID:19141712
NCBI chr 1:48,235,476...48,324,617
Ensembl chr 1:48,235,476...48,324,612
G
Slc25a12
solute carrier family 25 member 12
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of SLC25A12 mRNA
CTD
PMID:18313992
NCBI chr 3:56,097,166...56,191,841
Ensembl chr 3:56,097,269...56,192,100
G
Slc25a15
solute carrier family 25 member 15
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of SLC25A15 mRNA
CTD
PMID:18313992
NCBI chr16:69,631,581...69,654,869
Ensembl chr16:69,634,414...69,653,010
G
Slc25a19
solute carrier family 25 member 19
multiple interactions
ISO
SLC25A19 protein affects the susceptibility to [Stavudine co-treated with Lamivudine co-treated with Indinavir]; SLC25A19 protein affects the susceptibility to [Zidovudine co-treated with Lamivudine co-treated with Indinavir] [Zidovudine co-treated with Lamivudine] results in decreased expression of SLC25A19 mRNA
CTD
PMID:15951836 PMID:18313992
NCBI chr10:100,853,554...100,867,517
Ensembl chr10:100,847,168...100,867,447
G
Slc25a2
solute carrier family 25 member 2
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of SLC25A2 mRNA
CTD
PMID:18313992
NCBI chr18:29,452,943...29,456,324
Ensembl chr18:29,453,582...29,460,383
G
Slc25a20
solute carrier family 25 member 20
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of SLC25A20 mRNA
CTD
PMID:18313992
NCBI chr 8:109,365,056...109,386,512
Ensembl chr 8:109,365,002...109,386,512
G
Slc25a29
solute carrier family 25 member 29
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of SLC25A29 mRNA
CTD
PMID:18313992
NCBI chr 6:127,742,027...127,752,915
Ensembl chr 6:127,742,033...127,752,940
G
Slc25a3
solute carrier family 25 member 3
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of SLC25A3 mRNA
CTD
PMID:18313992
NCBI chr 7:25,611,937...25,619,401
Ensembl chr 7:25,586,725...25,667,727
G
Slc25a4
solute carrier family 25 member 4
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of SLC25A4 mRNA
CTD
PMID:18313992
NCBI chr16:46,072,935...46,076,730
Ensembl chr16:46,072,939...46,076,733
G
Slc28a1
solute carrier family 28 member 1
multiple interactions
ISO
Lamivudine inhibits the reaction [SLC28A1 protein results in increased transport of Uridine]
CTD
PMID:10772724
NCBI chr 1:135,079,375...135,122,791
Ensembl chr 1:135,081,385...135,122,464
G
Slc31a1
solute carrier family 31 member 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of SLC31A1 mRNA
CTD
PMID:15784690
NCBI chr 5:75,814,744...75,844,241
Ensembl chr 5:75,814,743...75,844,228
G
Slc3a2
solute carrier family 3 member 2
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of SLC3A2 mRNA
CTD
PMID:15784690
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
G
Slc40a1
solute carrier family 40 member 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of SLC40A1 mRNA
CTD
PMID:18313992
NCBI chr 9:48,033,526...48,053,876
Ensembl chr 9:48,033,526...48,051,481
G
Slc6a4
solute carrier family 6 member 4
multiple interactions increases expression
ISO
[Lamivudine co-treated with IFNA2 protein] results in increased expression of SLC6A4 mRNA; Lamivudine promotes the reaction [SLC6A4 protein results in increased uptake of Serotonin]; Lamivudine results in increased expression of and results in increased activity of SLC6A4 protein Lamivudine results in increased expression of SLC6A4 mRNA
CTD
PMID:16476009
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
G
Spink5
serine peptidase inhibitor, Kazal type 5
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of SPINK5 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of SPINK5 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of SPINK5 mRNA
CTD
PMID:16931933
NCBI chr18:36,264,452...36,333,143
Ensembl chr18:36,264,452...36,332,185
G
Star
steroidogenic acute regulatory protein
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of STAR mRNA
CTD
PMID:18313992
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
G
Stc2
stanniocalcin 2
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of STC2 mRNA
CTD
PMID:15784690
NCBI chr10:16,251,046...16,260,815
Ensembl chr10:16,250,853...16,262,973
G
Sub1
SUB1 regulator of transcription
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of SUB1 mRNA
CTD
PMID:16931933
NCBI chr 2:61,005,646...61,020,486
Ensembl chr 2:61,005,666...61,020,436 Ensembl chr 2:61,005,666...61,020,436
G
Tcea1
transcription elongation factor A1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of TCEA1 mRNA
CTD
PMID:15784690
NCBI chr 5:14,631,454...14,668,769
Ensembl chr 5:14,631,454...14,668,745 Ensembl chr15:14,631,454...14,668,745
G
Tgfb1
transforming growth factor, beta 1
decreases expression
ISO
Lamivudine results in decreased expression of TGFB1 protein
CTD
PMID:15309715
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Timm17b
translocase of inner mitochondrial membrane 17b
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of TIMM17B mRNA
CTD
PMID:18313992
NCBI chr X:14,596,330...14,603,491
Ensembl chr X:14,594,577...14,603,416
G
Timm23
translocase of inner mitochondrial membrane 23
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of TIMM23 mRNA
CTD
PMID:18313992
NCBI chr16:7,410,308...7,436,392
Ensembl chr16:7,409,688...7,436,379
G
Timp1
TIMP metallopeptidase inhibitor 1
decreases expression
ISO
Lamivudine results in decreased expression of TIMP1 protein
CTD
PMID:15309715
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Timp2
TIMP metallopeptidase inhibitor 2
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of TIMP2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of TIMP2 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of TIMP2 mRNA
CTD
PMID:16931933
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
G
Tk2
thymidine kinase 2
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of TK2 mRNA
CTD
PMID:18313992
NCBI chr19:708,859...731,786
Ensembl chr19:708,891...730,924
G
Tnf
tumor necrosis factor
multiple interactions
EXP
[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased expression of TNF protein; Zinc inhibits the reaction [[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased expression of TNF protein]
CTD
PMID:36309141
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Trib3
tribbles pseudokinase 3
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of TRIB3 mRNA
CTD
PMID:15784690
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
G
Trim42
tripartite motif-containing 42
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of TRIM42 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of TRIM42 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of TRIM42 mRNA
CTD
PMID:16931933
NCBI chr 8:97,902,349...97,923,268
Ensembl chr 8:97,902,353...97,923,268
G
Twnk
twinkle mtDNA helicase
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of TWNK mRNA
CTD
PMID:18313992
NCBI chr 1:243,867,568...243,874,802
Ensembl chr 1:243,868,330...243,874,802
G
Tyms
thymidylate synthetase
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of TYMS mRNA
CTD
PMID:15784690
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
G
Tyrp1
tyrosinase-related protein 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of TYRP1 mRNA
CTD
PMID:15784690
NCBI chr 5:95,280,982...95,299,516
Ensembl chr 5:95,280,982...95,299,516
G
Uqcrb
ubiquinol-cytochrome c reductase binding protein
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of UQCRB mRNA
CTD
PMID:18313992
NCBI chr 7:63,814,784...63,820,150
Ensembl chr 7:63,814,797...63,820,150
G
Uqcrc1
ubiquinol-cytochrome c reductase core protein 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of UQCRC1 mRNA
CTD
PMID:17526437 PMID:18313992
NCBI chr 8:109,589,735...109,601,481
Ensembl chr 8:109,589,706...109,601,480
G
Uqcrc2
ubiquinol cytochrome c reductase core protein 2
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of UQCRC2 mRNA
CTD
PMID:18313992
NCBI chr 1:175,167,933...175,198,499
Ensembl chr 1:175,167,894...175,199,453
G
Vdac1
voltage-dependent anion channel 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of VDAC1 mRNA
CTD
PMID:18313992
NCBI chr10:36,532,306...36,559,642
Ensembl chr10:36,532,244...36,559,640
G
Vdr
vitamin D receptor
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of VDR mRNA
CTD
PMID:11741158
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Vps4b
vacuolar protein sorting 4 homolog B
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in decreased expression of VPS4B mRNA
CTD
PMID:16931933
NCBI chr13:22,907,105...22,932,200
Ensembl chr13:22,907,109...22,932,229
G
Wars1
tryptophanyl-tRNA synthetase 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of WARS1 mRNA
CTD
PMID:15784690
NCBI chr 6:127,776,088...127,807,273
Ensembl chr 6:127,776,090...127,807,269
G
Wnt10a
Wnt family member 10A
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of WNT10A mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of WNT10A mRNA
CTD
PMID:16931933
NCBI chr 9:76,349,931...76,362,400
Ensembl chr 9:76,349,931...76,362,400
G
Yars1
tyrosyl-tRNA synthetase 1
multiple interactions
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of YARS1 mRNA
CTD
PMID:15784690
NCBI chr 5:141,535,815...141,564,029
Ensembl chr 5:141,535,759...141,563,833
G
Aars1
alanyl-tRNA synthetase 1
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of AARS mRNA
CTD
PMID:37748715
NCBI chr19:38,999,130...39,021,152
Ensembl chr19:38,999,163...39,021,147
G
Abcf3
ATP binding cassette subfamily F member 3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ABCF3 mRNA
CTD
PMID:37748715
NCBI chr11:80,340,476...80,352,211
Ensembl chr11:80,339,977...80,352,211
G
Ace
angiotensin I converting enzyme
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ACE mRNA
CTD
PMID:37748715
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Adap2
ArfGAP with dual PH domains 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ADAP2 mRNA
CTD
PMID:37748715
NCBI chr10:65,138,006...65,166,147
Ensembl chr10:65,138,020...65,165,604
G
Adgra2
adhesion G protein-coupled receptor A2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ADGRA2 mRNA
CTD
PMID:37748715
NCBI chr16:64,932,964...64,971,433
Ensembl chr16:64,933,315...64,971,483
G
Adgra3
adhesion G protein-coupled receptor A3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ADGRA3 mRNA
CTD
PMID:37748715
NCBI chr14:60,874,719...60,976,341
Ensembl chr14:60,874,715...60,976,332
G
Adgrg1
adhesion G protein-coupled receptor G1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ADGRG1 mRNA
CTD
PMID:37748715
NCBI chr19:10,003,963...10,041,122
Ensembl chr19:10,003,975...10,041,108
G
Akirin1
akirin 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of AKIRIN1 mRNA
CTD
PMID:37748715
NCBI chr 5:135,989,378...136,004,782
Ensembl chr 5:135,989,465...136,004,762
G
Aldh18a1
aldehyde dehydrogenase 18 family, member A1
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of ALDH18A1 mRNA
CTD
PMID:37748715
NCBI chr 1:239,375,657...239,407,956
Ensembl chr 1:239,375,669...239,407,890
G
Alkbh5
alkB homolog 5, RNA demethylase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ALKBH5 mRNA
CTD
PMID:37748715
NCBI chr10:45,344,888...45,366,331
Ensembl chr10:45,343,395...45,366,331
G
Apbb1ip
amyloid beta precursor protein binding family B member 1 interacting protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of APBB1IP mRNA
CTD
PMID:37748715
NCBI chr17:84,941,404...85,033,020
Ensembl chr17:84,982,243...85,033,010
G
Apela
apelin receptor early endogenous ligand
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of APELA mRNA
CTD
PMID:37748715
NCBI chr16:24,694,356...24,703,466
Ensembl chr16:24,694,324...24,703,465
G
Arih2
ariadne RBR E3 ubiquitin protein ligase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ARIH2 mRNA
CTD
PMID:37748715
NCBI chr 8:109,296,738...109,355,909
Ensembl chr 8:109,296,738...109,355,852
G
Arl14ep
ADP-ribosylation factor like GTPase 14 effector protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ARL14EP mRNA
CTD
PMID:37748715
NCBI chr 3:93,441,952...93,454,282
Ensembl chr 3:93,443,183...93,454,155
G
Arnt
aryl hydrocarbon receptor nuclear translocator
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ARNT mRNA
CTD
PMID:37748715
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
G
Arrdc4
arrestin domain containing 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ARRDC4 mRNA
CTD
PMID:37748715
NCBI chr 1:122,369,355...122,383,351
Ensembl chr 1:122,369,360...122,383,290
G
Asb8
ankyrin repeat and SOCS box-containing 8
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ASB8 mRNA
CTD
PMID:37748715
NCBI chr 7:129,261,397...129,297,492
Ensembl chr 7:129,261,397...129,297,485
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
increases expression multiple interactions
ISO
N(4)-hydroxycytidine results in increased expression of ASNS mRNA 4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of ASNS mRNA]
CTD
PMID:37748715
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
G
Ate1
arginyltransferase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ATE1 mRNA
CTD
PMID:37748715
NCBI chr 1:184,961,548...185,081,112
Ensembl chr 1:184,963,562...185,080,908
G
Atf2
activating transcription factor 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ATF2 mRNA
CTD
PMID:37748715
NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236
G
Atf3
activating transcription factor 3
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of ATF3 mRNA
CTD
PMID:37748715
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Atf4
activating transcription factor 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ATF4 mRNA
CTD
PMID:37748715
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
G
Atf5
activating transcription factor 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ATF5 mRNA
CTD
PMID:37748715
NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707
G
Atf6
activating transcription factor 6
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ATF6 mRNA
CTD
PMID:37748715
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
G
Aup1
AUP1, lipid droplet regulating VLDL assembly factor
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of AUP1 mRNA
CTD
PMID:37748715
NCBI chr 4:115,560,274...115,563,346
Ensembl chr 4:115,560,261...115,563,346
G
Avil
advillin
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of AVIL mRNA
CTD
PMID:37748715
NCBI chr 7:62,825,459...62,844,103
Ensembl chr 7:62,826,025...62,844,071
G
B3galnt1
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of B3GALNT1 mRNA
CTD
PMID:37748715
NCBI chr 2:153,847,297...153,877,371
Ensembl chr 2:153,846,474...153,877,332
G
Bbx
BBX high mobility group box domain containing
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of BBX mRNA
CTD
PMID:37748715
NCBI chr11:50,381,249...50,628,934
Ensembl chr11:50,381,247...50,623,251
G
Bglap
bone gamma-carboxyglutamate protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of BGLAP mRNA
CTD
PMID:37748715
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
G
Brms1l
BRMS1 like transcriptional repressor
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of BRMS1L mRNA
CTD
PMID:37748715
NCBI chr 6:73,266,673...73,300,630
Ensembl chr 6:73,266,691...73,300,631
G
Calml4
calmodulin-like 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CALML4 mRNA
CTD
PMID:37748715
NCBI chr 8:63,323,426...63,335,234
Ensembl chr 8:63,323,351...63,335,234
G
Carhsp1
calcium regulated heat stable protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CARHSP1 mRNA
CTD
PMID:37748715
NCBI chr10:6,946,036...6,960,556
Ensembl chr10:6,946,959...7,020,019
G
Carmil1
capping protein regulator and myosin 1 linker 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of LRRC16A mRNA
CTD
PMID:37748715
NCBI chr17:40,807,921...41,088,326
Ensembl chr17:40,808,389...41,088,326
G
Cars1
cysteinyl-tRNA synthetase 1
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of CARS mRNA
CTD
PMID:37748715
NCBI chr 1:198,753,689...198,796,016
Ensembl chr 1:198,753,691...198,795,941
G
Cbx7
chromobox 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CBX7 mRNA
CTD
PMID:37748715
NCBI chr 7:111,460,656...111,479,231
Ensembl chr 7:111,460,656...111,477,973
G
Ccnb2
cyclin B2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CCNB2 mRNA
CTD
PMID:37748715
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
G
Cd68
Cd68 molecule
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CD68 mRNA
CTD
PMID:37748715
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
G
Cdca3
cell division cycle associated 3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CDCA3 mRNA
CTD
PMID:37748715
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
G
Cebpg
CCAAT/enhancer binding protein gamma
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CEBPG mRNA
CTD
PMID:37748715
NCBI chr 1:87,683,060...87,692,772
Ensembl chr 1:87,684,019...87,694,569
G
Cep170
centrosomal protein 170
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CEP170 mRNA
CTD
PMID:37748715
NCBI chr13:88,669,672...88,754,011
Ensembl chr13:88,670,358...88,732,226
G
Chac1
ChaC glutathione-specific gamma-glutamylcyclotransferase 1
multiple interactions increases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of CHAC1 mRNA]
CTD
PMID:37748715
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
G
Coa7
cytochrome c oxidase assembly factor 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of COA7 mRNA
CTD
PMID:37748715
NCBI chr 5:123,069,356...123,080,942
Ensembl chr 5:123,069,371...123,080,199
G
Commd5
COMM domain containing 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of COMMD5 mRNA
CTD
PMID:37748715
NCBI chr 7:108,621,766...108,623,616
Ensembl chr 7:108,598,673...108,624,764
G
Cox6a2
cytochrome c oxidase subunit 6A2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of COX6A2 mRNA
CTD
PMID:37748715
NCBI chr 1:182,788,528...182,790,746
Ensembl chr 1:182,788,528...182,789,274
G
Cpt1a
carnitine palmitoyltransferase 1A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CPT1A mRNA
CTD
PMID:37748715
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
G
Cryzl1
crystallin zeta like 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CRYZL1 mRNA
CTD
PMID:37748715
NCBI chr11:30,933,140...30,977,936
Ensembl chr11:30,933,144...30,977,867
G
Csf3r
colony stimulating factor 3 receptor
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CSF3R mRNA
CTD
PMID:37748715
NCBI chr 5:138,298,605...138,318,224
Ensembl chr 5:138,301,506...138,317,881
G
Ctps2
CTP synthase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CTPS2 mRNA
CTD
PMID:37748715
NCBI chr X:31,645,873...31,786,733
Ensembl chr X:31,645,873...31,786,733
G
Cyb5b
cytochrome b5 type B
multiple interactions
ISO
[CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC1 protein] results in increased reduction of N(4)-hydroxycytidine; [CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC2 protein] results in increased reduction of N(4)-hydroxycytidine
CTD
PMID:22924387
NCBI chr19:35,062,871...35,096,741
Ensembl chr19:35,062,813...35,098,249
G
Cyb5r3
cytochrome b5 reductase 3
multiple interactions
ISO
[CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC1 protein] results in increased reduction of N(4)-hydroxycytidine; [CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC2 protein] results in increased reduction of N(4)-hydroxycytidine
CTD
PMID:22924387
NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298
G
Dcaf15
DDB1 and CUL4 associated factor 15
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DCAF15 mRNA
CTD
PMID:37748715
NCBI chr19:24,053,925...24,061,277
Ensembl chr19:24,053,925...24,061,277
G
Ddhd2
DDHD domain containing 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DDHD2 mRNA
CTD
PMID:37748715
NCBI chr16:66,319,469...66,349,025
Ensembl chr16:66,319,466...66,349,023
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions increases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of DDIT3 mRNA]
CTD
PMID:37748715
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Ddit4
DNA-damage-inducible transcript 4
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of DDIT4 mRNA
CTD
PMID:37748715
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
G
Ddx19b
DEAD-box helicase 19B
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DDX19B mRNA
CTD
PMID:37748715
NCBI chr19:38,968,215...38,998,907
Ensembl chr19:38,968,215...38,997,259
G
Ddx4
DEAD-box helicase 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DDX4 mRNA
CTD
PMID:37748715
NCBI chr 2:44,227,946...44,282,867
Ensembl chr 2:44,227,946...44,282,723
G
Def8
differentially expressed in FDCP 8 homolog
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DEF8 mRNA
CTD
PMID:37748715
NCBI chr19:51,474,783...51,495,638
Ensembl chr19:51,474,878...51,495,638
G
Dnajc5g
DnaJ heat shock protein family (Hsp40) member C5 gamma
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DNAJC5G mRNA
CTD
PMID:37748715
NCBI chr 6:25,260,087...25,264,251
Ensembl chr 6:25,260,088...25,264,152
G
Dnmt1
DNA methyltransferase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DNMT1 mRNA
CTD
PMID:37748715
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
G
Dusp11
dual specificity phosphatase 11
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DUSP11 mRNA
CTD
PMID:37748715
NCBI chr 4:118,367,673...118,385,183
Ensembl chr 4:118,368,053...118,385,181
G
Dusp16
dual specificity phosphatase 16
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DUSP16 mRNA
CTD
PMID:37748715
NCBI chr 4:167,546,780...167,630,173
Ensembl chr 4:167,548,155...167,629,980
G
Dusp19
dual specificity phosphatase 19
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DUSP19 mRNA
CTD
PMID:37748715
NCBI chr 3:65,538,424...65,554,465
Ensembl chr 3:65,538,420...65,553,534
G
Dynll1
dynein light chain LC8-type 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DYNLL1 mRNA
CTD
PMID:37748715
NCBI chr12:41,312,365...41,316,157
Ensembl chr12:41,312,367...41,314,741
G
Dyrk4
dual specificity tyrosine phosphorylation regulated kinase 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DYRK4 mRNA
CTD
PMID:37748715
NCBI chr 4:159,715,658...159,757,660
Ensembl chr 4:159,715,417...159,757,627
G
E2f8
E2F transcription factor 8
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of E2F8 mRNA
CTD
PMID:37748715
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of EIF4EBP1 mRNA
CTD
PMID:37748715
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
G
Elf1
E74 like ETS transcription factor 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ELF1 mRNA
CTD
PMID:37748715
NCBI chr15:54,890,644...54,986,721
Ensembl chr15:54,865,616...54,986,699
G
Emc9
ER membrane protein complex subunit 9
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of EMC9 mRNA
CTD
PMID:37748715
NCBI chr15:29,071,881...29,076,098
Ensembl chr15:29,071,883...29,076,098
G
Enpep
glutamyl aminopeptidase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ENPEP mRNA
CTD
PMID:37748715
NCBI chr 2:217,781,985...217,851,947
Ensembl chr 2:217,782,005...217,851,947
G
Epb41l5
erythrocyte membrane protein band 4.1 like 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of EPB41L5 mRNA
CTD
PMID:37748715
NCBI chr13:30,670,792...30,770,213
Ensembl chr13:30,669,764...30,768,360
G
Exosc6
exosome component 6
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of EXOSC6 mRNA
CTD
PMID:37748715
NCBI chr19:39,022,171...39,023,585
Ensembl chr19:39,022,183...39,023,515
G
Fam98a
family with sequence similarity 98, member A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FAM98A mRNA
CTD
PMID:37748715
NCBI chr 6:19,874,082...19,888,744
Ensembl chr 6:19,874,071...19,888,742
G
Fanca
FA complementation group A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FANCA mRNA
CTD
PMID:37748715
NCBI chr19:51,304,126...51,362,586
Ensembl chr19:51,304,021...51,362,527
G
Fbxl12
F-box and leucine-rich repeat protein 12
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FBXL12 mRNA
CTD
PMID:37748715
NCBI chr 8:19,175,864...19,183,373
Ensembl chr 8:19,160,352...19,183,607
G
Fbxo5
F-box protein 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FBXO5 mRNA
CTD
PMID:37748715
NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437
G
Fetub
fetuin B
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FETUB mRNA
CTD
PMID:37748715
NCBI chr11:78,082,158...78,093,022
Ensembl chr11:78,082,156...78,095,135
G
Fhip2b
FHF complex subunit HOOK interacting protein 2B
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FAM160B2 mRNA
CTD
PMID:37748715
NCBI chr15:45,656,641...45,674,603
Ensembl chr15:45,656,647...45,674,105
G
Foxk2
forkhead box K2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FOXK2 mRNA
CTD
PMID:37748715
NCBI chr10:106,542,643...106,592,569
Ensembl chr10:106,542,566...106,592,563
G
Fzd4
frizzled class receptor 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FZD4 mRNA
CTD
PMID:37748715
NCBI chr 1:143,279,934...143,288,799
Ensembl chr 1:143,280,065...143,285,724
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GADD45A mRNA
CTD
PMID:37748715
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gars1
glycyl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GARS mRNA
CTD
PMID:37748715
NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609
G
Gas2
growth arrest-specific 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GAS2 mRNA
CTD
PMID:37748715
NCBI chr 1:101,452,361...101,582,619
Ensembl chr 1:101,482,591...101,582,619
G
Gdf15
growth differentiation factor 15
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GDF15 mRNA
CTD
PMID:37748715
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
G
Gid4
GID complex subunit 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GID4 mRNA
CTD
PMID:37748715
NCBI chr10:45,221,556...45,247,627
Ensembl chr10:45,245,754...45,247,621 Ensembl chr10:45,245,754...45,247,621
G
Glb1
galactosidase, beta 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GLB1 mRNA
CTD
PMID:37748715
NCBI chr 8:114,085,508...114,158,127
Ensembl chr 8:114,085,508...114,158,127
G
Gpt2
glutamic--pyruvic transaminase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GPT2 mRNA
CTD
PMID:37748715
NCBI chr19:21,526,800...21,561,314
Ensembl chr19:21,517,621...21,560,610
G
Grb10
growth factor receptor bound protein 10
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of GRB10 mRNA
CTD
PMID:37748715
NCBI chr14:86,495,051...86,602,800
Ensembl chr14:86,495,054...86,602,806
G
Grcc10
gene rich cluster, C10 gene
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GRCC10 mRNA
CTD
PMID:37748715
NCBI chr 4:157,551,276...157,552,924
G
Hadha
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HADHA mRNA
CTD
PMID:37748715
NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
G
Hadhb
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HADHB mRNA
CTD
PMID:37748715
NCBI chr 6:26,153,572...26,187,668
Ensembl chr 6:26,153,578...26,184,869
G
Hax1
HCLS1 associated protein X-1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HAX1 mRNA
CTD
PMID:37748715
NCBI chr 2:175,434,242...175,437,926
Ensembl chr 2:175,434,238...175,437,714
G
Helz
helicase with zinc finger
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HELZ mRNA
CTD
PMID:37748715
NCBI chr10:92,479,403...92,645,234
Ensembl chr10:92,501,518...92,638,383
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
increases expression multiple interactions
ISO
N(4)-hydroxycytidine results in increased expression of HERPUD1 mRNA 4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of HERPUD1 mRNA]
CTD
PMID:37748715
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
G
Herpud2
HERPUD family member 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HERPUD2 mRNA
CTD
PMID:37748715
NCBI chr 8:23,573,374...23,618,380
Ensembl chr 8:23,573,379...23,617,874
G
Hexa
hexosaminidase subunit alpha
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HEXA mRNA
CTD
PMID:37748715
NCBI chr 8:59,936,526...59,961,654
Ensembl chr 8:59,936,660...59,962,013
G
Hexim1
HEXIM P-TEFb complex subunit 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HEXIM1 mRNA
CTD
PMID:37748715
NCBI chr10:88,062,808...88,064,920
Ensembl chr10:88,062,803...88,066,189
G
Hmox1
heme oxygenase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HMOX1 mRNA
CTD
PMID:37748715
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Iars1
isoleucyl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of IARS mRNA
CTD
PMID:37748715
NCBI chr17:14,940,919...14,987,277
Ensembl chr17:14,940,924...14,987,237
G
Id2
inhibitor of DNA binding 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ID2 mRNA
CTD
PMID:37748715
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
G
Inip
INTS3 and NABP interacting protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of INIP mRNA
CTD
PMID:37748715
NCBI chr 5:74,648,392...74,662,628
Ensembl chr 5:74,648,392...74,662,628
G
Irak1bp1
interleukin-1 receptor-associated kinase 1 binding protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of IRAK1BP1 mRNA
CTD
PMID:37748715
NCBI chr 8:83,731,512...83,748,289
Ensembl chr 8:83,731,507...83,748,289
G
Irf2bp2
interferon regulatory factor 2 binding protein 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of IRF2BP2 mRNA
CTD
PMID:37748715
NCBI chr19:54,559,417...54,565,096
Ensembl chr19:54,560,128...54,566,642
G
Jam3
junctional adhesion molecule 3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of JAM3 mRNA
CTD
PMID:37748715
NCBI chr 8:25,508,461...25,569,306
Ensembl chr 8:25,507,057...25,569,355
G
Jdp2
Jun dimerization protein 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of JDP2 mRNA
CTD
PMID:37748715
NCBI chr 6:105,261,619...105,302,386
Ensembl chr 6:105,261,373...105,301,485
G
Lgals1
galectin 1
multiple interactions decreases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in decreased expression of LGALS1 mRNA]
CTD
PMID:37748715
NCBI chr 7:110,485,239...110,488,345
Ensembl chr 7:110,481,392...110,488,345
G
Lig1
DNA ligase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of LIG1 mRNA
CTD
PMID:37748715
NCBI chr 1:74,165,688...74,204,400
Ensembl chr 1:74,165,842...74,204,413
G
Lrfn1
leucine rich repeat and fibronectin type III domain containing 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of LRFN1 mRNA
CTD
PMID:37748715
NCBI chr 1:83,742,442...83,761,450
Ensembl chr 1:83,682,964...83,761,449
G
Lyrm7
LYR motif containing 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of LYRM7 mRNA
CTD
PMID:37748715
NCBI chr10:38,964,299...38,983,628
Ensembl chr10:38,964,311...38,983,601
G
Map2k5
mitogen activated protein kinase kinase 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MAP2K5 mRNA
CTD
PMID:37748715
NCBI chr 8:63,625,220...63,852,090
Ensembl chr 8:63,625,221...63,851,983
G
Mapre3
microtubule-associated protein, RP/EB family, member 3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MAPRE3 mRNA
CTD
PMID:37748715
NCBI chr 6:25,513,800...25,558,876
Ensembl chr 6:25,513,800...25,558,881
G
Mcam
melanoma cell adhesion molecule
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MCAM mRNA
CTD
PMID:37748715
NCBI chr 8:44,479,391...44,487,575
Ensembl chr 8:44,479,376...44,487,571
G
Mdh1
malate dehydrogenase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MDH1 mRNA
CTD
PMID:37748715
NCBI chr14:95,630,625...95,645,920
Ensembl chr14:95,630,306...95,645,925
G
Midn
midnolin
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MIDN mRNA
CTD
PMID:37748715
NCBI chr 7:9,548,100...9,559,605
Ensembl chr 7:9,549,650...9,559,752
G
Mknk1
MAPK interacting serine/threonine kinase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MKNK1 mRNA
CTD
PMID:37748715
NCBI chr 5:129,318,128...129,357,641
Ensembl chr 5:129,318,170...129,357,639
G
Mob4
MOB family member 4, phocein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MOB4 mRNA
CTD
PMID:37748715
NCBI chr 9:56,617,374...56,641,336
Ensembl chr 9:56,617,368...56,641,329
G
Mrps12
mitochondrial ribosomal protein S12
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MRPS12 mRNA
CTD
PMID:37748715
NCBI chr 1:84,025,896...84,028,896
Ensembl chr 1:84,025,899...84,028,780
G
Mrps27
mitochondrial ribosomal protein S27
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MRPS27 mRNA
CTD
PMID:37748715
NCBI chr 2:30,740,007...30,808,577
Ensembl chr 2:30,740,033...30,808,577
G
Msmo1
methylsterol monooxygenase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MSMO1 mRNA
CTD
PMID:37748715
NCBI chr16:24,980,680...24,997,927
Ensembl chr16:24,980,697...24,998,016
G
Mt2A
metallothionein 2A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MT2 mRNA
CTD
PMID:37748715
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Mtarc1
mitochondrial amidoxime reducing component 1
multiple interactions
ISO
[CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC1 protein] results in increased reduction of N(4)-hydroxycytidine
CTD
PMID:22924387
NCBI chr13:96,324,377...96,362,677
Ensembl chr13:96,339,757...96,397,796
G
Mtarc2
mitochondrial amidoxime reducing component 2
multiple interactions
ISO
[CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC2 protein] results in increased reduction of N(4)-hydroxycytidine
CTD
PMID:22924387
NCBI chr13:96,362,810...96,397,284
G
Mtbp
MDM2 binding protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MTBP mRNA
CTD
PMID:37748715
NCBI chr 7:86,973,215...87,055,775
Ensembl chr 7:86,973,069...87,050,827
G
Mthfd1l
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MTHFD1L mRNA
CTD
PMID:37748715
NCBI chr 1:40,443,926...40,632,911
Ensembl chr 1:40,444,008...40,632,905
G
Mthfd2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
multiple interactions increases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of MTHFD2 mRNA]
CTD
PMID:37748715
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
G
Mtx1
Metaxin 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MTX1 mRNA
CTD
PMID:37748715
NCBI chr 2:174,615,460...174,621,383
Ensembl chr 2:174,615,461...174,620,982
G
Myc
MYC proto-oncogene, bHLH transcription factor
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MYC mRNA
CTD
PMID:37748715
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Nabp1
nucleic acid binding protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NABP1 mRNA
CTD
PMID:37748715
NCBI chr 9:50,098,552...50,133,982
Ensembl chr 9:50,126,726...50,134,107
G
Nars1
asparaginyl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NARS mRNA
CTD
PMID:37748715
NCBI chr18:57,989,308...58,005,584
Ensembl chr18:57,989,308...58,005,622
G
Ncapd2
non-SMC condensin I complex, subunit D2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NCAPD2 mRNA
CTD
PMID:37748715
NCBI chr 4:157,968,814...157,992,314
Ensembl chr 4:157,968,815...157,992,020
G
Ncapg
non-SMC condensin I complex, subunit G
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NCAPG mRNA
CTD
PMID:37748715
NCBI chr14:65,403,930...65,432,902
Ensembl chr14:65,404,163...65,432,902
G
Ncor1
nuclear receptor co-repressor 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NCOR1 mRNA
CTD
PMID:37748715
NCBI chr10:46,999,536...47,142,294
Ensembl chr10:46,999,536...47,141,032
G
Nectin1
nectin cell adhesion molecule 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PVRL1 mRNA
CTD
PMID:37748715
NCBI chr 8:44,101,776...44,164,863
Ensembl chr 8:44,101,776...44,189,787
G
Nsf
N-ethylmaleimide sensitive factor, vesicle fusing ATPase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NSF mRNA
CTD
PMID:37748715
NCBI chr10:88,727,912...88,857,375
Ensembl chr10:88,727,912...88,857,386
G
Nsun3
NOP2/Sun RNA methyltransferase 3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NSUN3 mRNA
CTD
PMID:37748715
NCBI chr11:37,490,832...37,575,607
Ensembl chr11:37,490,838...37,568,543
G
Ntaq1
N-terminal glutamine amidase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of WDYHV1 mRNA
CTD
PMID:37748715
NCBI chr 7:89,684,318...89,704,484
Ensembl chr 7:89,684,323...89,704,474
G
Nup85
nucleoporin 85
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NUP85 mRNA
CTD
PMID:37748715
NCBI chr10:100,806,482...100,825,029
Ensembl chr10:100,806,437...100,825,043
G
Nupr1
nuclear protein 1, transcriptional regulator
multiple interactions increases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of NUPR1 mRNA]
CTD
PMID:37748715
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
G
Nxf7
nuclear RNA export factor 7
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of NXF2 mRNA
CTD
PMID:37748715
NCBI chr X:98,535,374...98,552,562
Ensembl chr X:98,535,375...98,552,526
G
Ogdh
oxoglutarate dehydrogenase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of OGDH mRNA
CTD
PMID:37748715
NCBI chr14:81,150,021...81,217,479
Ensembl chr14:81,150,091...81,217,479
G
Oip5
Opa interacting protein 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of OIP5 mRNA
CTD
PMID:37748715
NCBI chr 3:106,593,746...106,603,281
Ensembl chr 3:106,593,760...106,603,250
G
Optn
optineurin
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of OPTN mRNA
CTD
PMID:37748715
NCBI chr17:73,209,572...73,260,251
Ensembl chr17:73,209,575...73,260,251
G
Osgepl1
O-sialoglycoprotein endopeptidase-like 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of OSGEPL1 mRNA
CTD
PMID:37748715
NCBI chr 9:48,214,995...48,229,440
Ensembl chr 9:48,215,402...48,229,388
G
P2rx3
purinergic receptor P2X 3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of P2RX3 mRNA
CTD
PMID:37748715
NCBI chr 3:70,080,850...70,124,664
Ensembl chr 3:70,080,851...70,125,178
G
P2rx7
purinergic receptor P2X 7
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of P2RX7 mRNA
CTD
PMID:37748715
NCBI chr12:33,889,709...33,934,168
Ensembl chr12:33,879,745...33,934,619
G
P4ha2
prolyl 4-hydroxylase subunit alpha 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of P4HA2 mRNA
CTD
PMID:37748715
NCBI chr10:38,243,136...38,271,983
Ensembl chr10:38,243,139...38,287,314
G
Pak2
p21 (RAC1) activated kinase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PAK2 mRNA
CTD
PMID:37748715
NCBI chr11:68,707,940...68,768,816
Ensembl chr11:68,707,969...68,768,816
G
Pde3a
phosphodiesterase 3A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PDE3A mRNA
CTD
PMID:37748715
NCBI chr 4:174,172,804...174,443,944
Ensembl chr 4:174,172,868...174,438,274
G
Pde4dip
phosphodiesterase 4D interacting protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PDE4DIP mRNA
CTD
PMID:37748715
NCBI chr 2:185,293,236...185,490,100
Ensembl chr 2:185,293,214...185,468,379
G
Pds5b
PDS5 cohesin associated factor B
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PDS5B mRNA
CTD
PMID:37748715
NCBI chr12:202,481...345,596
Ensembl chr12:255,313...345,596
G
Pex1
peroxisomal biogenesis factor 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PEX1 mRNA
CTD
PMID:37748715
NCBI chr 4:30,519,950...30,558,953
Ensembl chr 4:30,519,955...30,558,921
G
Pgam2
phosphoglycerate mutase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PGAM2 mRNA
CTD
PMID:37748715
NCBI chr14:80,681,796...80,683,907
Ensembl chr14:80,681,776...80,683,940
G
Pgp
phosphoglycolate phosphatase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PGP mRNA
CTD
PMID:37748715
NCBI chr10:13,495,232...13,497,858
Ensembl chr10:13,494,291...13,497,858
G
Pmch
pro-melanin-concentrating hormone
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PMCH mRNA
CTD
PMID:37748715
NCBI chr 7:22,511,934...22,513,250
Ensembl chr 7:22,511,934...22,513,250
G
Polr2a
RNA polymerase II subunit A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of POLR2A mRNA
CTD
PMID:37748715
NCBI chr10:54,452,438...54,478,486
Ensembl chr10:54,452,441...54,478,455
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PPP1R15A mRNA
CTD
PMID:37748715
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Ppp1r3c
protein phosphatase 1, regulatory subunit 3C
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PPP1R3C mRNA
CTD
PMID:37748715
NCBI chr 1:234,460,958...234,465,961
Ensembl chr 1:234,460,652...234,465,961
G
Psat1
phosphoserine aminotransferase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PSAT1 mRNA
CTD
PMID:37748715
NCBI chr 1:213,196,709...213,218,564
Ensembl chr 1:213,196,709...213,218,682
G
Psph
phosphoserine phosphatase
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of PSPH mRNA
CTD
PMID:37748715
NCBI chr12:26,882,524...26,905,084
Ensembl chr12:26,883,133...26,905,074
G
Ptk2
protein tyrosine kinase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PTK2 mRNA
CTD
PMID:37748715
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
G
Rab21
RAB21, member RAS oncogene family
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RAB21 mRNA
CTD
PMID:37748715
NCBI chr 7:50,904,050...50,928,890
Ensembl chr 7:50,904,057...50,928,839
G
Rabggta
Rab geranylgeranyltransferase subunit alpha
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RABGGTA mRNA
CTD
PMID:37748715
NCBI chr15:29,206,328...29,213,398
Ensembl chr15:29,206,157...29,213,348
G
Rad54l
RAD54 like
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RAD54L mRNA
CTD
PMID:37748715
NCBI chr 5:129,575,431...129,605,100
Ensembl chr 5:129,575,378...129,605,070
G
Reep6
receptor accessory protein 6
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of REEP6 mRNA
CTD
PMID:37748715
NCBI chr 7:9,373,927...9,380,845
Ensembl chr 7:9,373,927...9,380,597
G
Rfc2
replication factor C subunit 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RFC2 mRNA
CTD
PMID:37748715
NCBI chr12:22,120,449...22,133,576
Ensembl chr12:22,120,010...22,133,557
G
Rhbdd1
rhomboid domain containing 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RHBDD1 mRNA
CTD
PMID:37748715
NCBI chr 9:83,630,037...83,748,690
Ensembl chr 9:83,630,063...83,748,689
G
Rragc
Ras-related GTP binding C
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RRAGC mRNA
CTD
PMID:37748715
NCBI chr 5:136,148,239...136,167,773
Ensembl chr 5:136,148,276...136,167,767
G
Rspry1
ring finger and SPRY domain containing 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RSPRY1 mRNA
CTD
PMID:37748715
NCBI chr19:10,352,449...10,403,015
Ensembl chr19:10,353,821...10,401,102
G
Samm50
SAMM50 sorting and assembly machinery component
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SAMM50 mRNA
CTD
PMID:37748715
NCBI chr 7:115,317,472...115,341,682
Ensembl chr 7:115,317,404...115,341,682
G
Sars1
seryl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SARS mRNA
CTD
PMID:37748715
NCBI chr 2:196,065,543...196,081,240
Ensembl chr 2:196,065,430...196,081,277
G
Sema6a
semaphorin 6A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SEMA6A mRNA
CTD
PMID:37748715
NCBI chr18:40,050,623...40,171,954
Ensembl chr18:40,050,624...40,171,954
G
Sesn1
sestrin 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SESN1 mRNA
CTD
PMID:37748715
NCBI chr20:45,294,876...45,387,698
Ensembl chr20:45,294,871...45,387,697
G
Sesn2
sestrin 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SESN2 mRNA
CTD
PMID:37748715
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
G
Sh3tc1
SH3 domain and tetratricopeptide repeats 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SH3TC1 mRNA
CTD
PMID:37748715
NCBI chr14:75,005,691...75,050,001
Ensembl chr14:75,016,875...75,049,995
G
Shmt2
serine hydroxymethyltransferase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SHMT2 mRNA
CTD
PMID:37748715
NCBI chr 7:63,358,961...63,364,293
Ensembl chr 7:63,358,961...63,364,236
G
Ska2
spindle and kinetochore associated complex subunit 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SKA2 mRNA
CTD
PMID:37748715
NCBI chr10:71,921,474...71,939,461
Ensembl chr10:71,921,582...71,939,458
G
Slc1a4
solute carrier family 1 member 4
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of SLC1A4 mRNA
CTD
PMID:37748715
NCBI chr14:94,530,801...94,560,190
Ensembl chr14:94,529,084...94,560,418
G
Slc1a5
solute carrier family 1 member 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC1A5 mRNA
CTD
PMID:37748715
NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:77,456,694...77,470,952
G
Slc25a31
solute carrier family 25 member 31
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC25A31 mRNA
CTD
PMID:37748715
NCBI chr 2:123,695,387...123,711,275
Ensembl chr 2:123,695,408...123,710,795
G
Slc25a36
solute carrier family 25 member 36
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC25A36 mRNA
CTD
PMID:37748715
NCBI chr 8:97,659,848...97,693,735
Ensembl chr 8:97,662,127...97,693,703
G
Slc25a4
solute carrier family 25 member 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC25A4 mRNA
CTD
PMID:37748715
NCBI chr16:46,072,935...46,076,730
Ensembl chr16:46,072,939...46,076,733
G
Slc26a2
solute carrier family 26 member 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC26A2 mRNA
CTD
PMID:37748715
NCBI chr18:54,648,276...54,666,627
Ensembl chr18:54,652,951...54,666,626
G
Slc2a1
solute carrier family 2 member 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC2A1 mRNA
CTD
PMID:37748715
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
G
Slc35a4
solute carrier family 35, member A4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC35A4 mRNA
CTD
PMID:37748715
NCBI chr18:28,280,483...28,284,610
Ensembl chr18:28,279,750...28,284,725
G
Slc38a1
solute carrier family 38, member 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC38A1 mRNA
CTD
PMID:37748715
NCBI chr 7:127,733,230...127,802,541
Ensembl chr 7:127,738,226...127,802,218
G
Slc38a2
solute carrier family 38, member 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC38A2 mRNA
CTD
PMID:37748715
NCBI chr 7:127,851,267...127,863,482
Ensembl chr 7:127,851,267...127,863,436
G
Slc38a7
solute carrier family 38, member 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC38A7 mRNA
CTD
PMID:37748715
NCBI chr19:9,209,203...9,225,472
Ensembl chr19:9,209,257...9,225,454
G
Slc39a4
solute carrier family 39 member 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC39A4 mRNA
CTD
PMID:37748715
NCBI chr 7:108,333,368...108,337,553
Ensembl chr 7:108,333,381...108,337,553
G
Slc3a2
solute carrier family 3 member 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC3A2 mRNA
CTD
PMID:37748715
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
G
Slc44a4
solute carrier family 44, member 4
multiple interactions decreases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in decreased expression of SLC44A4 mRNA]
CTD
PMID:37748715
NCBI chr20:3,903,099...3,919,215
Ensembl chr20:3,903,099...3,919,215
G
Slc6a9
solute carrier family 6 member 9
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC6A9 mRNA
CTD
PMID:37748715
NCBI chr 5:131,374,562...131,408,733
Ensembl chr 5:131,374,542...131,408,728
G
Slc7a1
solute carrier family 7 member 1
multiple interactions increases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of SLC7A1 mRNA]
CTD
PMID:37748715
NCBI chr12:6,628,288...6,703,849
Ensembl chr12:6,628,007...6,703,849
G
Slc7a3
solute carrier family 7 member 3
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of SLC7A3 mRNA
CTD
PMID:37748715
NCBI chr X:66,210,071...66,216,482
Ensembl chr X:66,210,081...66,215,708
G
Slc7a5
solute carrier family 7 member 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC7A5 mRNA
CTD
PMID:37748715
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
G
Slc7a7
solute carrier family 7 member 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC7A7 mRNA
CTD
PMID:37748715
NCBI chr15:27,822,088...27,873,121
Ensembl chr15:27,822,091...27,865,648
G
Smcr8
SMCR8-C9orf72 complex subunit
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SMCR8 mRNA
CTD
PMID:37748715
NCBI chr10:45,457,962...45,465,101
Ensembl chr10:45,457,605...45,468,876
G
Smim22
small integral membrane protein 22
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SMIM22 mRNA
CTD
PMID:37748715
NCBI chr10:10,572,146...10,574,339
G
Snord1c
small nucleolar RNA, C/D box 1C
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SNORD1C mRNA
CTD
PMID:37748715
NCBI chr10:101,905,797...101,905,872
Ensembl chr10:101,905,797...101,905,872
G
Snx4
sorting nexin 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SNX4 mRNA
CTD
PMID:37748715
NCBI chr11:67,460,872...67,518,143
Ensembl chr11:67,460,870...67,518,174
G
Spag7
sperm associated antigen 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SPAG7 mRNA
CTD
PMID:37748715
NCBI chr10:55,377,249...55,383,404
Ensembl chr10:55,377,249...55,383,404
G
Sqle
squalene epoxidase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SQLE mRNA
CTD
PMID:37748715
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
G
Srxn1
sulfiredoxin 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SRXN1 mRNA
CTD
PMID:37748715
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
Stc2
stanniocalcin 2
multiple interactions increases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of STC2 mRNA]
CTD
PMID:37748715
NCBI chr10:16,251,046...16,260,815
Ensembl chr10:16,250,853...16,262,973
G
Stil
STIL, centriolar assembly protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of STIL mRNA
CTD
PMID:37748715
NCBI chr 5:128,520,837...128,573,732
Ensembl chr 5:128,520,953...128,573,730
G
Stx7
syntaxin 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of STX7 mRNA
CTD
PMID:37748715
NCBI chr 1:21,197,075...21,237,320
Ensembl chr 1:21,197,075...21,237,279
G
Svil
supervillin
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SVIL mRNA
CTD
PMID:37748715
NCBI chr17:52,648,502...52,844,114
Ensembl chr17:52,648,502...52,793,404
G
Sycp1
synaptonemal complex protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SYCP1 mRNA
CTD
PMID:37748715
NCBI chr 2:190,296,688...190,456,687
Ensembl chr 2:190,296,954...190,456,737
G
Tars1
threonyl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TARS mRNA
CTD
PMID:37748715
NCBI chr 2:60,368,893...60,387,715
Ensembl chr 2:60,367,796...60,387,717
G
Tas2r108
taste receptor, type 2, member 108
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TAS2R108 mRNA
CTD
PMID:37748715
NCBI chr 4:69,287,667...69,288,581
Ensembl chr 4:69,287,667...69,288,581
G
Tat
tyrosine aminotransferase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TAT mRNA
CTD
PMID:37748715
NCBI chr19:37,947,153...37,957,717
Ensembl chr19:37,947,112...37,958,031
G
Tbcc
tubulin folding cofactor C
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TBCC mRNA
CTD
PMID:37748715
NCBI chr 9:14,098,855...14,100,043
Ensembl chr 9:14,098,868...14,100,042
G
Tdg
thymine-DNA glycosylase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TDG mRNA
CTD
PMID:37748715
NCBI chr 7:21,077,853...21,097,617
Ensembl chr 7:21,077,853...21,097,567
G
Tec
tec protein tyrosine kinase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TEC mRNA
CTD
PMID:37748715
NCBI chr14:35,352,551...35,461,585
Ensembl chr14:35,352,829...35,461,557
G
Terf1
telomeric repeat binding factor 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TERF1 mRNA
CTD
PMID:37748715
NCBI chr 5:3,443,103...3,472,377
Ensembl chr 5:3,443,106...3,472,340
G
Thap4
THAP domain containing 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of THAP4 mRNA
CTD
PMID:37748715
NCBI chr 9:94,242,581...94,282,312
Ensembl chr 9:94,242,581...94,282,306
G
Tmppe
transmembrane protein with metallophosphoesterase domain
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TMPPE mRNA
CTD
PMID:37748715
NCBI chr 8:114,085,497...114,093,388
Ensembl chr 8:114,084,831...114,094,286
G
Top2a
DNA topoisomerase II alpha
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TOP2A mRNA
CTD
PMID:37748715
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
G
Tor1aip1
torsin 1A interacting protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TOR1AIP1 mRNA
CTD
PMID:37748715
NCBI chr13:68,196,681...68,226,121
Ensembl chr13:68,196,681...68,225,862
G
Tp53inp1
tumor protein p53 inducible nuclear protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TRP53INP1 mRNA
CTD
PMID:37748715
NCBI chr 5:24,253,986...24,272,250
Ensembl chr 5:24,260,568...24,267,968
G
Tpcn2
two pore segment channel 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TPCN2 mRNA
CTD
PMID:37748715
NCBI chr 1:200,416,538...200,446,252
Ensembl chr 1:200,416,540...200,446,236
G
Trib3
tribbles pseudokinase 3
increases expression multiple interactions
ISO
N(4)-hydroxycytidine results in increased expression of TRIB3 mRNA 4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of TRIB3 mRNA]
CTD
PMID:37748715
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
G
Trim32
tripartite motif-containing 32
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TRIM32 mRNA
CTD
PMID:37748715
NCBI chr 5:79,005,139...79,016,615
Ensembl chr 5:78,999,389...79,022,018
G
Trip12
thyroid hormone receptor interactor 12
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TRIP12 mRNA
CTD
PMID:37748715
NCBI chr 9:85,916,691...86,043,312
Ensembl chr 9:85,916,691...86,051,403
G
Trpm6
transient receptor potential cation channel, subfamily M, member 6
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TRPM6 mRNA
CTD
PMID:37748715
NCBI chr 1:216,136,407...216,320,523
Ensembl chr 1:216,170,038...216,320,520
G
Tubb5
tubulin, beta 5 class I
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TUBB5 mRNA
CTD
PMID:37748715
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
G
Tug1
taurine up-regulated 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TUG1 mRNA
CTD
PMID:37748715
NCBI chr14:78,519,894...78,526,927
Ensembl chr14:78,522,506...78,526,927
G
Txnip
thioredoxin interacting protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TXNIP mRNA
CTD
PMID:37748715
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
G
Ugdh
UDP-glucose 6-dehydrogenase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of UGDH mRNA
CTD
PMID:37748715
NCBI chr14:42,848,704...42,872,351
Ensembl chr14:42,848,854...42,872,354
G
Vangl1
VANGL planar cell polarity protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of VANGL1 mRNA
CTD
PMID:37748715
NCBI chr 2:189,586,681...189,637,609
Ensembl chr 2:189,589,229...189,637,619
G
Vegfa
vascular endothelial growth factor A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of VEGFA mRNA
CTD
PMID:37748715
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vtcn1
V-set domain containing T cell activation inhibitor 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of VTCN1 mRNA
CTD
PMID:37748715
NCBI chr 2:188,253,594...188,321,658
Ensembl chr 2:188,253,594...188,321,658
G
Yars1
tyrosyl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of YARS mRNA
CTD
PMID:37748715
NCBI chr 5:141,535,815...141,564,029
Ensembl chr 5:141,535,759...141,563,833
G
Yipf2
Yip1 domain family, member 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of YIPF2 mRNA
CTD
PMID:37748715
NCBI chr 8:20,141,148...20,145,349
Ensembl chr 8:20,141,155...20,145,339
G
Ypel5
yippee-like 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of YPEL5 mRNA
CTD
PMID:37748715
NCBI chr 6:22,656,284...22,671,741
Ensembl chr 6:22,656,285...22,671,691
G
Zfp516
zinc finger protein 516
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ZFP516 mRNA
CTD
PMID:37748715
NCBI chr18:76,286,453...76,386,526
Ensembl chr18:76,302,096...76,385,269
G
Zswim5
zinc finger, SWIM-type containing 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ZSWIM5 mRNA
CTD
PMID:37748715
NCBI chr 5:130,346,733...130,463,791
Ensembl chr 5:130,343,034...130,463,784
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases expression
ISO
Stavudine results in increased expression of ABCB1 mRNA
CTD
PMID:18310046
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Adipoq
adiponectin, C1Q and collagen domain containing
decreases expression
ISO
Stavudine results in decreased expression of ADIPOQ protein Stavudine results in decreased expression of ADIPOQ mRNA; Stavudine results in decreased expression of ADIPOQ protein
CTD
PMID:15865214 PMID:17503663 PMID:17668557
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Alb
albumin
affects binding
ISO
Stavudine binds to ALB protein
CTD
PMID:15814459 PMID:16336266
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Atp5f1e
ATP synthase F1 subunit epsilon
decreases expression
EXP
Stavudine results in decreased expression of ATP5F1E mRNA
CTD
PMID:18299183
NCBI chr 3:163,259,072...163,261,974
Ensembl chr 3:163,260,476...163,261,450
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
Stavudine results in decreased expression of BCL2 protein
CTD
PMID:9007205
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
increases expression
EXP
Stavudine results in increased expression of BCL2L1 mRNA
CTD
PMID:18299183
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Casp3
caspase 3
increases cleavage
ISO
Stavudine results in increased cleavage of CASP3 protein
CTD
PMID:32278789
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Ccl2
C-C motif chemokine ligand 2
increases expression
ISO
Stavudine results in increased expression of CCL2 protein
CTD
PMID:17668557
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
affects expression
ISO
Stavudine affects the expression of CDKN1A protein
CTD
PMID:18389896
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
affects expression
ISO
Stavudine affects the expression of CDKN2A protein
CTD
PMID:18389896
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
G
Cebpa
CCAAT/enhancer binding protein alpha
decreases expression
ISO
Stavudine results in decreased expression of CEBPA protein
CTD
PMID:15722030
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Cebpb
CCAAT/enhancer binding protein beta
increases expression
EXP
Stavudine results in increased expression of CEBPB mRNA
CTD
PMID:18299183
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
G
Chek1
checkpoint kinase 1
increases phosphorylation
ISO
Stavudine results in increased phosphorylation of CHEK1 protein
CTD
PMID:32278789
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
G
Cpt1a
carnitine palmitoyltransferase 1A
increases expression
ISO
Stavudine results in increased expression of CPT1A mRNA
CTD
PMID:14576092
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
G
Fasn
fatty acid synthase
multiple interactions decreases expression
ISO
[Stavudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of FASN mRNA; [Stavudine co-treated with Lamivudine] results in increased expression of FASN mRNA Stavudine results in decreased expression of FASN protein
CTD
PMID:11741158 PMID:15722030
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Fth1
ferritin heavy chain 1
increases expression
EXP
Stavudine results in increased expression of FTH1 mRNA
CTD
PMID:18299183
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
G
Gan
gigaxonin
decreases expression
ISO
Stavudine results in decreased expression of GAN mRNA; Stavudine results in decreased expression of GAN protein
CTD
PMID:19398414
NCBI chr19:45,207,783...45,265,066
Ensembl chr19:45,207,184...45,254,107
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression
EXP
Stavudine results in increased expression of GCLC mRNA
CTD
PMID:18299183
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gpx4
glutathione peroxidase 4
decreases expression
EXP
Stavudine results in decreased expression of GPX4 mRNA
CTD
PMID:18299183
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
G
Gsta1
glutathione S-transferase alpha 1
increases expression
EXP
Stavudine results in increased expression of GSTA1 mRNA
CTD
PMID:18299183
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
G
Gstp1
glutathione S-transferase pi 1
increases expression
EXP
Stavudine results in increased expression of GSTP1 mRNA
CTD
PMID:18299183
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Hfe
homeostatic iron regulator
multiple interactions
ISO
HFE gene SNP affects the susceptibility to [Didanosine co-treated with Stavudine]
CTD
PMID:16847405
NCBI chr17:41,413,451...41,421,502
Ensembl chr17:41,413,451...41,421,502
G
Hspd1
heat shock protein family D (Hsp60) member 1
affects expression
ISO
Stavudine affects the expression of HSPD1 protein
CTD
PMID:27041070
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
G
Igfbp1
insulin-like growth factor binding protein 1
increases expression
EXP
Stavudine results in increased expression of IGFBP1 mRNA
CTD
PMID:18299183
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
G
Il1b
interleukin 1 beta
increases expression
ISO
Stavudine results in increased expression of IL1B protein
CTD
PMID:17668557
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
increases expression
ISO
Stavudine results in increased expression of IL6 protein
CTD
PMID:17668557
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
Stavudine results in increased expression of JUN mRNA
CTD
PMID:18299183
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Lep
leptin
decreases expression
ISO
Stavudine results in decreased expression of LEP protein
CTD
PMID:17668557
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lonp1
lon peptidase 1, mitochondrial
affects expression
ISO
Stavudine affects the expression of LONP1 protein
CTD
PMID:27041070
NCBI chr 9:1,447,444...1,459,771
Ensembl chr 9:1,447,447...1,459,771
G
Lpl
lipoprotein lipase
multiple interactions
ISO
[Stavudine co-treated with Lamivudine co-treated with Indinavir] affects the expression of LPL mRNA; [Stavudine co-treated with Lamivudine co-treated with Nelfinavir] results in decreased expression of LPL mRNA; [Stavudine co-treated with Lamivudine] affects the expression of LPL mRNA
CTD
PMID:11741158
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Mapk8
mitogen-activated protein kinase 8
decreases phosphorylation
ISO
Stavudine results in decreased phosphorylation of MAPK8 protein
CTD
PMID:27041070
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Me1
malic enzyme 1
multiple interactions increases expression
ISO
[Stavudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ME1 mRNA; [Stavudine co-treated with Lamivudine co-treated with Nelfinavir] results in decreased expression of ME1 mRNA; [Stavudine co-treated with Lamivudine] results in increased expression of ME1 mRNA Stavudine results in increased expression of ME1 mRNA
CTD
PMID:11741158
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
G
Mttp
microsomal triglyceride transfer protein
multiple interactions decreases expression
EXP
Carnitine inhibits the reaction [Stavudine results in decreased expression of MTTP mRNA]
CTD
PMID:18299183
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
G
Nrf1
nuclear respiratory factor 1
increases expression
ISO
Stavudine results in increased expression of NRF1 mRNA
CTD
PMID:17926646
NCBI chr 4:58,664,932...58,772,328
Ensembl chr 4:58,664,957...58,825,328
G
Pcna
proliferating cell nuclear antigen
increases expression decreases expression
EXP ISO
Stavudine results in increased expression of PCNA mRNA Stavudine results in decreased expression of PCNA protein
CTD
PMID:18299183 PMID:32278789
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pparg
peroxisome proliferator-activated receptor gamma
decreases expression
ISO
Stavudine results in decreased expression of PPARG mRNA Stavudine results in decreased expression of PPARG mRNA; Stavudine results in decreased expression of PPARG protein
CTD
PMID:14518702 PMID:15722030 PMID:17926646
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases expression
ISO
Stavudine results in decreased expression of PTGS2 protein
CTD
PMID:18389896
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Sirt3
sirtuin 3
increases expression
ISO
Stavudine results in increased expression of SIRT3 protein
CTD
PMID:27041070
NCBI chr 1:195,942,066...195,964,472
Ensembl chr 1:195,942,073...195,964,808
G
Slc25a19
solute carrier family 25 member 19
multiple interactions
ISO
SLC25A19 protein affects the susceptibility to [Stavudine co-treated with Lamivudine co-treated with Indinavir]
CTD
PMID:15951836
NCBI chr10:100,853,554...100,867,517
Ensembl chr10:100,847,168...100,867,447
G
Slc25a5
solute carrier family 25 member 5
increases expression
EXP
Stavudine results in increased expression of SLC25A5 mRNA
CTD
PMID:18299183
NCBI chr X:116,031,896...116,034,963
Ensembl chr X:116,031,803...116,034,967
G
Slc29a3
solute carrier family 29 member 3
affects transport
ISO
SLC29A3 protein affects the transport of Stavudine
CTD
PMID:19164483
NCBI chr20:28,645,265...28,685,388
Ensembl chr20:28,647,391...28,685,388
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions increases expression
EXP
Carnitine inhibits the reaction [Stavudine results in increased expression of SREBF1 mRNA]
CTD
PMID:18299183
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Stat3
signal transducer and activator of transcription 3
decreases expression
EXP
Stavudine results in decreased expression of STAT3 mRNA
CTD
PMID:18299183
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Tfap2a
transcription factor AP-2 alpha
decreases expression
ISO
Stavudine results in decreased expression of TFAP2A mRNA
CTD
PMID:17926646
NCBI chr17:24,028,716...24,047,507
Ensembl chr17:24,024,432...24,047,507
G
Tnf
tumor necrosis factor
increases expression
ISO
Stavudine results in increased expression of TNF protein
CTD
PMID:17668557
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tymp
thymidine phosphorylase
increases expression
ISO
Stavudine results in increased expression of TYMP protein
CTD
PMID:16457948
NCBI chr 7:120,438,768...120,444,088
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
G
Ucp1
uncoupling protein 1
decreases expression increases expression
ISO
Stavudine results in decreased expression of UCP1 mRNA Stavudine results in increased expression of UCP1
CTD
PMID:16038477 PMID:17926646
NCBI chr19:24,808,782...24,816,853
Ensembl chr19:24,808,783...24,816,852
G
Ucp2
uncoupling protein 2
decreases expression
ISO
Stavudine results in decreased expression of UCP2 mRNA
CTD
PMID:14518702
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
G
Ucp3
uncoupling protein 3
decreases expression
ISO
Stavudine results in decreased expression of UCP3 mRNA
CTD
PMID:14518702
NCBI chr 1:154,815,777...154,828,764
Ensembl chr 1:154,815,777...154,828,762
G
Abcb4
ATP binding cassette subfamily B member 4
decreases activity
ISO
Tenofovir results in decreased activity of ABCB4 protein
CTD
PMID:28437613
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
G
Acacb
acetyl-CoA carboxylase beta
affects expression
ISO
Tenofovir affects the expression of ACACB mRNA
CTD
PMID:20032539
NCBI chr12:42,365,800...42,477,651
Ensembl chr12:42,366,548...42,457,655
G
Bnip3l
BCL2 interacting protein 3 like
increases expression
ISO
Tenofovir results in increased expression of BNIP3L protein
CTD
PMID:23640862
NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803
G
Casp3
caspase 3
multiple interactions
EXP
[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased activity of CASP3 protein; Zinc inhibits the reaction [[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased activity of CASP3 protein]
CTD
PMID:36309141
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cat
catalase
multiple interactions
EXP
[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in decreased activity of CAT protein
CTD
PMID:34118364
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl20
C-C motif chemokine ligand 20
increases expression multiple interactions
ISO
Tenofovir results in increased expression of CCL20 mRNA Tenofovir results in increased expression of and results in increased secretion of CCL20 protein
CTD
PMID:24205323
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions increases expression
ISO
[Emtricitabine co-treated with Tenofovir] results in increased expression of CDKN1A protein Tenofovir results in increased expression of CDKN1A protein
CTD
PMID:31545371
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases activity
ISO
Tenofovir results in decreased activity of CYP2E1 protein
CTD
PMID:17162464
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Ddx3y
DEAD box helicase 3, Y-linked
increases expression
EXP
Tenofovir results in increased expression of DDX3Y mRNA
CTD
PMID:37852574
NCBI chr Y:1,115,095...1,135,754
Ensembl chr Y:1,116,309...1,135,706
G
Edn1
endothelin 1
increases secretion multiple interactions
ISO
Tenofovir results in increased secretion of EDN1 protein coenzyme Q10 inhibits the reaction [Tenofovir results in increased secretion of EDN1 protein]
CTD
PMID:23640862
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
affects phosphorylation
ISO
Tenofovir affects the phosphorylation of EIF2S1 protein
CTD
PMID:27041070
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
G
Fgb
fibrinogen beta chain
decreases expression
EXP
Tenofovir results in decreased expression of FGB mRNA
CTD
PMID:37852574
NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979
G
Gjc2
gap junction protein, gamma 2
increases expression
EXP
Tenofovir results in increased expression of GJC2 mRNA
CTD
PMID:37852574
NCBI chr10:43,962,642...43,971,358
Ensembl chr10:43,962,642...43,970,467
G
Havcr1
hepatitis A virus cellular receptor 1
increases secretion multiple interactions
ISO
Tenofovir results in increased secretion of HAVCR1 protein Tenofovir inhibits the reaction [cidofovir results in increased secretion of HAVCR1 protein]
CTD
PMID:29738843
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Hsd11b1
hydroxysteroid 11-beta dehydrogenase 1
affects expression
ISO
Tenofovir affects the expression of HSD11B1 mRNA
CTD
PMID:20032539
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
G
Hspd1
heat shock protein family D (Hsp60) member 1
affects expression
ISO
Tenofovir affects the expression of HSPD1 protein
CTD
PMID:27041070
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
G
Il1b
interleukin 1 beta
multiple interactions
EXP
[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased expression of IL1B protein; Zinc inhibits the reaction [[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased expression of IL1B protein]
CTD
PMID:36309141
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Irf4
interferon regulatory factor 4
decreases expression
EXP
Tenofovir results in decreased expression of IRF4 mRNA
CTD
PMID:37852574
NCBI chr17:33,721,800...33,742,570
Ensembl chr17:33,721,811...33,740,070
G
Kdm5d
lysine demethylase 5D
increases expression
EXP
Tenofovir results in increased expression of KDM5D mRNA
CTD
PMID:37852574
NCBI chr Y:527,069...624,019
Ensembl chr Y:530,401...624,018
G
Klf15
KLF transcription factor 15
decreases expression
EXP
Tenofovir results in decreased expression of KLF15 mRNA
CTD
PMID:37852574
NCBI chr 4:122,965,718...122,978,403
Ensembl chr 4:122,965,807...122,978,374
G
Lipe
lipase E, hormone sensitive type
affects expression
ISO
Tenofovir affects the expression of LIPE mRNA
CTD
PMID:20032539
NCBI chr 1:80,965,612...80,984,313
Ensembl chr 1:80,965,627...80,984,310
G
Lonp1
lon peptidase 1, mitochondrial
affects expression
ISO
Tenofovir affects the expression of LONP1 protein
CTD
PMID:27041070
NCBI chr 9:1,447,444...1,459,771
Ensembl chr 9:1,447,447...1,459,771
G
Lpin1
lipin 1
decreases expression
EXP
Tenofovir results in decreased expression of LPIN1 mRNA
CTD
PMID:37852574
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
G
Mapk8
mitogen-activated protein kinase 8
affects phosphorylation
ISO
Tenofovir affects the phosphorylation of MAPK8 protein
CTD
PMID:27041070
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mpo
myeloperoxidase
multiple interactions
EXP
[efavirenz co-treated with Lamivudine co-treated with Tenofovir] promotes the reaction [[isoniazid, pyrazinamide, rifampin drug combination co-treated with Ethambutol] results in increased activity of MPO protein]; [efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased activity of MPO protein
CTD
PMID:34118364
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Mt-co2
mitochondrially encoded cytochrome c oxidase II
multiple interactions
ISO
Tenofovir promotes the reaction [Didanosine results in decreased expression of COX2 mRNA]
CTD
PMID:16940060
NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689
Ensembl chr MT:7,006...7,689
G
Nfkbia
NFKB inhibitor alpha
decreases expression
EXP
Tenofovir results in decreased expression of NFKBIA protein
CTD
PMID:27899301
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nos2
nitric oxide synthase 2
increases expression
EXP
Tenofovir results in increased expression of NOS2 mRNA; Tenofovir results in increased expression of NOS2 protein
CTD
PMID:27899301
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
multiple interactions decreases phosphorylation
ISO
coenzyme Q10 inhibits the reaction [Tenofovir results in decreased phosphorylation of NOS3 protein]
CTD
PMID:23640862
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
affects expression
ISO
Tenofovir affects the expression of NR3C1 mRNA
CTD
PMID:20032539
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Nt5e
5' nucleotidase, ecto
increases expression
ISO
Tenofovir results in increased expression of NT5E mRNA
CTD
PMID:24205323
NCBI chr 8:89,271,046...89,314,918
Ensembl chr 8:89,270,696...89,314,881
G
Nt5m
5',3'-nucleotidase, mitochondrial
decreases expression
ISO
Tenofovir results in decreased expression of NT5M mRNA
CTD
PMID:24205323
NCBI chr10:44,652,845...44,680,549
Ensembl chr10:44,652,975...44,679,150
G
Pparg
peroxisome proliferator-activated receptor gamma
affects expression
ISO
Tenofovir affects the expression of PPARG mRNA
CTD
PMID:20032539
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Prkn
parkin RBR E3 ubiquitin protein ligase
multiple interactions
ISO
[Emtricitabine co-treated with Tenofovir] results in decreased expression of PRKN protein
CTD
PMID:31545371
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression
EXP
Tenofovir results in increased expression of PTGS2 mRNA; Tenofovir results in increased expression of PTGS2 protein
CTD
PMID:27899301
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions affects localization increases expression
EXP
Melatonin inhibits the reaction [Tenofovir affects the localization of RELA protein]; Melatonin inhibits the reaction [Tenofovir results in increased expression of and results in increased activity of RELA protein]; Melatonin inhibits the reaction [Tenofovir results in increased expression of RELA mRNA]; Tenofovir results in increased expression of and results in increased activity of RELA protein
CTD
PMID:27899301
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Sirt3
sirtuin 3
increases expression
ISO
Tenofovir results in increased expression of SIRT3 protein
CTD
PMID:27041070
NCBI chr 1:195,942,066...195,964,472
Ensembl chr 1:195,942,073...195,964,808
G
Slc22a6
solute carrier family 22 member 6
increases response to substance increases import multiple interactions
ISO
SLC22A6 protein results in increased susceptibility to Tenofovir SLC22A6 protein results in increased import of Tenofovir Probenecid inhibits the reaction [SLC22A6 protein results in increased susceptibility to Tenofovir]; SLC22A6 protein results in increased uptake of and results in increased susceptibility to Tenofovir; Tenofovir inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]
CTD
PMID:23856525 PMID:25448811 PMID:29738843
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
G
Slc22a8
solute carrier family 22 member 8
increases response to substance increases import
ISO
SLC22A8 protein results in increased susceptibility to Tenofovir SLC22A8 protein results in increased import of Tenofovir
CTD
PMID:25448811 PMID:29738843
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Tnf
tumor necrosis factor
decreases expression multiple interactions increases expression
ISO EXP
Tenofovir results in decreased expression of TNF mRNA [efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased expression of TNF protein; Zinc inhibits the reaction [[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased expression of TNF protein] Tenofovir results in increased expression of TNF mRNA; Tenofovir results in increased expression of TNF protein
CTD
PMID:24205323 PMID:27899301 PMID:36309141
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
multiple interactions increases expression
ISO
[Emtricitabine co-treated with Tenofovir] results in increased expression of TP53 protein Tenofovir results in increased expression of TP53 protein
CTD
PMID:31545371
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Usp18
ubiquitin specific peptidase 18
increases expression
EXP
Tenofovir results in increased expression of USP18 mRNA
CTD
PMID:37852574
NCBI chr 4:154,471,634...154,499,154
Ensembl chr 4:154,471,592...154,499,144
G
Akt1
AKT serine/threonine kinase 1
decreases phosphorylation
ISO
triciribine results in decreased phosphorylation of AKT1 protein
CTD
PMID:20857426
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Akt2
AKT serine/threonine kinase 2
decreases phosphorylation
ISO
triciribine results in decreased phosphorylation of AKT2 protein
CTD
PMID:20857426
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
triciribine inhibits the reaction [Ursodeoxycholic Acid inhibits the reaction [Nitroprusside affects the localization of BAX protein]]
CTD
PMID:22178905
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Casp3
caspase 3
multiple interactions increases expression
ISO
triciribine promotes the reaction [[epothilone A co-treated with Metformin] results in increased expression of CASP3 mRNA] triciribine results in increased expression of CASP3 mRNA
CTD
PMID:29117515
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
ISO
triciribine inhibits the reaction [1-nitropyrene results in increased stability of CYP1A1 mRNA]
CTD
PMID:19961161
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Fshb
follicle stimulating hormone subunit beta
decreases activity
ISO
triciribine results in decreased activity of FSHB protein
CTD
PMID:23254195
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
G
H2ax
H2A.X variant histone
increases expression
ISO
triciribine results in increased expression of H2AX mRNA
CTD
PMID:29117515
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
Hras
HRas proto-oncogene, GTPase
multiple interactions
ISO
triciribine inhibits the reaction [HRAS protein results in increased activity of MMP2 protein]
CTD
PMID:23877152
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
G
Ins2
insulin 2
multiple interactions
ISO
triciribine inhibits the reaction [INS protein results in decreased susceptibility to sodium arsenite]
CTD
PMID:25982963
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
G
Mmp2
matrix metallopeptidase 2
multiple interactions
ISO
triciribine inhibits the reaction [HRAS protein results in increased activity of MMP2 protein]
CTD
PMID:23877152
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Nos2
nitric oxide synthase 2
multiple interactions
EXP
triciribine inhibits the reaction [Mevinphos results in increased expression of NOS2 protein]
CTD
PMID:24462917
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions increases expression
ISO
triciribine inhibits the reaction [epothilone A results in increased expression of PARP1 mRNA]; triciribine promotes the reaction [[epothilone A co-treated with Metformin] results in increased expression of PARP1 mRNA] triciribine results in increased expression of PARP1 mRNA
CTD
PMID:29117515
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Phb1
prohibitin 1
increases expression
EXP
triciribine results in increased expression of PHB1 protein
CTD
PMID:23254195
NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP
triciribine inhibits the reaction [Mevinphos results in increased activity of RELA protein]
CTD
PMID:24462917
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Casp3
caspase 3
multiple interactions
ISO
CA 074 methyl ester inhibits the reaction [Trifluridine results in increased cleavage of CASP3 protein]; Trifluridine results in increased cleavage of and results in increased activity of CASP3 protein
CTD
PMID:19816940
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
increases cleavage
ISO
Trifluridine results in increased cleavage of CASP8 protein
CTD
PMID:19816940
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases cleavage
ISO
Trifluridine results in increased cleavage of CASP9 protein
CTD
PMID:19816940
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ctsb
cathepsin B
increases cleavage multiple interactions
ISO
Trifluridine results in increased cleavage of CTSB protein CA 074 methyl ester inhibits the reaction [Trifluridine results in increased cleavage of CTSB protein]
CTD
PMID:19816940
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
ISO
[Trifluridine results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA
CTD
PMID:25455453
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Esr2
estrogen receptor 2
multiple interactions
ISO
Trifluridine inhibits the reaction [Estradiol results in increased activity of ESR2 protein]
CTD
PMID:30818834
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Esrra
estrogen related receptor, alpha
multiple interactions
ISO
Trifluridine inhibits the reaction [XCT790 results in decreased activity of ESRRA protein]
CTD
PMID:30818834
NCBI chr 1:204,104,100...204,114,182
Ensembl chr 1:204,104,101...204,114,268
G
Nfe2l2
NFE2 like bZIP transcription factor 2
increases activity
ISO
Trifluridine results in increased activity of NFE2L2 protein
CTD
PMID:30818834
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases activity multiple interactions
ISO
Trifluridine results in increased activity of NR1I2 protein [Trifluridine results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA
CTD
PMID:25455453
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
multiple interactions
ISO
Trifluridine inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased activity of NR1I3 protein]
CTD
PMID:30818834
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
Trifluridine results in increased cleavage of PARP1 protein
CTD
PMID:19816940
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Tp53
tumor protein p53
affects activity
ISO
Trifluridine affects the activity of TP53 protein
CTD
PMID:35435491
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all